1 00:00:05,640 --> 00:00:08,400 I'D LIKE TO WELCOME THE MEMBERS 2 00:00:08,400 --> 00:00:11,520 OF THE NATIONAL CANCER ADVISORY 3 00:00:11,520 --> 00:00:14,320 BOARD, OFFICIAL MEMBERS, 4 00:00:14,320 --> 00:00:15,840 PRESIDENT'S CANCER PANEL 5 00:00:15,840 --> 00:00:17,240 MEMBERS, STAFF, AND GUESTS. 6 00:00:17,240 --> 00:00:20,920 MEMBERS OF THE PUBLIC WHO MAY 7 00:00:20,920 --> 00:00:22,960 WISH TO EXPRESS THEIR VIEWS 8 00:00:22,960 --> 00:00:24,040 REGARDING ANY ITEMS DISCUSSED 9 00:00:24,040 --> 00:00:26,520 DURING THIS MEETING MAY DO SO BY 10 00:00:26,520 --> 00:00:30,640 WRITING DR. PAULETTE GRAY, THE 11 00:00:30,640 --> 00:00:31,520 EXECUTIVE SECRETARY OF THE BOARD 12 00:00:31,520 --> 00:00:34,560 WITHIN TEN DAYS OF THE MEETING. 13 00:00:34,560 --> 00:00:35,760 ANY WRITTEN STATEMENTS OR 14 00:00:35,760 --> 00:00:36,560 QUESTIONS SUBMITTED BY MEMBERS 15 00:00:36,560 --> 00:00:39,520 OF THE PUBLIC WILL RECEIVE 16 00:00:39,520 --> 00:00:40,600 CAREFUL CONSIDERATION. 17 00:00:40,600 --> 00:00:43,000 BOARD MEMBERS, I WANT TO REMIND 18 00:00:43,000 --> 00:00:47,040 YOU THAT YOU MUST ABSENT 19 00:00:47,040 --> 00:00:48,240 YOURSELVES VIRTUALLY WHEN YOUR 20 00:00:48,240 --> 00:00:49,960 PARTICIPATION IN DELIBERATIONS 21 00:00:49,960 --> 00:00:51,480 ON A PARTICULAR PRODUCT, 22 00:00:51,480 --> 00:00:53,240 PROGRAM, OR OTHER SPECIFIC 23 00:00:53,240 --> 00:00:54,680 MATTER WOULD CONSTITUTE CONFLICT 24 00:00:54,680 --> 00:00:56,160 OF INTEREST OR CREATE APPEARANCE 25 00:00:56,160 --> 00:00:57,280 OF ONE. 26 00:00:57,280 --> 00:00:59,400 IT IS INCUMBENT UPON YOU TO 27 00:00:59,400 --> 00:01:01,320 ADVISE THE EXECUTIVE SECRETARY, 28 00:01:01,320 --> 00:01:05,640 DR. GRAY, AND ABSTAIN FROM ANY 29 00:01:05,640 --> 00:01:07,400 PARTICIPATION, DISCUSSION, OR 30 00:01:07,400 --> 00:01:08,280 ACTIONS REGARDING THOSE MATTERS. 31 00:01:08,280 --> 00:01:11,560 IN LIGHT OF THE CURRENT POLICIES 32 00:01:11,560 --> 00:01:12,200 GOVERN CONFLICT OF INTEREST 33 00:01:12,200 --> 00:01:16,800 BASED ON FINANCIAL HOLDINGS OF 34 00:01:16,800 --> 00:01:17,400 SPECIAL GOVERNMENT EMPLOYEES 35 00:01:17,400 --> 00:01:19,520 INCLUDING ALL MEMBERS OF THE 36 00:01:19,520 --> 00:01:23,400 BOARD WE MUST DEPEND ON YOU TO 37 00:01:23,400 --> 00:01:24,560 VOLUNTARY ABSENT YOURSELF ON 38 00:01:24,560 --> 00:01:26,240 MATTERS THAT COULD IMPACT THE 39 00:01:26,240 --> 00:01:27,640 STATUS OF THOSE HOLDINGS. 40 00:01:27,640 --> 00:01:31,120 WE TRUST YOUR JUDGMENT IN THESE 41 00:01:31,120 --> 00:01:31,880 INSTANCES. 42 00:01:31,880 --> 00:01:34,080 DURING ANY CLOSED SESSION, ANY 43 00:01:34,080 --> 00:01:36,920 MATERIALS OR DISCUSSIONS OF 44 00:01:36,920 --> 00:01:38,040 CONFIDENTIAL NATURE, DELIBERATED 45 00:01:38,040 --> 00:01:40,920 ON TODAY, ARE PRIVILEGED 46 00:01:40,920 --> 00:01:41,520 INFORMATION. 47 00:01:41,520 --> 00:01:44,680 AND ARE MADE AVAILABLE TO YOU ON 48 00:01:44,680 --> 00:01:45,880 A NEED-TO-KNOW BASIS, SUCH 49 00:01:45,880 --> 00:01:46,800 DELIBERATIONS ARE PRIVATE AND 50 00:01:46,800 --> 00:01:50,880 CONTENT SHOULD NOT BE DIVULGED. 51 00:01:50,880 --> 00:01:52,440 SO, THE FUTURE MEETINGS, DATES 52 00:01:52,440 --> 00:01:53,720 OF FUTURE MEETINGS WERE PROVIDED 53 00:01:53,720 --> 00:01:57,960 TO ALL OF YOU AND ARE LISTED ON 54 00:01:57,960 --> 00:01:59,560 THE AGENDA. 55 00:01:59,560 --> 00:02:03,640 ALSO, WE NEED TO APPROVE THE 56 00:02:03,640 --> 00:02:12,920 JUNE 14-15, 2022 JOINT BSA NCAB 57 00:02:12,920 --> 00:02:13,440 VIRTUAL MEETING SUMMARY. 58 00:02:13,440 --> 00:02:15,960 I'D LIKE TO CALL FOR A MOTION TO 59 00:02:15,960 --> 00:02:18,720 APPROVE THE MEETING SUMMARY. 60 00:02:18,720 --> 00:02:20,080 PLEASE UNMUTE IF YOU WOULD LIKE 61 00:02:20,080 --> 00:02:22,600 TO MAKE A MOTION. 62 00:02:22,600 --> 00:02:24,040 >> I MOVE. 63 00:02:24,040 --> 00:02:25,480 >> SECOND? 64 00:02:25,480 --> 00:02:25,800 >> SECOND. 65 00:02:25,800 --> 00:02:26,440 >> SECOND. 66 00:02:26,440 --> 00:02:28,560 >> PROPERLY MOVED AND SECONDED. 67 00:02:28,560 --> 00:02:30,120 TO APPROVE THE MEETING MINUTES, 68 00:02:30,120 --> 00:02:31,240 LET'S VOTE. 69 00:02:31,240 --> 00:02:36,080 ARE THERE ANY NAYS? 70 00:02:36,080 --> 00:02:37,280 ANY ABSTENTION? 71 00:02:37,280 --> 00:02:38,800 PAULETTE, WE HAVE UNANIMOUS VOTE 72 00:02:38,800 --> 00:02:43,120 TO APPROVE. 73 00:02:43,120 --> 00:02:43,640 >> AGREED. 74 00:02:43,640 --> 00:02:45,840 >> BY LAW, A QUORUM OF BOARD 75 00:02:45,840 --> 00:02:47,240 MEMBERS IS REQUIRED FOR EACH 76 00:02:47,240 --> 00:02:49,880 INSTANCE IN WHICH A VOTE MAY 77 00:02:49,880 --> 00:02:51,560 OCCUR, WHETHER IN OPEN OR CLOSED 78 00:02:51,560 --> 00:02:53,760 SESSION, DURING THIS MEETING A 79 00:02:53,760 --> 00:02:55,040 MINIMUM OF TEN APPOINTED MEMBERS 80 00:02:55,040 --> 00:02:58,200 MUST BE PRESENT TO VOICE THEIR 81 00:02:58,200 --> 00:02:58,600 VOTES. 82 00:02:58,600 --> 00:03:00,240 SINCE WE CAN'T PREDICT THE TIME 83 00:03:00,240 --> 00:03:01,720 OR OCCURRENCE OF ANY MOTION, 84 00:03:01,720 --> 00:03:03,840 YOUR PRESENCE IN THE VIRTUAL 85 00:03:03,840 --> 00:03:06,640 ROOM FOR ALL SEGMENTS OF THE 86 00:03:06,640 --> 00:03:07,760 MEETINGS IS A MUST. 87 00:03:07,760 --> 00:03:11,960 PAULETTE, DO WE HAVE A QUORUM? 88 00:03:11,960 --> 00:03:14,760 >> YES. 89 00:03:14,760 --> 00:03:15,520 >> GREAT. 90 00:03:15,520 --> 00:03:18,720 SO, ALSO, FOR EVERYONE 91 00:03:18,720 --> 00:03:21,640 PARTICIPATING IN THE MEETING, 92 00:03:21,640 --> 00:03:24,040 PLEASE, IN ORDER TO MAKE SURE WE 93 00:03:24,040 --> 00:03:25,160 DON'T HAVE ANY INTERRUPTIONS 94 00:03:25,160 --> 00:03:28,080 PLEASE MAKE SURE THAT YOU'RE 95 00:03:28,080 --> 00:03:28,560 MUTED. 96 00:03:28,560 --> 00:03:31,600 AND REMAIN SO UNTIL RECOGNIZED 97 00:03:31,600 --> 00:03:33,120 BY EITHER MYSELF, PAULETTE, 98 00:03:33,120 --> 00:03:37,040 DOUG, OR WHOEVER THE SPEAKER IS. 99 00:03:37,040 --> 00:03:39,240 SO, WE CAN NOW OPEN TODAY'S 100 00:03:39,240 --> 00:03:41,880 MEETINGS BASED ON OUR CURRENT 101 00:03:41,880 --> 00:03:45,560 AGENDA, A REPORT FROM THE ACTING 102 00:03:45,560 --> 00:03:50,800 NCI DIRECTOR, DR. DOUG LOWY. 103 00:03:50,800 --> 00:03:51,280 DOUG? 104 00:03:51,280 --> 00:03:52,280 >> JOHN, THANK YOU VERY MUCH. 105 00:03:52,280 --> 00:03:54,200 I WOULD LIKE TO WELCOME EVERYONE 106 00:03:54,200 --> 00:03:56,720 FROM THE NATIONAL CANCER 107 00:03:56,720 --> 00:03:57,440 ADVISORY BOARD. 108 00:03:57,440 --> 00:04:00,640 WE REALIZE THIS IS THE END OF 109 00:04:00,640 --> 00:04:04,360 AUGUST, IT IS BEFORE LABOR DAY, 110 00:04:04,360 --> 00:04:07,320 AND GREATLY APPRECIATE YOUR 111 00:04:07,320 --> 00:04:09,040 ACTIVE PARTICIPATION TODAY. 112 00:04:09,040 --> 00:04:11,160 IN ADDITION, FOR THOSE PEOPLE 113 00:04:11,160 --> 00:04:13,400 WHO ARE NOT MEMBERS OF THE NCAB, 114 00:04:13,400 --> 00:04:18,280 THANK YOU VERY MUCH FOR YOUR 115 00:04:18,280 --> 00:04:19,880 INTEREST IN LISTENING ON THIS 116 00:04:19,880 --> 00:04:20,480 IMPORTANT MEETING. 117 00:04:20,480 --> 00:04:31,040 IF I COULD HAVE THE FIRST SLIDE 118 00:04:32,240 --> 00:04:32,400 PLEASE. 119 00:04:32,400 --> 00:04:33,720 I ENTITLED THIS PRESENTATION 120 00:04:33,720 --> 00:04:37,000 ENDING CANCER AS WE KNOW IT FOR 121 00:04:37,000 --> 00:04:39,880 ALL, WHICH REALLY TAKES AS ITS 122 00:04:39,880 --> 00:04:42,600 TITLE WHAT PRESIDENT BIDEN HAS 123 00:04:42,600 --> 00:04:46,400 SAID ON MORE THAN ONE OCCASION. 124 00:04:46,400 --> 00:04:48,280 AND I'M GOING TO -- IF I COULD 125 00:04:48,280 --> 00:04:52,000 HAVE THE SECOND SLIDE. 126 00:04:52,000 --> 00:04:54,200 I'M GOING TO TALK ABOUT A NUMBER 127 00:04:54,200 --> 00:05:00,920 OF DIFFERENT ISSUES, BUT 128 00:05:00,920 --> 00:05:02,120 ULTIMATELY THEY REALLY ARE ABOUT 129 00:05:02,120 --> 00:05:03,960 TRYING TO IMPROVE THE OUTLOOK 130 00:05:03,960 --> 00:05:06,000 FOR PEOPLE WITH CANCER, AND TO 131 00:05:06,000 --> 00:05:08,400 THE EXTENT POSSIBLE FOR CANCER 132 00:05:08,400 --> 00:05:11,160 NOT TO HAPPEN AT ALL. 133 00:05:11,160 --> 00:05:16,520 I'M GOING TO GO OVER SOME NCI 134 00:05:16,520 --> 00:05:17,040 NEWS. 135 00:05:17,040 --> 00:05:21,160 THEN TALK ABOUT SCIENTIFIC 136 00:05:21,160 --> 00:05:22,480 UPDATES, CANCER MOONSHOT, AND 137 00:05:22,480 --> 00:05:25,320 FREDERICK NATIONAL LAB PROGRAMS. 138 00:05:25,320 --> 00:05:28,320 THESE WILL BE HIGH-LEVEL VIEWS 139 00:05:28,320 --> 00:05:32,680 FOR EACH OF THESE AREAS, AND I 140 00:05:32,680 --> 00:05:36,240 PLAN TO LEAVE ENOUGH TIME FOR 141 00:05:36,240 --> 00:05:37,680 NCAB MEMBERS TO FEEL COMFORTABLE 142 00:05:37,680 --> 00:05:43,280 IF THEY WANT TO ASK QUESTIONS 143 00:05:43,280 --> 00:05:45,000 AND/OR MAKE COMMENTS. 144 00:05:45,000 --> 00:05:47,560 LET'S GET TO SOME NCI NEWS, 145 00:05:47,560 --> 00:05:56,080 WHICH MANY OF YOU ARE AWARE THAT 146 00:05:56,080 --> 00:05:57,200 MONICA BERTINOLLI THIS MONTH WAS 147 00:05:57,200 --> 00:05:59,880 NAMED BY THE WHITE HOUSE TO 148 00:05:59,880 --> 00:06:09,280 BECOME THE NEW NCI DIRECTOR. 149 00:06:09,280 --> 00:06:11,840 SHE'S AN OUTSTANDING 150 00:06:11,840 --> 00:06:18,400 PHYSICIAN-SCIENTIST, SURGICAL 151 00:06:18,400 --> 00:06:20,280 ONCOLOGIST, FROM HARVARD, WE DO 152 00:06:20,280 --> 00:06:21,680 NOT KNOW EXACTLY WHEN SHE WILL 153 00:06:21,680 --> 00:06:23,000 BE APPOINTED. 154 00:06:23,000 --> 00:06:23,880 THE VETTING PROCESS TAKES A 155 00:06:23,880 --> 00:06:26,400 CERTAIN AMOUNT OF TIME BUT WE'RE 156 00:06:26,400 --> 00:06:30,280 LOOKING FORWARD TO HER ASSUMING 157 00:06:30,280 --> 00:06:34,800 THE LEADERSHIP ROLE OF THE NCI, 158 00:06:34,800 --> 00:06:36,240 AND AS MANY OF YOU ARE ALREADY 159 00:06:36,240 --> 00:06:40,320 AWARE SHE WILL BE THE FIRST 160 00:06:40,320 --> 00:06:46,520 WOMAN AS THE NCI DIRECTOR. 161 00:06:46,520 --> 00:06:48,880 NEXT SLIDE PLEASE. 162 00:06:48,880 --> 00:06:51,000 I WANTED TO HIGHLIGHT THAT WE 163 00:06:51,000 --> 00:06:52,800 ARE GOING TO -- WE PLAN TO 164 00:06:52,800 --> 00:06:55,840 PUBLISH IN A COUPLE OF WEEKS THE 165 00:06:55,840 --> 00:07:00,840 ANNUAL PLAN AND THE BUDGET 166 00:07:00,840 --> 00:07:04,480 PROPOSAL FOR FY 24, REFERRED TO 167 00:07:04,480 --> 00:07:07,520 AS THE BYPASS BUDGET. 168 00:07:07,520 --> 00:07:10,520 WE ARE ALWAYS A YEAR AHEAD WITH 169 00:07:10,520 --> 00:07:11,840 PUBLISHING THE BUDGET. 170 00:07:11,840 --> 00:07:16,040 LAST YEAR WAS THE FY23 BUDGET, 171 00:07:16,040 --> 00:07:18,800 AND AS YOU WILL HEAR IN MORE 172 00:07:18,800 --> 00:07:24,400 DETAIL FROM M.K. HOLOHAN, FY 23 173 00:07:24,400 --> 00:07:31,960 IS A MERE FIVE WEEKS AWAY FROM 174 00:07:31,960 --> 00:07:34,840 TODAY, WHEN IT WILL START. 175 00:07:34,840 --> 00:07:37,400 FY 24 THEREFORE WON'T BE 176 00:07:37,400 --> 00:07:39,120 STARTING FOR 13 MONTHS. 177 00:07:39,120 --> 00:07:42,520 IN ADDITION TO THE BUDGET 178 00:07:42,520 --> 00:07:43,480 PROPOSAL, WE'RE GOING TO, AS 179 00:07:43,480 --> 00:07:48,120 WE'VE DONE IN THE PAST, 180 00:07:48,120 --> 00:07:49,480 HIGHLIGHT SEVERAL SCIENTIFIC 181 00:07:49,480 --> 00:07:49,960 OPPORTUNITIES. 182 00:07:49,960 --> 00:07:53,440 THIS IS NOT INTENDED TO BE 183 00:07:53,440 --> 00:07:53,760 COMPREHENSIVE. 184 00:07:53,760 --> 00:07:56,560 INSTEAD, IT IS SIMPLY TRYING TO 185 00:07:56,560 --> 00:08:00,800 TALK ABOUT AREAS WHERE WE SEE 186 00:08:00,800 --> 00:08:02,960 IMPORTANT NEEDS AS WELL AS 187 00:08:02,960 --> 00:08:03,280 OPPORTUNITIES. 188 00:08:03,280 --> 00:08:06,600 THEN THE FOUR AREAS THAT WILL BE 189 00:08:06,600 --> 00:08:09,760 HIGHLIGHTED THIS YEAR ARE 190 00:08:09,760 --> 00:08:11,760 MULTI-CANCER DETECTION TESTS, 191 00:08:11,760 --> 00:08:13,360 UNDRUGGABLE TARGETS, WHICH I 192 00:08:13,360 --> 00:08:16,440 THINK REALLY ARE BECOMING 193 00:08:16,440 --> 00:08:20,840 PROGRESSIVELY FEWER AND FEWER, 194 00:08:20,840 --> 00:08:22,480 CELL THERAPY, AND PERSISTENT 195 00:08:22,480 --> 00:08:26,840 POVERTY BECAUSE OF ITS EXTREME 196 00:08:26,840 --> 00:08:29,160 ASSOCIATION WITH CANCER 197 00:08:29,160 --> 00:08:30,240 DISPARITIES. 198 00:08:30,240 --> 00:08:31,600 NEXT SLIDE PLEASE. 199 00:08:31,600 --> 00:08:33,080 THIS IS THE ONE BUDGET SLIDE 200 00:08:33,080 --> 00:08:34,840 THAT I HAVE. 201 00:08:34,840 --> 00:08:36,840 M.K. HOLOHAN WILL GO INTO THINGS 202 00:08:36,840 --> 00:08:38,800 IN MORE DETAIL. 203 00:08:38,800 --> 00:08:41,640 I ACTUALLY SHOWED THIS SLIDE 204 00:08:41,640 --> 00:08:45,480 BACK IN JUNE, AND IT WAS TO TRY 205 00:08:45,480 --> 00:08:49,160 TO ESSENTIALLY SAY THAT WE THINK 206 00:08:49,160 --> 00:08:51,600 THAT THE BUDGET FOR F.Y. 23, 207 00:08:51,600 --> 00:08:55,000 ALTHOUGH IT HAS NOT YET BEEN 208 00:08:55,000 --> 00:08:57,960 ENACTED, IF IT FOLLOWS OTHER 209 00:08:57,960 --> 00:09:01,680 YEARS IT WILL BE SUBSTANTIALLY 210 00:09:01,680 --> 00:09:03,600 HIGHER THAN THE PRESIDENT'S 211 00:09:03,600 --> 00:09:07,400 BUDGET THAT WAS ANNOUNCED FOR 212 00:09:07,400 --> 00:09:09,840 FY23, AND, AGAIN, YOU'LL HEAR 213 00:09:09,840 --> 00:09:16,840 FROM M.K. HOLOHAN THAT THE HOUSE 214 00:09:16,840 --> 00:09:21,320 IS $466 MILLION HIGHER AND THE 215 00:09:21,320 --> 00:09:22,520 PARTIAL SENATE MARK IS $290 216 00:09:22,520 --> 00:09:23,160 MILLION HIGHER. 217 00:09:23,160 --> 00:09:26,760 WE DO NOT KNOW WHERE IT WILL 218 00:09:26,760 --> 00:09:28,760 EVENTUALLY LAND OR WHEN THERE 219 00:09:28,760 --> 00:09:32,680 WILL BE A FULL YEAR BUDGET. 220 00:09:32,680 --> 00:09:33,440 NEXT SLIDE. 221 00:09:33,440 --> 00:09:40,600 SO, GETTING TO SOME OF THE 222 00:09:40,600 --> 00:09:43,560 SCIENCE, THIS PAPER THAT WAS 223 00:09:43,560 --> 00:09:45,560 PUBLISHED FROM THE INTRAMURAL 224 00:09:45,560 --> 00:09:48,440 PROGRAM, DIVISION OF CANCER 225 00:09:48,440 --> 00:09:52,840 EPIDEMIOLOGY AND GENETICS, LOOKS 226 00:09:52,840 --> 00:09:55,040 AT ALL CAUSE MORTALITY AND THE 227 00:09:55,040 --> 00:09:56,960 ASSOCIATION WITH PHYSICAL 228 00:09:56,960 --> 00:09:58,080 ACTIVITY. 229 00:09:58,080 --> 00:10:01,960 AND THERE ARE REALLY TWO 230 00:10:01,960 --> 00:10:03,600 IMPORTANT PARTS TO THIS AREA 231 00:10:03,600 --> 00:10:06,360 THAT I WANTED TO HIGHLIGHT. 232 00:10:06,360 --> 00:10:11,800 THE FIRST IS THAT IT IS AMONG 233 00:10:11,800 --> 00:10:14,320 OLDER ADULTS 59 TO 82, AVERAGE 234 00:10:14,320 --> 00:10:16,480 AGE WAS 70. 235 00:10:16,480 --> 00:10:22,040 THEY WERE FOLLOWED FOR MORE THAN 236 00:10:22,040 --> 00:10:23,000 TEN YEARS. 237 00:10:23,000 --> 00:10:25,320 THE SECOND POINT, THEY LOOKED AT 238 00:10:25,320 --> 00:10:26,800 DIFFERENT KINDS OF PHYSICAL 239 00:10:26,800 --> 00:10:30,000 ACTIVITY, AND NOT SHOWN IN THIS 240 00:10:30,000 --> 00:10:32,200 SLIDE BUT THE PAPER, THE 241 00:10:32,200 --> 00:10:35,680 CITATION FOR THE PAPER IS SHOWN 242 00:10:35,680 --> 00:10:39,400 ON THE BOTTOM, WATTS, ET AL., 243 00:10:39,400 --> 00:10:43,760 REALLY SHOWED THAT THE MORTALITY 244 00:10:43,760 --> 00:10:44,760 RATES WERE RELATIVELY 245 00:10:44,760 --> 00:10:48,000 INDEPENDENT OF TYPE OF PHYSICAL 246 00:10:48,000 --> 00:10:51,600 ACTIVITY BUT INSTEAD REALLY 247 00:10:51,600 --> 00:10:56,880 DEPENDED ON THE AMOUNT OF 248 00:10:56,880 --> 00:10:58,800 PHYSICAL ACTIVITY, AS SHOWN IN 249 00:10:58,800 --> 00:11:00,080 THE GRAPH. 250 00:11:00,080 --> 00:11:03,920 WHAT THEY USE AS THE METRIC IS 251 00:11:03,920 --> 00:11:06,520 WHAT'S CALLED NET OR METABOLIC 252 00:11:06,520 --> 00:11:09,160 EQUIVALENT OF TASK. 253 00:11:09,160 --> 00:11:12,640 IT'S A MORE PRECISE MEASURE THAN 254 00:11:12,640 --> 00:11:15,240 JUST NUMBER OF MINUTES, BUT TO 255 00:11:15,240 --> 00:11:18,320 TRANSLATE THAT, IF YOU'RE 256 00:11:18,320 --> 00:11:21,680 WALKING AT 20 MINUTES PER MILE 257 00:11:21,680 --> 00:11:26,440 OR 3 MILES PER HOUR THAT'S 3 258 00:11:26,440 --> 00:11:26,880 METs. 259 00:11:26,880 --> 00:11:29,880 IF YOU DO FIVE HOURS OF WALKING, 260 00:11:29,880 --> 00:11:34,160 OF 3 MILES AN HOUR PER WEEK, 261 00:11:34,160 --> 00:11:37,680 THAT MEETS THE GOAL OF 15 MET. 262 00:11:37,680 --> 00:11:42,480 AND 7 1/2 IS HALF OF THAT. 263 00:11:42,480 --> 00:11:44,840 THERE'S A SUBSTANTIAL DECREASE 264 00:11:44,840 --> 00:11:48,760 IN MORTALITY RATE WHETHER IT'S 265 00:11:48,760 --> 00:11:55,520 CANCER MORTALITY, ALL-CAUSE 266 00:11:55,520 --> 00:11:56,480 MORTALITY, OR CARDIOVASCULAR 267 00:11:56,480 --> 00:11:58,440 MORTALITY, BUT WHAT'S REALLY 268 00:11:58,440 --> 00:11:59,040 IMPORTANT THE COMPARATOR, 269 00:11:59,040 --> 00:12:03,400 BASICALLY THE PEOPLE THAT DIDN'T 270 00:12:03,400 --> 00:12:03,920 EXERCISE. 271 00:12:03,920 --> 00:12:05,920 SO, IT'S EXERCISING RATHER THAN 272 00:12:05,920 --> 00:12:08,320 THE TYPE OF EXERCISE THAT'S MOST 273 00:12:08,320 --> 00:12:09,920 IMPORTANT, AND IF PEOPLE DO MORE 274 00:12:09,920 --> 00:12:13,280 THAN ONE TYPE OF EXERCISE THAT'S 275 00:12:13,280 --> 00:12:13,760 GREAT. 276 00:12:13,760 --> 00:12:16,560 BUT FINDING SOMETHING THAT YOU 277 00:12:16,560 --> 00:12:23,600 FEEL COMFORTABLE DOING IS A WAY 278 00:12:23,600 --> 00:12:24,240 OF LIVING LONGER. 279 00:12:24,240 --> 00:12:24,560 NEXT SLIDE. 280 00:12:24,560 --> 00:12:29,200 THIS IS IN THE AREA OF CANCER 281 00:12:29,200 --> 00:12:36,320 TREATMENT WHERE THIS IS AN 282 00:12:36,320 --> 00:12:38,680 EXTENSION OF KEYNOTE 355 TRIAL 283 00:12:38,680 --> 00:12:43,600 PUBLISHED LAST MONTH, THIS IS AN 284 00:12:43,600 --> 00:12:47,480 INTERNATIONAL TRIAL WHICH 285 00:12:47,480 --> 00:12:50,480 BASICALLY SHOWS A SURVIVAL 286 00:12:50,480 --> 00:12:54,240 BENEFIT AFTER APPROXIMATELY 3 287 00:12:54,240 --> 00:12:57,280 1/2 YEARS OF THE TRIAL FOR WOMEN 288 00:12:57,280 --> 00:12:58,800 WITH ADVANCED TRIPLE NEGATIVE 289 00:12:58,800 --> 00:13:04,280 BREAST CANCER WHO HAVE HIGHER 290 00:13:04,280 --> 00:13:09,000 LEVELS OF PD-1 USING A 291 00:13:09,000 --> 00:13:11,080 COMBINATION OF STANDARD 292 00:13:11,080 --> 00:13:13,360 CHEMOTHERAPY, PLUS 293 00:13:13,360 --> 00:13:17,520 PEMBROLIZUMAB. 294 00:13:17,520 --> 00:13:19,120 I THINK IT'S IMPORTANT THERE ARE 295 00:13:19,120 --> 00:13:21,480 SO MANY WOMEN WHO HAVE 296 00:13:21,480 --> 00:13:23,040 TRIPLE-NEGATIVE BREAST CANCER 297 00:13:23,040 --> 00:13:26,280 AND WE DON'T HAVE AS MUCH TO 298 00:13:26,280 --> 00:13:29,160 OFFER THEM AS WE HAVE FOR OTHER 299 00:13:29,160 --> 00:13:33,440 KINDS OF BREAST CANCER. 300 00:13:33,440 --> 00:13:36,800 NEXT SLIDE PLEASE. 301 00:13:36,800 --> 00:13:39,800 THIS SLIDE REALLY HIGHLIGHTS A 302 00:13:39,800 --> 00:13:41,640 TOBACCO CONTROL MONOGRAPH, WHICH 303 00:13:41,640 --> 00:13:44,680 IS FOCUSED ON THE AREA OF 304 00:13:44,680 --> 00:13:47,960 SMOKING CESSATION IN CANCER 305 00:13:47,960 --> 00:13:48,520 PATIENTS. 306 00:13:48,520 --> 00:13:52,280 AND THE EVIDENCE BECOMES 307 00:13:52,280 --> 00:13:54,320 PROGRESSIVELY STRONGER THAT IF 308 00:13:54,320 --> 00:13:57,800 PATIENTS ARE CURRENT SMOKERS AND 309 00:13:57,800 --> 00:14:01,200 THEY DEVELOP CANCER, THEIR 310 00:14:01,200 --> 00:14:04,200 OUTCOME, AS A GROUP, WILL BE 311 00:14:04,200 --> 00:14:07,520 BETTER IF THEY STOP SMOKING. 312 00:14:07,520 --> 00:14:10,120 AND THIS IS SOMETHING THAT 313 00:14:10,120 --> 00:14:16,880 CLEARLY AT THE CANCER CENTERS WE 314 00:14:16,880 --> 00:14:19,840 ARE STRIVING TO HAVE AS REALLY 315 00:14:19,840 --> 00:14:25,560 STANDARD OF CARE AT ALL OF THE 316 00:14:25,560 --> 00:14:26,200 NCI-DESIGNATED CANCER CENTERS. 317 00:14:26,200 --> 00:14:29,360 BUT WE WANT TO MAKE SURE THAT 318 00:14:29,360 --> 00:14:31,280 THIS PRACTICE GETS WIDELY 319 00:14:31,280 --> 00:14:33,360 DISSEMINATED FOR THE MANY 320 00:14:33,360 --> 00:14:36,280 PATIENTS WHO ARE TREATED OUTSIDE 321 00:14:36,280 --> 00:14:38,880 OF THE MAJOR CANCER CENTERS, AND 322 00:14:38,880 --> 00:14:42,240 I THINK THAT THE QUOTE HERE ON 323 00:14:42,240 --> 00:14:43,600 THE BOTTOM RECTANGLE, IT'S NEVER 324 00:14:43,600 --> 00:14:46,800 TOO LATE TO QUIT SMOKING, AND 325 00:14:46,800 --> 00:14:49,680 THERE ARE CLEAR BENEFITS FOR 326 00:14:49,680 --> 00:14:51,200 QUITTING SMOKING REGARDLESS OF 327 00:14:51,200 --> 00:14:53,800 CANCER TYPE. 328 00:14:53,800 --> 00:14:57,600 NEXT SLIDE. 329 00:14:57,600 --> 00:14:59,360 AND THIS SLIDE IS REALLY 330 00:14:59,360 --> 00:15:01,560 CONTINUING GOOD NEWS WHERE WE 331 00:15:01,560 --> 00:15:03,320 OFTEN LOOK AT WHAT'S HAPPENING 332 00:15:03,320 --> 00:15:05,880 WITH MORTALITY RATES WITH 333 00:15:05,880 --> 00:15:06,960 MORTALITY RATES GOING DOWN, BUT 334 00:15:06,960 --> 00:15:08,800 PART OF THE REASON THAT 335 00:15:08,800 --> 00:15:11,000 MORTALITY RATES ARE GOING DOWN 336 00:15:11,000 --> 00:15:14,000 IS THAT SURVIVAL RATES ARE GOING 337 00:15:14,000 --> 00:15:16,880 UP AND THE NUMBER OF SURVIVORS 338 00:15:16,880 --> 00:15:19,440 IN THE UNITED STATES REALLY 339 00:15:19,440 --> 00:15:22,160 CONTINUES TO INCREASE. 340 00:15:22,160 --> 00:15:24,880 WE NOW ARE SUBSTANTIALLY OVER 5% 341 00:15:24,880 --> 00:15:32,000 OF THE TOTAL POPULATION OF THE 342 00:15:32,000 --> 00:15:32,720 UNITED STATES ARE CANCER 343 00:15:32,720 --> 00:15:33,040 SURVIVORS. 344 00:15:33,040 --> 00:15:38,960 MORE THAN 2/3 OF THEM ARE OVER 345 00:15:38,960 --> 00:15:39,600 65. 346 00:15:39,600 --> 00:15:43,080 THIS IS SOMETHING REALLY TO BE 347 00:15:43,080 --> 00:15:44,680 CELEBRATED BUT WE WANT MORTALITY 348 00:15:44,680 --> 00:15:47,000 RATES TO GO DOWN FASTER AND FOR 349 00:15:47,000 --> 00:15:49,200 THERE TO BE EVEN MORE SURVIVORS. 350 00:15:49,200 --> 00:15:50,360 THANK YOU. 351 00:15:50,360 --> 00:15:55,400 NEXT SLIDE. 352 00:15:55,400 --> 00:16:01,960 I NOW COME TO THE AREA OF THE 353 00:16:01,960 --> 00:16:02,600 CANCER MOONSHOT. 354 00:16:02,600 --> 00:16:07,040 AND I TALKED ABOUT IT A BIT IN 355 00:16:07,040 --> 00:16:07,240 JUNE. 356 00:16:07,240 --> 00:16:11,320 I NOW WANT TO UPDATE YOU WITH A 357 00:16:11,320 --> 00:16:13,320 SO-CALLED CANCER CABINET 358 00:16:13,320 --> 00:16:15,320 MEETING, THE FIRST LADY, DR. 359 00:16:15,320 --> 00:16:16,200 JILL BIDEN, PRESIDED AT THE 360 00:16:16,200 --> 00:16:18,400 WHITE HOUSE. 361 00:16:18,400 --> 00:16:24,280 THERE WERE MANY PEOPLE FROM 362 00:16:24,280 --> 00:16:25,320 DIFFERENT AGENCIES, MANY MEMBERS 363 00:16:25,320 --> 00:16:28,320 OF THE CABINET WHO PARTICIPATED. 364 00:16:28,320 --> 00:16:32,160 AND WHAT YOU CAN SEE ON THE 365 00:16:32,160 --> 00:16:36,160 RIGHT IS THAT THERE WERE A 366 00:16:36,160 --> 00:16:38,560 NUMBER OF PRIORITY ACTIONS AT 367 00:16:38,560 --> 00:16:41,040 THE CANCER CABINET, AND CLEARLY 368 00:16:41,040 --> 00:16:44,480 WE CAN EMBRACE ALL OF THEM. 369 00:16:44,480 --> 00:16:47,040 BUT I DO WANT TO HIGHLIGHT 370 00:16:47,040 --> 00:16:49,400 NUMBER 4, WHICH IS BRINGING 371 00:16:49,400 --> 00:16:51,520 CUTTING-EDGE RESEARCH THROUGH 372 00:16:51,520 --> 00:16:55,640 THE PIPELINE TO PATIENTS AND 373 00:16:55,640 --> 00:16:57,840 COMMUNITIES, BECAUSE AS I SAID 374 00:16:57,840 --> 00:17:01,800 AT THAT MEETING, EVEN IF WE CUT 375 00:17:01,800 --> 00:17:04,440 MORTALITY RATES BY 50% OR MORE, 376 00:17:04,440 --> 00:17:07,680 IF WE AREN'T GOING TO CHANGE THE 377 00:17:07,680 --> 00:17:11,560 OUTLOOK FOR PEOPLE WHO HAVE 378 00:17:11,560 --> 00:17:12,320 CANCERS WHERE CURRENTLY THERE'S 379 00:17:12,320 --> 00:17:14,920 NOT THAT MUCH THAT WE CAN DO TO 380 00:17:14,920 --> 00:17:17,480 HELP THEM, WE WILL NOT BE ENDING 381 00:17:17,480 --> 00:17:21,280 CANCER AS WE KNOW IT. 382 00:17:21,280 --> 00:17:23,800 ON THE LEFT SIDE YOU CAN SEE THE 383 00:17:23,800 --> 00:17:27,520 FACT SHEET WHERE IT SAYS 384 00:17:27,520 --> 00:17:30,280 PRESIDENT BIDEN APPOINTS CANCER 385 00:17:30,280 --> 00:17:30,960 PANEL MEMBERS. 386 00:17:30,960 --> 00:17:37,440 AND THAT'S SHOWN ON THE NEXT 387 00:17:37,440 --> 00:17:38,360 SLIDE. 388 00:17:38,360 --> 00:17:39,480 THIS ONCE AGAIN, ELIZABETH 389 00:17:39,480 --> 00:17:43,720 JAFFE, CAROL BROWN AND MITCHELL 390 00:17:43,720 --> 00:17:51,320 BERGER HAVE BEEN NAMED VERY 391 00:17:51,320 --> 00:17:52,440 ANALOGOUS TO MONICA BERTAGNOLLI 392 00:17:52,440 --> 00:17:54,360 BUT NOT YET APPOINTED. 393 00:17:54,360 --> 00:17:55,600 I WANT TO ACKNOWLEDGE, I'M SURE 394 00:17:55,600 --> 00:18:01,160 THEY WILL DO A GREAT JOB BUT I 395 00:18:01,160 --> 00:18:03,440 WANT TO ACKNOWLEDGE THE 396 00:18:03,440 --> 00:18:04,560 INCREDIBLE JOB - NEXT SLIDE 397 00:18:04,560 --> 00:18:06,680 PLEASE - THAT THE CURRENT 398 00:18:06,680 --> 00:18:08,080 MEMBERS OF THE PRESIDENT'S 399 00:18:08,080 --> 00:18:11,720 CANCER PANEL HAVE DONE, JOHN 400 00:18:11,720 --> 00:18:13,280 WILLIAMS, EDITH MITCHELL, AND 401 00:18:13,280 --> 00:18:15,000 ROBERT INGRAHAM. 402 00:18:15,000 --> 00:18:18,040 AS YOU MAY REMEMBER FROM THE 403 00:18:18,040 --> 00:18:23,040 PRESENTATION THAT JOHN WILLIAMS 404 00:18:23,040 --> 00:18:33,440 MADE BACK IN JUNE, THEIR 405 00:18:34,760 --> 00:18:36,360 MONOGRAPH WAS BRIDGING THE 406 00:18:36,360 --> 00:18:38,040 CANCER SCREENING GAP, EXACTLY 407 00:18:38,040 --> 00:18:39,440 NUMBER ONE PRIORITY ANNOUNCED AT 408 00:18:39,440 --> 00:18:42,280 THE CANCER CABINET. 409 00:18:42,280 --> 00:18:45,800 NEXT SLIDE. 410 00:18:45,800 --> 00:18:48,080 411 00:18:48,080 --> 00:18:52,360 THE MOONSHOT, THE NEXT PHASE, 412 00:18:52,360 --> 00:18:58,920 YOU'VE ALREADY HEARD PREVIEWS OF 413 00:18:58,920 --> 00:19:00,720 THIS WHEREAS WE DO WITH ALL OF 414 00:19:00,720 --> 00:19:04,760 OUR RFAs, THE BOARD OF 415 00:19:04,760 --> 00:19:06,000 SCIENTIFIC ADVISORS REVIEW THEM 416 00:19:06,000 --> 00:19:08,360 BUT YOU WERE PRESENT AT THE 417 00:19:08,360 --> 00:19:10,600 JOINT BOARD MEETING WHERE WE 418 00:19:10,600 --> 00:19:14,200 DISCUSSED THE MOONSHOT SCHOLARS 419 00:19:14,200 --> 00:19:16,600 PROGRAM, AND PREVIOUSLY 420 00:19:16,600 --> 00:19:18,120 TELEHEALTH AND MULTI-CANCER 421 00:19:18,120 --> 00:19:18,480 DETECTION. 422 00:19:18,480 --> 00:19:21,320 AND THOSE THREE PROGRAMS ARE 423 00:19:21,320 --> 00:19:23,280 GETTING OFF THE GROUND WHERE WE 424 00:19:23,280 --> 00:19:25,240 ANTICIPATE THE FIRST SET OF 425 00:19:25,240 --> 00:19:29,120 MOONSHOT SCHOLARS WILL BE NEXT 426 00:19:29,120 --> 00:19:30,160 YEAR. 427 00:19:30,160 --> 00:19:34,000 TELEHEALTH MADE THE FIRST AWARDS 428 00:19:34,000 --> 00:19:36,880 ACTUALLY A FEW WEEKS AGO. 429 00:19:36,880 --> 00:19:40,880 AND MULTI-CANCER DETECTION, AS 430 00:19:40,880 --> 00:19:43,520 YOU HEARD IN JUNE, IT WAS 431 00:19:43,520 --> 00:19:45,080 ROUNDLY ENDORSED AND GOING 432 00:19:45,080 --> 00:19:47,560 FORWARD TO TRY TO DEVELOP THAT 433 00:19:47,560 --> 00:19:52,600 IMPORTANT AREA. 434 00:19:52,600 --> 00:19:53,840 NEXT SLIDE. 435 00:19:53,840 --> 00:19:57,920 SO, THE NEXT THREE SLIDES REALLY 436 00:19:57,920 --> 00:20:03,080 ARE TALKING ABOUT TRYING TO 437 00:20:03,080 --> 00:20:04,320 OVERCOME HEALTH DISPARITIES, AND 438 00:20:04,320 --> 00:20:08,320 ONE OF THE AREAS THAT NCI HAS 439 00:20:08,320 --> 00:20:11,560 HAD A LONG-TERM COMMITMENT IS 440 00:20:11,560 --> 00:20:17,720 WITH CLINICAL TRIAL ENROLLMENT 441 00:20:17,720 --> 00:20:23,080 FOR NCI CLINICAL TRIALS. 442 00:20:23,080 --> 00:20:25,080 DR. MCCASKILL-STEVENS AND HER 443 00:20:25,080 --> 00:20:27,360 COLLEAGUES HAVE DONE AN AMAZING 444 00:20:27,360 --> 00:20:30,120 JOB AS YOU SEE SUMMARIZED ON THE 445 00:20:30,120 --> 00:20:30,480 RIGHT. 446 00:20:30,480 --> 00:20:32,680 WHEN WE STARTED THIS EFFORT NOW 447 00:20:32,680 --> 00:20:35,560 20 YEARS AGO, ABOUT 14% OF THE 448 00:20:35,560 --> 00:20:37,080 ENROLLMENT WAS MINORITIES. 449 00:20:37,080 --> 00:20:42,280 BUT IN THE MOST RECENT FULL 450 00:20:42,280 --> 00:20:44,200 THREE-YEAR PERIOD BEFORE THE 451 00:20:44,200 --> 00:20:47,480 PANDEMIC BEGAN, IT HAD INCREASED 452 00:20:47,480 --> 00:20:48,520 TO 25%. 453 00:20:48,520 --> 00:20:52,880 AND MOST OF THE INCREASE IS IN 454 00:20:52,880 --> 00:20:55,480 AFRICAN AMERICAN AND HISPANIC 455 00:20:55,480 --> 00:20:57,160 POPULATIONS. 456 00:20:57,160 --> 00:20:58,440 ACTUALLY, ESPECIALLY HISPANIC 457 00:20:58,440 --> 00:20:59,840 POPULATIONS. 458 00:20:59,840 --> 00:21:02,720 AND THE DATA DURING THE PANDEMIC 459 00:21:02,720 --> 00:21:06,200 HAVE NOT GONE DOWN IN TERMS OF 460 00:21:06,200 --> 00:21:08,280 MINORITY ENROLLMENT, BUT WE 461 00:21:08,280 --> 00:21:11,000 DON'T HAVE REALLY OFFICIAL DATA 462 00:21:11,000 --> 00:21:15,160 YET FOR 20 AND 21. 463 00:21:15,160 --> 00:21:15,600 NEXT SLIDE. 464 00:21:15,600 --> 00:21:19,360 SO, ONE OF THE THINGS THAT I 465 00:21:19,360 --> 00:21:23,400 TALKED ABOUT IN JUNE WAS THAT A 466 00:21:23,400 --> 00:21:25,040 VERY IMPORTANT PART OF WHAT WE 467 00:21:25,040 --> 00:21:27,000 SEE AS THE NEW PHASE OF THE 468 00:21:27,000 --> 00:21:31,000 CANCER MOONSHOT IS TO INCREASE 469 00:21:31,000 --> 00:21:32,800 ENROLLMENT OF UNDERREPRESENTED 470 00:21:32,800 --> 00:21:35,880 GROUPS, TO NCI CLINICAL TRIALS. 471 00:21:35,880 --> 00:21:41,480 AND PART OF THE GOAL IS TO MIMIC 472 00:21:41,480 --> 00:21:43,080 THE AT-RISK POPULATION FOR THIS 473 00:21:43,080 --> 00:21:43,960 SPECIFIC CANCER STUDY. 474 00:21:43,960 --> 00:21:47,600 SO WE KNOW THAT THE RESULTS WILL 475 00:21:47,600 --> 00:21:50,640 BE MORE REPRESENTATIVE. 476 00:21:50,640 --> 00:21:54,680 SO, THIS IS TO HAVE MORE 477 00:21:54,680 --> 00:21:56,440 UNDERREPRESENTED MINORITIES IN 478 00:21:56,440 --> 00:21:59,280 TRIALS, BUT ALSO PATIENTS WITH 479 00:21:59,280 --> 00:22:00,000 COMORBIDITIES, PATIENTS FROM 480 00:22:00,000 --> 00:22:00,800 RURAL AREAS. 481 00:22:00,800 --> 00:22:04,520 IN ORDER TO DO THIS, WE ARE 482 00:22:04,520 --> 00:22:05,720 GOING TO NEED GREATER INVESTMENT 483 00:22:05,720 --> 00:22:09,320 BECAUSE IT'S GOING TO BE 484 00:22:09,320 --> 00:22:12,120 CRITICAL TO HAVE COMMUNITY 485 00:22:12,120 --> 00:22:12,520 ENGAGEMENT. 486 00:22:12,520 --> 00:22:16,160 AND WE NEED TO MODIFY THINGS IF 487 00:22:16,160 --> 00:22:18,280 WE'RE GOING TO INCREASE 488 00:22:18,280 --> 00:22:20,800 ENROLLMENT, NOT JUST AT THE 489 00:22:20,800 --> 00:22:22,920 LEVEL OF THE PATIENT BUT ALSO AT 490 00:22:22,920 --> 00:22:25,040 THE LEVEL OF THE HEALTH CARE 491 00:22:25,040 --> 00:22:25,960 PROVIDER. 492 00:22:25,960 --> 00:22:30,160 SO THAT THERE IS MORE DIVERSITY 493 00:22:30,160 --> 00:22:31,280 AMONG HEALTH CARE PROVIDERS. 494 00:22:31,280 --> 00:22:35,040 AND WE ARE IN THE PROCESS OF 495 00:22:35,040 --> 00:22:37,880 TAKING STEPS TO TRY TO ENSURE 496 00:22:37,880 --> 00:22:41,080 THAT THIS IS GOING TO BECOME 497 00:22:41,080 --> 00:22:44,400 MORE OF A REALITY. 498 00:22:44,400 --> 00:22:46,720 NEXT SLIDE. 499 00:22:46,720 --> 00:22:48,960 THIS IS JUST AN ANNOUNCEMENT OR, 500 00:22:48,960 --> 00:22:52,560 IF YOU WILL, LETTING EVERYONE 501 00:22:52,560 --> 00:22:54,160 KNOW THAT IN NOVEMBER THERE'S 502 00:22:54,160 --> 00:22:58,360 GOING TO BE AN NCI SUMMIT ON 503 00:22:58,360 --> 00:23:00,440 INCREASING DIVERSITY, EQUITY, 504 00:23:00,440 --> 00:23:01,440 INCLUSION IN EARLY-PHASE 505 00:23:01,440 --> 00:23:01,960 CLINICAL TRIALS. 506 00:23:01,960 --> 00:23:05,640 ABILITY THE GOAL WILL BE TO 507 00:23:05,640 --> 00:23:07,040 IDENTIFY AND DISCUSS 508 00:23:07,040 --> 00:23:09,040 IMPLEMENTATION, BEST PRACTICES 509 00:23:09,040 --> 00:23:12,000 FOR INCREASING INCLUSION AND 510 00:23:12,000 --> 00:23:14,760 EQUITY IN OUR CANCER CLINICAL 511 00:23:14,760 --> 00:23:15,120 TRIALS. 512 00:23:15,120 --> 00:23:18,320 AND THE NCI EQUITY INCLUSION 513 00:23:18,320 --> 00:23:21,960 PROGRAM WILL BE HOSTING THIS AND 514 00:23:21,960 --> 00:23:23,680 REGISTRATION INFORMATION WILL BE 515 00:23:23,680 --> 00:23:27,560 AVAILABLE IN THE NEAR FUTURE. 516 00:23:27,560 --> 00:23:28,920 NEXT SLIDE. 517 00:23:28,920 --> 00:23:32,640 I'M NOW GOING TO TURN TO THE 518 00:23:32,640 --> 00:23:35,400 LAST THREE SLIDES, WHICH IS 519 00:23:35,400 --> 00:23:36,880 TALKING ABOUT FREDERICK. 520 00:23:36,880 --> 00:23:41,360 WE'RE GOING TO HAVE A LARGER 521 00:23:41,360 --> 00:23:41,920 DISCUSSION OF THE FREDERICK 522 00:23:41,920 --> 00:23:44,360 NATIONAL LABORATORY WHEN WE HAVE 523 00:23:44,360 --> 00:23:46,360 THE JOINT BOARD MEETING IN 524 00:23:46,360 --> 00:23:46,960 DECEMBER. 525 00:23:46,960 --> 00:23:50,440 BUT I WANTED TO TELL YOU ABOUT 526 00:23:50,440 --> 00:23:53,120 THREE THINGS. 527 00:23:53,120 --> 00:23:55,200 THE FIRST IS THAT MONKEYPOX HAS 528 00:23:55,200 --> 00:24:03,560 OF COURSE BEEN IN THE NEWS VERY 529 00:24:03,560 --> 00:24:05,160 HIGH PROFILE. 530 00:24:05,160 --> 00:24:07,280 AND THERE ACTUALLY IS TREATMENT 531 00:24:07,280 --> 00:24:11,840 AVAILABLE BUT HASN'T BEEN 532 00:24:11,840 --> 00:24:12,840 SUBJECTED TO RIGOROUS EFFICACY 533 00:24:12,840 --> 00:24:16,880 TRIAL IN PEOPLE. 534 00:24:16,880 --> 00:24:18,680 SO THE FREDERICK NATIONAL 535 00:24:18,680 --> 00:24:29,240 LABORATORY AND AUSPICE OF NIAID 536 00:24:29,560 --> 00:24:32,000 HAS BEEN WORKING WITH THE 537 00:24:32,000 --> 00:24:37,080 REPUBLIC OF THE CONGO CAN THE 538 00:24:37,080 --> 00:24:40,440 OUTBREAK OF STRAIN 1, CAUSING 539 00:24:40,440 --> 00:24:42,360 MORE THAN THE STRAIN 3 IN THE 540 00:24:42,360 --> 00:24:43,680 UNITED STATES, THE EFFICACY 541 00:24:43,680 --> 00:24:48,640 TRIAL HOPEFULLY WILL LEAD TO 542 00:24:48,640 --> 00:24:53,080 DEMONSTRATION OF EFFICACY AND 543 00:24:53,080 --> 00:24:56,160 ANTICIPATION IF STRAIN 1 WILL IS 544 00:24:56,160 --> 00:24:57,920 DEMONSTRATED EFFICACY WILL ALSO 545 00:24:57,920 --> 00:25:06,280 WILL BE FOR STRAIN 3. 546 00:25:06,280 --> 00:25:06,920 NEXT SLIDE. 547 00:25:06,920 --> 00:25:13,080 IN ADDITION, THE IMPORTANCE OF 548 00:25:13,080 --> 00:25:14,840 TRAINING AND DIVERSITY AND 549 00:25:14,840 --> 00:25:18,640 EQUITY DOESN'T JUST STAY IN 550 00:25:18,640 --> 00:25:22,400 BETHESDA BUT ALSO EXTENDS TO THE 551 00:25:22,400 --> 00:25:23,480 FREDERICK NATIONAL LABORATORY. 552 00:25:23,480 --> 00:25:26,920 AND THERE ARE A NUMBER OF 553 00:25:26,920 --> 00:25:30,040 ACADEMIC PARTNERSHIPS THAT HAVE 554 00:25:30,040 --> 00:25:37,760 BEEN DEVELOPED IN RECENT YEARS 555 00:25:37,760 --> 00:25:39,120 WITH ETHAN DEMOTROSKI LEADING 556 00:25:39,120 --> 00:25:40,280 THE EFFORT WITH SEMINARS, 557 00:25:40,280 --> 00:25:41,520 GRADUATE STUDENTS FROM 558 00:25:41,520 --> 00:25:43,800 UNDERREPRESENTED GROUPS, AND 559 00:25:43,800 --> 00:25:46,200 MORE PARTNERSHIPS UNDERWAY. 560 00:25:46,200 --> 00:25:52,000 MY LAST SLIDE, WHICH IS THE NEXT 561 00:25:52,000 --> 00:25:55,680 SLIDE, TALKS ABOUT A SURPRISING 562 00:25:55,680 --> 00:26:00,840 VISIT THAT WE HAD A FEW WEEKS 563 00:26:00,840 --> 00:26:04,920 AGO TO FREDERICK, WHERE WE HAD 564 00:26:04,920 --> 00:26:08,040 SECRETARY BECERRA AND THE TWO 565 00:26:08,040 --> 00:26:10,760 SENATORS FROM MARYLAND, BEN 566 00:26:10,760 --> 00:26:13,320 CARDON AND CHRIS VALHOLEN AND 567 00:26:13,320 --> 00:26:17,400 ONE OF THE CONGRESSMEN FROM 568 00:26:17,400 --> 00:26:20,200 MARYLAND, DAVID TRONE, COME TO 569 00:26:20,200 --> 00:26:27,920 THE FREDERICK NATIONAL 570 00:26:27,920 --> 00:26:29,160 LABORATORY TO SEE IT, THEY HAVE 571 00:26:29,160 --> 00:26:31,520 ALL BEEN WITH THE EXCEPTION OF 572 00:26:31,520 --> 00:26:37,080 SECRETARY BECERRA, AND WE TALKED 573 00:26:37,080 --> 00:26:37,720 ABOUT THE CAPABILITIES 574 00:26:37,720 --> 00:26:40,040 ESPECIALLY IN AREAS OF CANCER 575 00:26:40,040 --> 00:26:43,040 RESEARCH FOR THE FREDERICK 576 00:26:43,040 --> 00:26:49,560 NATIONAL LABORATORY, AND MELINDA 577 00:26:49,560 --> 00:26:55,800 HOLLINGSHEAD FROM NCI RUNS THE 578 00:26:55,800 --> 00:26:58,320 MOUSE MODELS REPOSITORY, 579 00:26:58,320 --> 00:26:59,440 PATIENT-DERIVED MODELS 580 00:26:59,440 --> 00:27:00,440 REPOSITORY, GAVE THEM 581 00:27:00,440 --> 00:27:03,080 DEMONSTRATION OF PATIENT DERIVED 582 00:27:03,080 --> 00:27:05,520 XENOGRAFTS DEVELOPED FROM 583 00:27:05,520 --> 00:27:10,600 PATIENT TUMORS AND EVERYONE WAS 584 00:27:10,600 --> 00:27:12,520 VERY ENGAGED AND DR. 585 00:27:12,520 --> 00:27:14,920 HOLLINGSHEAD DID A TERRIFIC JOB 586 00:27:14,920 --> 00:27:22,360 IN EXPLAINING HOW WE DEVELOP 587 00:27:22,360 --> 00:27:22,560 THESE. 588 00:27:22,560 --> 00:27:24,360 WE NOW HAVE 600 MODELS WITH THE 589 00:27:24,360 --> 00:27:26,200 GOAL OF GETTING TO 1,000, MADE 590 00:27:26,200 --> 00:27:31,040 READILY AVAILABLE TO THE CANCER 591 00:27:31,040 --> 00:27:32,000 RESEARCH COMMUNITY FOR PEOPLE 592 00:27:32,000 --> 00:27:37,080 WHO WANT TO DO VARIOUS KINDS OF 593 00:27:37,080 --> 00:27:38,920 TRANSLATIONAL RESEARCH 594 00:27:38,920 --> 00:27:46,920 ESPECIALLY FOR DEVELOPING NEW 595 00:27:46,920 --> 00:27:47,440 INTERVENTIONS. 596 00:27:47,440 --> 00:27:48,400 THAT WAS AN UNEXPECTED 597 00:27:48,400 --> 00:27:51,760 OPPORTUNITY TO TALK ABOUT THE 598 00:27:51,760 --> 00:27:52,720 FREDERICK NATIONAL LABORATORY, 599 00:27:52,720 --> 00:27:57,400 NATIONAL CANCER INSTITUTE, DR. 600 00:27:57,400 --> 00:28:00,720 TABAK CAME UP FROM BETHESDA. 601 00:28:00,720 --> 00:28:04,600 IT REALLY WAS AN IMPORTANT 602 00:28:04,600 --> 00:28:07,320 OPPORTUNITY TO TELL THEM ABOUT 603 00:28:07,320 --> 00:28:09,480 THE OPPORTUNITIES THAT WE SEE 604 00:28:09,480 --> 00:28:12,640 FOR CANCER RESEARCH. 605 00:28:12,640 --> 00:28:14,840 SO, I'LL STOP NOW AND THANK YOU 606 00:28:14,840 --> 00:28:16,360 FOR YOUR ATTENTION. 607 00:28:16,360 --> 00:28:18,560 AND LOOK FORWARD TO YOUR 608 00:28:18,560 --> 00:28:23,240 QUESTIONS AND YOUR COMMENTS. 609 00:28:23,240 --> 00:28:23,960 610 00:28:23,960 --> 00:28:24,880 >> THANK YOU, DOUG. 611 00:28:24,880 --> 00:28:27,840 WE NOW OPEN THE FLOOR FOR 612 00:28:27,840 --> 00:28:28,120 QUESTIONS. 613 00:28:28,120 --> 00:28:31,680 WE HAVE TIME FOR QUITE A FEW 614 00:28:31,680 --> 00:28:31,960 QUESTIONS. 615 00:28:31,960 --> 00:28:34,200 I WOULD, YOU KNOW, FROM A 616 00:28:34,200 --> 00:28:35,520 STANDPOINT OF JUST CHAIR'S 617 00:28:35,520 --> 00:28:37,600 PREROGATIVE WANT TO THANK YOU 618 00:28:37,600 --> 00:28:38,840 FOR DISCUSSING THE PDX NET AND 619 00:28:38,840 --> 00:28:40,720 ALL THE WORK IN DEVELOPING THE 620 00:28:40,720 --> 00:28:41,000 MODELS. 621 00:28:41,000 --> 00:28:43,680 I THINK, YOU KNOW, ONE REALLY 622 00:28:43,680 --> 00:28:46,040 IMPORTANT POINT IS SOME OF THE 623 00:28:46,040 --> 00:28:50,880 PROGRAMS THAT ARE IN PLAY TO 624 00:28:50,880 --> 00:28:54,320 INCREASE DIVERSITY. 625 00:28:54,320 --> 00:29:01,320 THE EXPANSION OF PBX NET TO 626 00:29:01,320 --> 00:29:02,080 DERIVE 60% FROM MINORITY 627 00:29:02,080 --> 00:29:05,800 PATIENTS TO UNDERSTAND THE 628 00:29:05,800 --> 00:29:08,440 BROADER CONTEXT OF CANCER WITH A 629 00:29:08,440 --> 00:29:09,440 MORE DIVERSE SET OF MODELS. 630 00:29:09,440 --> 00:29:11,000 >> THANK YOU FOR POINTING THAT 631 00:29:11,000 --> 00:29:15,360 OUT, JOHN, CLEARLY AN IMPORTANT 632 00:29:15,360 --> 00:29:16,000 AND NEEDED INITIATIVE. 633 00:29:16,000 --> 00:29:18,360 >> SO I KNOW WE'RE GOING TO HAVE 634 00:29:18,360 --> 00:29:22,720 AN EXPANDED DISCUSSION ON NCI 635 00:29:22,720 --> 00:29:25,040 FREDERICK AT THE JOINT BSA 636 00:29:25,040 --> 00:29:27,080 MEETING YOU MENTIONED. 637 00:29:27,080 --> 00:29:28,720 BUT IF YOU COULD, IS IT POSSIBLE 638 00:29:28,720 --> 00:29:32,760 TO AT LEAST PROVIDE SOME CONTEXT 639 00:29:32,760 --> 00:29:34,640 AROUND HOW THAT OPERATION WORKS 640 00:29:34,640 --> 00:29:37,840 IN TERMS OF ITS FUNDING, ITS 641 00:29:37,840 --> 00:29:40,040 RELATIONSHIP WITH NCI, AND I 642 00:29:40,040 --> 00:29:42,480 KNOW THE RECOMPETING AND THINGS 643 00:29:42,480 --> 00:29:45,600 OF THAT NATURE. 644 00:29:45,600 --> 00:29:49,560 >> SO, THE FREDERICK NATIONAL 645 00:29:49,560 --> 00:29:53,880 LABORATORY IS REALLY, IF YOU 646 00:29:53,880 --> 00:29:56,960 WILL, A GOVERNMENT RESOURCE. 647 00:29:56,960 --> 00:30:03,520 IT IS A CONTRACT LABORATORY. 648 00:30:03,520 --> 00:30:05,520 AND ABOUT I WOULD SAY -- THE 649 00:30:05,520 --> 00:30:09,160 AMOUNT OF MONEY THAT IS SPENT UP 650 00:30:09,160 --> 00:30:12,880 THERE VARIES WITH THE YEARS, BUT 651 00:30:12,880 --> 00:30:16,240 ABOUT TWO-THIRDS OF THE FUNDING 652 00:30:16,240 --> 00:30:20,240 COMES FROM NCI, AND ONE-THIRD 653 00:30:20,240 --> 00:30:23,080 FROM NIAID, WITH A NUMBER OF 654 00:30:23,080 --> 00:30:29,240 DIFFERENT AGENCIES AND OTHER 655 00:30:29,240 --> 00:30:35,640 PARTS OF NIH BENEFITING FROM IT. 656 00:30:35,640 --> 00:30:39,800 IN TERMS OF THE ACTIVITIES, ONE 657 00:30:39,800 --> 00:30:44,000 OF THE AREAS THAT WE ESSENTIALLY 658 00:30:44,000 --> 00:30:45,560 TRANSITIONED TO WAS LOOKING AT 659 00:30:45,560 --> 00:30:51,480 COVID IN A NUMBER OF DIFFERENT 660 00:30:51,480 --> 00:30:55,080 WAYS DURING THE PANDEMIC, NCI 661 00:30:55,080 --> 00:31:00,120 TOOK A LEAD ROLE IN SEROLOGY. 662 00:31:00,120 --> 00:31:03,440 AND WE ACTUALLY ENDED UP 663 00:31:03,440 --> 00:31:06,680 ESSENTIALLY BEING A TEST CENTER 664 00:31:06,680 --> 00:31:12,080 FOR THE FDA, AND THEY USED OUR 665 00:31:12,080 --> 00:31:14,360 RESULTS AS AN IMPORTANT 666 00:31:14,360 --> 00:31:18,800 PARAMETER IN DECIDING WHETHER 667 00:31:18,800 --> 00:31:20,000 EMERGENCY USE AUTHORIZATIONS 668 00:31:20,000 --> 00:31:21,120 WERE GIVEN TO DIFFERENT 669 00:31:21,120 --> 00:31:23,640 COMPANIES THAT WERE MAKING 670 00:31:23,640 --> 00:31:24,680 VARIOUS DEVICES. 671 00:31:24,680 --> 00:31:30,600 MOST OF WHAT WE DO IS CANCER 672 00:31:30,600 --> 00:31:32,320 RESEARCH. 673 00:31:32,320 --> 00:31:37,920 YOU HAVE HEARD ABOUT THE RAS 674 00:31:37,920 --> 00:31:41,680 INITIATIVE, AND DINAH SINGER AND 675 00:31:41,680 --> 00:31:45,760 OTHERS ARE INVOLVED IN LOOKING 676 00:31:45,760 --> 00:31:47,560 AT BASICALLY HEARING FROM THE 677 00:31:47,560 --> 00:31:49,080 COMMUNITY, FIRST WITH AN RFI, 678 00:31:49,080 --> 00:31:52,800 AND THEN GOING OUT ACTUALLY IN 679 00:31:52,800 --> 00:31:56,840 THE COMMUNITY AND ASKING PEOPLE 680 00:31:56,840 --> 00:31:59,400 WHAT ARE SOME SIGNATURE 681 00:31:59,400 --> 00:32:09,840 INITIATIVES THAT MIGHT BE 682 00:32:15,040 --> 00:32:16,880 PURSUED AT FREDERICK. 683 00:32:16,880 --> 00:32:20,920 FREDERICK AS A RESOURCE FOR 684 00:32:20,920 --> 00:32:23,080 MODELS, PATIENT DERIVED 685 00:32:23,080 --> 00:32:28,040 REPOSITORY, SPHEROID AND OTHER 686 00:32:28,040 --> 00:32:31,200 MODELS, THE RAS INITIATIVE HAS 687 00:32:31,200 --> 00:32:36,280 PATHWAY REAGENTS OF VARIOUS 688 00:32:36,280 --> 00:32:37,920 TYPES. 689 00:32:37,920 --> 00:32:39,120 THE FREDERICK NATIONAL 690 00:32:39,120 --> 00:32:44,160 LABORATORY, WHEN WE STOOD UP THE 691 00:32:44,160 --> 00:32:47,560 MATCH TRIAL, IT WAS IMPORTANT TO 692 00:32:47,560 --> 00:32:51,480 HAVE MULTIPLE CENTERS FOR 693 00:32:51,480 --> 00:32:58,280 SEQUENCING FOR DETERMINING IF 694 00:32:58,280 --> 00:32:59,680 PATIENTS WOULD BE ELIGIBLE TO 695 00:32:59,680 --> 00:33:01,320 JOIN THE MATCH TRIAL. 696 00:33:01,320 --> 00:33:03,400 THAT WAS CENTERED AT FREDERICK. 697 00:33:03,400 --> 00:33:06,000 AND THE OTHER CENTERS, THERE WAS 698 00:33:06,000 --> 00:33:07,840 A LOT OF UPFRONT WORK THAT WENT 699 00:33:07,840 --> 00:33:13,360 TO MAKE SURE THAT THERE WAS AT 700 00:33:13,360 --> 00:33:15,680 LEAST 95% AGREEMENT BETWEEN THE 701 00:33:15,680 --> 00:33:17,720 DIFFERENT GROUPS. 702 00:33:17,720 --> 00:33:20,320 THE NEXT PROGRAM FOR EXAMPLE, 703 00:33:20,320 --> 00:33:24,160 YOU KNOW, WHICH WE HAVE 704 00:33:24,160 --> 00:33:30,360 PRESENTED IN THE RECENT PAST, 705 00:33:30,360 --> 00:33:32,440 WHICH REALLY IS INVESTIGATOR -- 706 00:33:32,440 --> 00:33:36,600 IF YOU WILL, IT'S 707 00:33:36,600 --> 00:33:37,040 INVESTIGATOR-INITIATED 708 00:33:37,040 --> 00:33:38,240 TRANSLATION WHERE GROUPS THEN 709 00:33:38,240 --> 00:33:43,960 APPLY TO TRY TO DEVELOP THEIR 710 00:33:43,960 --> 00:33:45,120 TRANSLATIONAL IDEAS. 711 00:33:45,120 --> 00:33:49,080 I THINK I'VE GONE ON ENOUGH. 712 00:33:49,080 --> 00:33:50,320 >> THIS IS GREAT. 713 00:33:50,320 --> 00:33:52,720 ARE THERE ANY OTHER QUESTIONS? 714 00:33:52,720 --> 00:33:56,920 PLEASE USE THE RAISE YOUR HAND 715 00:33:56,920 --> 00:33:57,440 TOOL. 716 00:33:57,440 --> 00:33:58,520 >> YEAH, QUICKLY, DOUG, I KNOW A 717 00:33:58,520 --> 00:34:00,200 LOT OF PEOPLE ARE ASKING 718 00:34:00,200 --> 00:34:03,000 THEMSELF THE FOLLOWING QUESTION. 719 00:34:03,000 --> 00:34:08,360 YOU KNOW, HOW THE PAYLINES LOOK 720 00:34:08,360 --> 00:34:09,600 FOR 2023, WE KNOW 2022 IS PRETTY 721 00:34:09,600 --> 00:34:10,440 MUCH IN THE BAG. 722 00:34:10,440 --> 00:34:11,840 >> YEAH, AS SOON AS YOU TELL ME 723 00:34:11,840 --> 00:34:15,800 WHAT OUR BUDGET IS FOR FY23, I 724 00:34:15,800 --> 00:34:17,080 WILL GIVE YOU AN ANSWER. 725 00:34:17,080 --> 00:34:18,160 >> I WAS JUST GIVING YOU A 726 00:34:18,160 --> 00:34:19,440 CHANCE TO ANSWER THAT QUESTION 727 00:34:19,440 --> 00:34:21,400 SO EVERYONE KNOWS WE DON'T HAVE 728 00:34:21,400 --> 00:34:25,040 A BUDGET FOR 2023. 729 00:34:25,040 --> 00:34:31,160 IF I COULD FOLLOW UP -- 730 00:34:31,160 --> 00:34:32,360 >> INSTEAD, LET ME -- 731 00:34:32,360 --> 00:34:33,680 >> THAT'S OKAY, JUST GIVING YOU 732 00:34:33,680 --> 00:34:36,120 A CHANCE TO SAY THAT. 733 00:34:36,120 --> 00:34:39,960 >> THIS IS A VERY, VERY HIGH 734 00:34:39,960 --> 00:34:40,600 PRIORITY. 735 00:34:40,600 --> 00:34:46,760 AS I HAVE TALKED WITH YOU 736 00:34:46,760 --> 00:34:49,600 PREVIOUSLY, WE ARE PROGRESSIVELY 737 00:34:49,600 --> 00:34:52,520 INCREASING THE INVESTMENT IN THE 738 00:34:52,520 --> 00:34:54,840 RPG POOL, COMPARED TO ITS 739 00:34:54,840 --> 00:34:57,280 PERCENTAGE OF THE OVERALL NCI 740 00:34:57,280 --> 00:34:59,320 BUDGET, WHICH HAS LED TO AN 741 00:34:59,320 --> 00:35:01,520 OVERALL INCREASE IN THE 742 00:35:01,520 --> 00:35:04,040 PERCENTAGE OF THE NCI BUDGET 743 00:35:04,040 --> 00:35:06,880 THAT IS IN THE RPG POOL. 744 00:35:06,880 --> 00:35:10,800 AND WE LOOK FORWARD TO DOING 745 00:35:10,800 --> 00:35:11,040 THAT. 746 00:35:11,040 --> 00:35:12,160 >> YEAH A FOLLOW-UP, I WAS 747 00:35:12,160 --> 00:35:13,240 ASKING BECAUSE I REALLY WANTED 748 00:35:13,240 --> 00:35:15,280 TO ASK THIS QUESTION. 749 00:35:15,280 --> 00:35:18,160 DO YOU SEE ANY REAL LEVELING OFF 750 00:35:18,160 --> 00:35:20,560 OR EVEN ANY DECREASE IN THE 751 00:35:20,560 --> 00:35:26,800 NUMBER OF GRANT APPLICATIONS, 752 00:35:26,800 --> 00:35:27,720 ESPECIALLY R01s? 753 00:35:27,720 --> 00:35:28,960 >> THE SHORT ANSWER, THE BIG 754 00:35:28,960 --> 00:35:31,320 INCREASE THAT WE SAW A NUMBER OF 755 00:35:31,320 --> 00:35:35,320 YEARS AGO SEEMS TO HAVE 756 00:35:35,320 --> 00:35:35,880 PLATEAUED, YES. 757 00:35:35,880 --> 00:35:37,360 >> THAT'S ONE OF THE REASONS 758 00:35:37,360 --> 00:35:38,600 OBVIOUSLY FOR OUR SUCCESS RATE, 759 00:35:38,600 --> 00:35:41,880 AND I THINK THAT'S NOT ALWAYS 760 00:35:41,880 --> 00:35:43,520 UNDERSTOOD. 761 00:35:43,520 --> 00:35:44,040 THANK YOU. 762 00:35:44,040 --> 00:35:46,000 >> YEAH, AND, YOU KNOW, I THINK 763 00:35:46,000 --> 00:35:48,080 THAT IF YOU LOOK AT THE METRIC 764 00:35:48,080 --> 00:35:50,000 OF HOW MANY AWARDS ARE WE 765 00:35:50,000 --> 00:35:54,640 GIVING, YOU KNOW, WE'RE GIVING 766 00:35:54,640 --> 00:35:57,120 MORE AWARDS EVERY YEAR. 767 00:35:57,120 --> 00:35:58,880 BUT THE -- YOU KNOW, WE HAVEN'T 768 00:35:58,880 --> 00:36:04,560 BEEN ABLE TO KEEP PACE WITH THE 769 00:36:04,560 --> 00:36:05,480 NUMBER OF APPLICATIONS, EVEN 770 00:36:05,480 --> 00:36:09,080 WITH THEM BEING FLAT. 771 00:36:09,080 --> 00:36:12,000 BUT, YOU KNOW, NED REALLY 772 00:36:12,000 --> 00:36:15,280 DEVELOPED THE IDEA OF 15 BY 25. 773 00:36:15,280 --> 00:36:21,200 WE NEEDED TO TAKE A PAUSE DURING 774 00:36:21,200 --> 00:36:24,480 FY 22 BUT I'LL -- YOU KNOW, TELL 775 00:36:24,480 --> 00:36:27,080 YOU THAT WE WENT FROM WE WENT 776 00:36:27,080 --> 00:36:29,480 FROM 8 TO 11, YOU KNOW, IN A 777 00:36:29,480 --> 00:36:31,480 VERY SHORT TIME PERIOD. 778 00:36:31,480 --> 00:36:34,320 AND I'M HOPEFUL THAT WE WILL BE 779 00:36:34,320 --> 00:36:38,600 ABLE TO RESUME GOING UP TOWARDS 780 00:36:38,600 --> 00:36:40,520 15 BY 25. 781 00:36:40,520 --> 00:36:46,080 BUT AS YOU UNDERSTAND, IT REALLY 782 00:36:46,080 --> 00:36:48,400 IS DEPENDENT ON CONGRESS. 783 00:36:48,400 --> 00:36:52,480 >> SO, DOUG, JUST TO AGUESS 784 00:36:52,480 --> 00:36:55,400 DOVETAIL OFF THE CONVERSATION, I 785 00:36:55,400 --> 00:36:56,640 THINK ONE OF THE ISSUES THAT'S 786 00:36:56,640 --> 00:36:58,360 NEAR AND DEAR TO THE HEARTS OF 787 00:36:58,360 --> 00:37:00,840 MANY OF OUR MEMBERS AND THE 788 00:37:00,840 --> 00:37:03,560 COMMUNITY AS A WHOLE ARE ESIs. 789 00:37:03,560 --> 00:37:06,520 AND SO, CAN YOU SPEAK TO, YOU 790 00:37:06,520 --> 00:37:08,680 KNOW, WHERE WE ARE WITH THAT? 791 00:37:08,680 --> 00:37:13,280 >> JOHN, WE CONTINUE TO GIVE 792 00:37:13,280 --> 00:37:14,840 ESIs A 5 PERCENTILE BOOST, 793 00:37:14,840 --> 00:37:15,760 OKAY? 794 00:37:15,760 --> 00:37:18,800 WHENEVER WE TALK ABOUT THE 795 00:37:18,800 --> 00:37:23,080 PAYLINE, IF IT'S 11 FOR 796 00:37:23,080 --> 00:37:25,200 EXPERIENCED INVESTIGATORS, IT'S 797 00:37:25,200 --> 00:37:26,320 16 FOR ESIs. 798 00:37:26,320 --> 00:37:29,400 WE HAVE GIVEN MANY MORE AWARDS, 799 00:37:29,400 --> 00:37:30,920 I DON'T WANT TO MAKE A MISTAKE 800 00:37:30,920 --> 00:37:33,760 AND GIVE YOU THE QUANTITATION, 801 00:37:33,760 --> 00:37:36,120 BUT WE'VE GIVEN MANY MORE AWARDS 802 00:37:36,120 --> 00:37:37,560 TO ESI, LET'S SAY LAST YEAR, 803 00:37:37,560 --> 00:37:43,640 THAN WE DID THREE OR FOUR YEARS 804 00:37:43,640 --> 00:37:43,800 AGO. 805 00:37:43,800 --> 00:37:45,360 ELECTRA, YOU HAVE A QUESTION? 806 00:37:45,360 --> 00:37:46,240 >> HI, DOUG. 807 00:37:46,240 --> 00:37:47,640 THANK YOU SO MUCH FOR YOUR 808 00:37:47,640 --> 00:37:50,360 REPORT, ALL THAT YOU DO AND WILL 809 00:37:50,360 --> 00:37:53,000 CONTINUE TO DO, I KNOW YOU WILL. 810 00:37:53,000 --> 00:37:56,600 I JUST WANTED TO MAKE A POINT 811 00:37:56,600 --> 00:38:00,880 AND ESPECIALLY FOR THE RECORD, I 812 00:38:00,880 --> 00:38:04,240 APPRECIATE THE MOONSHOT 813 00:38:04,240 --> 00:38:07,880 CONSIDERATION OF ENROLLING 814 00:38:07,880 --> 00:38:08,640 UNDERREPRESENTED POPULATIONS, 815 00:38:08,640 --> 00:38:09,520 THROUGH TRIALS, THAT WOULD 816 00:38:09,520 --> 00:38:13,680 REPRESENT THE POPULATION WITH 817 00:38:13,680 --> 00:38:14,480 THAT DISEASE. 818 00:38:14,480 --> 00:38:17,000 I THINK THAT'S FABULOUS. 819 00:38:17,000 --> 00:38:18,720 IT'S A HUMONGOUS START, A GREAT 820 00:38:18,720 --> 00:38:20,480 CHANGE FROM WHERE WE ARE. 821 00:38:20,480 --> 00:38:25,480 BUT I WOULD REALLY LIKE TO 822 00:38:25,480 --> 00:38:27,360 REMIND PEOPLE THAT IF WE WANT TO 823 00:38:27,360 --> 00:38:30,560 SAY THAT A TREATMENT, FOR 824 00:38:30,560 --> 00:38:36,080 EXAMPLE, WILL WORK IN LET'S SAY 825 00:38:36,080 --> 00:38:37,000 A SPECIFIC MINORITY POPULATION, 826 00:38:37,000 --> 00:38:39,240 WHERE THE QUESTION IS RELEVANT 827 00:38:39,240 --> 00:38:40,800 AND IMPORTANT FOR THAT MINORITY 828 00:38:40,800 --> 00:38:45,160 POPULATION WE'RE GOING TO HAVE 829 00:38:45,160 --> 00:38:46,920 TO RECRUIT PATIENTS TO THE 830 00:38:46,920 --> 00:38:49,080 NUMBER THAT WE WILL HAVE 831 00:38:49,080 --> 00:38:50,520 SUFFICIENT STATISTICAL POWER TO 832 00:38:50,520 --> 00:38:55,520 ANSWER THAT QUESTION FOR THAT 833 00:38:55,520 --> 00:38:55,880 RESEARCH GROUP. 834 00:38:55,880 --> 00:38:58,800 SO, WE IN THE ALLIANCE FOR 835 00:38:58,800 --> 00:38:59,960 CLINICAL TRIALS HAVE BEEN 836 00:38:59,960 --> 00:39:02,400 LOOKING AT THIS. 837 00:39:02,400 --> 00:39:05,600 AND WE ACTUALLY HAVE SEVERAL 838 00:39:05,600 --> 00:39:08,920 TRIALS THROUGH THE NCTN 839 00:39:08,920 --> 00:39:12,040 MECHANISM THAT ARE TAILORED TO 840 00:39:12,040 --> 00:39:12,680 CERTAIN UNDERREPRESENTED 841 00:39:12,680 --> 00:39:14,840 POPULATION GROUPS, AND ONE IS 842 00:39:14,840 --> 00:39:15,960 OUR GET SET STUDY, FOR EXAMPLE, 843 00:39:15,960 --> 00:39:20,840 WE SET A GOAL TO ENROLL 30% 844 00:39:20,840 --> 00:39:25,800 MINORITY WOMEN, AND WE HAVE 845 00:39:25,800 --> 00:39:27,200 CLOSED CELLS TO YOUNG WHITE 846 00:39:27,200 --> 00:39:28,120 WOMEN BECAUSE WE HAVE FILLED 847 00:39:28,120 --> 00:39:29,880 THOSE CELLS UP. 848 00:39:29,880 --> 00:39:34,040 AND WE'RE NOW ONLY RECRUITING 849 00:39:34,040 --> 00:39:36,480 BLACK WOMEN, YOUNG WOMEN, TO 850 00:39:36,480 --> 00:39:36,880 THAT. 851 00:39:36,880 --> 00:39:43,160 AND ONE MORE POINT I WANT TO 852 00:39:43,160 --> 00:39:50,280 MAKE SO PEOPLE KNOW WE CAN DO 853 00:39:50,280 --> 00:39:50,920 THIS, MONICA BERTAGNOLLI WAS THE 854 00:39:50,920 --> 00:39:54,480 GROUP CHAIR AND GAVE US A 855 00:39:54,480 --> 00:39:54,960 CHALLENGE 30% MINORITY 856 00:39:54,960 --> 00:39:55,640 REPRESENTATION ON THE CLINICAL 857 00:39:55,640 --> 00:39:56,080 TRIALS. 858 00:39:56,080 --> 00:40:00,240 AS OF LAST MONTH IN ALLIANCE, WE 859 00:40:00,240 --> 00:40:04,800 WERE ALMOST 24% FOR TREATMENT 860 00:40:04,800 --> 00:40:06,480 TRIALS, AND ALMOST 44% FOR 861 00:40:06,480 --> 00:40:08,880 CANCER CONTROL TRIALS. 862 00:40:08,880 --> 00:40:11,480 SO, WE DID IT BY THE TOP SAYS 863 00:40:11,480 --> 00:40:13,400 YOU'RE GOING TO DO IT. 864 00:40:13,400 --> 00:40:17,200 SECOND OF ALL, YOU KNOW, WE 865 00:40:17,200 --> 00:40:19,040 OPENED PROTOCOLS THAT 866 00:40:19,040 --> 00:40:19,560 SPECIFICALLY ADDRESS OUR 867 00:40:19,560 --> 00:40:20,640 MINORITY POPULATIONS AND THE 868 00:40:20,640 --> 00:40:23,440 ISSUES THAT WERE RELEVANT TO 869 00:40:23,440 --> 00:40:26,720 THEM, AND WHERE APPROPRIATE WE 870 00:40:26,720 --> 00:40:28,680 MADE SURE IN PROTOCOLS THAT WE 871 00:40:28,680 --> 00:40:30,520 SET OUR ACCRUAL TARGETS NOT JUST 872 00:40:30,520 --> 00:40:33,640 TO BE REPRESENTATIVE OF THE 873 00:40:33,640 --> 00:40:35,400 POPULATION WITH THE DISEASE BUT 874 00:40:35,400 --> 00:40:40,880 FHIR SO WE COULD SAY IN THAT 875 00:40:40,880 --> 00:40:42,120 POPULATION IF THE TREATMENT, IF 876 00:40:42,120 --> 00:40:43,160 THE INTERVENTION ALSO WORKED. 877 00:40:43,160 --> 00:40:47,520 AND I WOULD REALLY LIKE FOR THE 878 00:40:47,520 --> 00:40:49,720 SCIENTIFIC COMMUNITY TO REALLY 879 00:40:49,720 --> 00:40:52,040 VIEW THIS DIFFERENTLY AND REALLY 880 00:40:52,040 --> 00:40:54,640 ASPIRE TO THESE GOALS BECAUSE 881 00:40:54,640 --> 00:40:57,600 PERSONALLY I DON'T THINK WHERE 882 00:40:57,600 --> 00:40:59,600 APPROPRIATE IT'S ADEQUATE ENOUGH 883 00:40:59,600 --> 00:41:00,680 JUST TO RECRUIT TO THE 884 00:41:00,680 --> 00:41:02,640 DISTRIBUTION OF THE DISEASE IN 885 00:41:02,640 --> 00:41:03,680 THE POPULATION. 886 00:41:03,680 --> 00:41:05,640 THANKS, DOUG, FOR LETTING ME SAY 887 00:41:05,640 --> 00:41:08,000 THAT. 888 00:41:08,000 --> 00:41:09,080 >> THANK YOU, ELECTRA. 889 00:41:09,080 --> 00:41:12,480 ANNA, YOUR HAND IS UP. 890 00:41:12,480 --> 00:41:14,320 IS THAT FROM PREVIOUS OR -- 891 00:41:14,320 --> 00:41:16,160 >> I'M SORRY, I'LL TAKE THAT 892 00:41:16,160 --> 00:41:19,080 DOWN, YES. 893 00:41:19,080 --> 00:41:22,240 >> ANYWAY, WE'RE GETTING CLOSE 894 00:41:22,240 --> 00:41:25,520 TO THE 2:00 -- JOHN, FOR YOU, 895 00:41:25,520 --> 00:41:26,120 11:00. 896 00:41:26,120 --> 00:41:27,360 >> WE HAVE A COUPLE MINUTES IF 897 00:41:27,360 --> 00:41:31,160 THERE ARE ANY OTHER BURNING 898 00:41:31,160 --> 00:41:31,560 QUESTIONS. 899 00:41:31,560 --> 00:41:33,560 >> YES. 900 00:41:33,560 --> 00:41:37,760 901 00:41:37,760 --> 00:41:41,360 >> YOU NEED TO UNMUTE, HOWARD. 902 00:41:41,360 --> 00:41:45,320 >> DOUG, COULD YOU GIVE US A 903 00:41:45,320 --> 00:41:46,920 COMMENT ON YOUR PREDICTED 904 00:41:46,920 --> 00:41:49,360 DIRECTIONS AND HOW WE'RE SEEING 905 00:41:49,360 --> 00:41:54,960 FRUIT COMING FROM THE OTHER -- 906 00:41:54,960 --> 00:41:57,040 FROM THE SIMX AND 907 00:41:57,040 --> 00:41:58,320 IMMUNO-ONCOLOGY BIOMARKERS NOW 908 00:41:58,320 --> 00:41:59,640 GETTING PUBLISHED AND VALIDATION 909 00:41:59,640 --> 00:42:01,760 WORK GOING ON, DO YOU SEE HOW 910 00:42:01,760 --> 00:42:03,800 THAT MIGHT BE COMING BACK TO 911 00:42:03,800 --> 00:42:06,680 FURTHER ADVANCE THE GOALS THAT 912 00:42:06,680 --> 00:42:07,760 ELECTRA ARTICULATED, NOT ONLY 913 00:42:07,760 --> 00:42:16,360 JUST ACCRUAL BUT LET'S SAY GOOD 914 00:42:16,360 --> 00:42:17,560 RESPONSES, NOT WASTING TIME OF 915 00:42:17,560 --> 00:42:19,280 THE PATIENTS WHO DO ENROLL IN 916 00:42:19,280 --> 00:42:20,200 THOSE STUDIES. 917 00:42:20,200 --> 00:42:23,040 >> THEY HAVE REALLY BEEN 918 00:42:23,040 --> 00:42:24,400 VALIDATING ASSAYS AND SHOWING 919 00:42:24,400 --> 00:42:27,920 THAT THEY ARE RIGOROUS. 920 00:42:27,920 --> 00:42:30,440 JIM DOROSHOW IS HERE, AND JIM 921 00:42:30,440 --> 00:42:34,200 MIGHT WANT TO COMMENT FURTHER. 922 00:42:34,200 --> 00:42:34,760 JIM? 923 00:42:34,760 --> 00:42:36,160 >> THANKS, DOUG. 924 00:42:36,160 --> 00:42:37,200 THANKS FOR THE QUESTION. 925 00:42:37,200 --> 00:42:41,680 SO, I THINK THE THING THAT IS 926 00:42:41,680 --> 00:42:45,400 PROBABLY MOST IMPORTANT IN THE 927 00:42:45,400 --> 00:42:49,120 INTERMEDIATE TERM IS THAT 928 00:42:49,120 --> 00:42:51,440 BECAUSE SIMAC ASSAY, IT'S A 929 00:42:51,440 --> 00:42:53,520 GREAT PROGRAM, BUT IT'S BASED ON 930 00:42:53,520 --> 00:42:55,400 OBTAINING SAMPLES FROM PATIENTS 931 00:42:55,400 --> 00:42:57,120 ALREADY ACCRUED TO TRIALS. 932 00:42:57,120 --> 00:43:03,440 WE ARE VERY FAR ALONG, AND IN A 933 00:43:03,440 --> 00:43:04,840 SUBSEQUENT MEET WILL GO SHARE 934 00:43:04,840 --> 00:43:06,760 THE NEW ACTIVITIES WE'RE 935 00:43:06,760 --> 00:43:09,040 UNDERTAKING BUT ONE IS I-MATCH, 936 00:43:09,040 --> 00:43:11,880 FOR THE FIRST TIME PATIENTS WILL 937 00:43:11,880 --> 00:43:15,800 GET A STANDARDIZED SET OF 938 00:43:15,800 --> 00:43:16,880 IMMUNOLOGICAL MARKERS BEFORE 939 00:43:16,880 --> 00:43:18,240 THEY GO ON TRIAL, HIGHLY 940 00:43:18,240 --> 00:43:26,880 VALIDATED, DONE IN CORE 941 00:43:26,880 --> 00:43:27,880 LABORATORIES, TO DEVELOPING 942 00:43:27,880 --> 00:43:28,160 BIOMARKERS. 943 00:43:28,160 --> 00:43:29,360 IT'S DIVERSITY RESULT TO PREDICT 944 00:43:29,360 --> 00:43:30,800 WHO WILL RESPOND AND WHO WILL 945 00:43:30,800 --> 00:43:31,320 NOT. 946 00:43:31,320 --> 00:43:32,560 THE ASSAYS ARE NOT STANDARDIZED 947 00:43:32,560 --> 00:43:33,800 SO WE HOPE TO BE ABLE TO SET UP 948 00:43:33,800 --> 00:43:35,600 A WAY IN WHICH WE CAN ACCRUE A 949 00:43:35,600 --> 00:43:37,160 SUBSTANTIAL NUMBER OF PATIENTS 950 00:43:37,160 --> 00:43:39,320 AND THEN GET FEEDBACK TO 951 00:43:39,320 --> 00:43:40,080 UNDERSTAND BETTER AND BETTER 952 00:43:40,080 --> 00:43:42,280 WAYS TO USE THAT INFORMATION TO 953 00:43:42,280 --> 00:43:43,480 CHOOSE PATIENTS FOR IMMUNE 954 00:43:43,480 --> 00:43:46,080 MODULATED TRIALS. 955 00:43:46,080 --> 00:43:49,920 956 00:43:49,920 --> 00:43:51,360 >> THANKS, JIM. 957 00:43:51,360 --> 00:43:53,640 WE'RE AT TOP OF HOUR. 958 00:43:53,640 --> 00:43:56,320 DOUG, THANKS FOR THE DIRECTOR'S 959 00:43:56,320 --> 00:43:56,640 REPORT. 960 00:43:56,640 --> 00:43:59,280 NEXT AGENDA ITEM IS REPORT FROM 961 00:43:59,280 --> 00:44:01,400 M.K. HOLOHAN WHICH WILL BE THE 962 00:44:01,400 --> 00:44:03,600 LEGISLATIVE REPORT. 963 00:44:03,600 --> 00:44:04,400 M.K.? 964 00:44:04,400 --> 00:44:05,280 >> THANK YOU, DR. CARPTEN. 965 00:44:05,280 --> 00:44:06,680 THANK YOU FOR THE OPPORTUNITY TO 966 00:44:06,680 --> 00:44:08,160 SPEAK WITH YOU ALL TODAY. 967 00:44:08,160 --> 00:44:09,640 I WANT TO REMIND THE BOARD 968 00:44:09,640 --> 00:44:11,680 MEMBERS AS I ALWAYS DO THERE'S A 969 00:44:11,680 --> 00:44:13,600 DETAILED LEGISLATIVE UPDATE IN 970 00:44:13,600 --> 00:44:14,160 YOUR MEETING MATERIALS. 971 00:44:14,160 --> 00:44:15,640 THE TIME I HAVE TODAY I'M GOING 972 00:44:15,640 --> 00:44:20,040 TO COVER SOME MAJOR TOPICS 973 00:44:20,040 --> 00:44:21,280 BRIEFLY BUT THERE'S MORE DETAIL 974 00:44:21,280 --> 00:44:22,000 IN THE UPDATE. 975 00:44:22,000 --> 00:44:26,720 MY TEAM ARE GLAD TO TALK WITH 976 00:44:26,720 --> 00:44:28,480 YOU OR STAFF SO REACH OUT WITH 977 00:44:28,480 --> 00:44:28,720 QUESTIONS. 978 00:44:28,720 --> 00:44:29,320 NEXT SLIDE PLEASE. 979 00:44:29,320 --> 00:44:31,080 AS I THINK YOU'RE ALL AWARE THE 980 00:44:31,080 --> 00:44:33,960 FISCAL YEAR ENDS IN LESS THAN A 981 00:44:33,960 --> 00:44:34,160 MONTH. 982 00:44:34,160 --> 00:44:37,200 WE'RE PREPARING FOR A CONTINUING 983 00:44:37,200 --> 00:44:38,080 RESOLUTION, A C.R. 984 00:44:38,080 --> 00:44:41,520 I WANT TO TELL YOU WE DO NOT 985 00:44:41,520 --> 00:44:42,880 ANTICIPATE A GOVERNMENT 986 00:44:42,880 --> 00:44:43,680 SHUTDOWN. 987 00:44:43,680 --> 00:44:45,240 IT IS ALWAYS UNPOPULAR, 988 00:44:45,240 --> 00:44:46,920 POLITICALLY RISKY, EVEN MORE SO 989 00:44:46,920 --> 00:44:47,920 DURING AN ELECTION YEAR. 990 00:44:47,920 --> 00:44:49,640 THAT DOESN'T MEAN THAT IT'S NOT 991 00:44:49,640 --> 00:44:52,800 GOING TO BE LAST MINUTE BEFORE A 992 00:44:52,800 --> 00:44:54,320 C.R. IS IN PLACE, THAT'S 993 00:44:54,320 --> 00:44:55,760 BUSINESS AS USUAL FOR CONGRESS. 994 00:44:55,760 --> 00:44:57,480 I WANTED TO SHOW YOU THIS 995 00:44:57,480 --> 00:44:59,520 GRAPHIC, I'VE SHOWN IT BEFORE. 996 00:44:59,520 --> 00:45:00,520 IF YOU'LL INDULGE ME IT 997 00:45:00,520 --> 00:45:02,160 REPRESENTS THE BIG PICTURE OF 998 00:45:02,160 --> 00:45:03,800 HOW NCI RECEIVES ITS FUNDING AS 999 00:45:03,800 --> 00:45:05,760 PART OF THE FEDERAL BUDGET 1000 00:45:05,760 --> 00:45:06,400 PROCESS. 1001 00:45:06,400 --> 00:45:07,880 SO, AFTER THE PRESIDENT'S BUDGET 1002 00:45:07,880 --> 00:45:09,760 IS RELEASED, PROPOSAL FOR THE 1003 00:45:09,760 --> 00:45:11,800 FOLLOWING FISCAL YEAR, PRESIDENT 1004 00:45:11,800 --> 00:45:14,640 BIDEN RELEASED HIS FY23 PROPOSAL 1005 00:45:14,640 --> 00:45:16,400 IN LATE MARCH. 1006 00:45:16,400 --> 00:45:18,200 THEN CONGRESS HOLDS HEARINGS IN 1007 00:45:18,200 --> 00:45:20,640 STEP 2, BEGIN WORK ON PREPARING 1008 00:45:20,640 --> 00:45:22,640 SPENDING BILLS, AGENCY HEADS AND 1009 00:45:22,640 --> 00:45:23,720 DEPARTMENT HEADS TESTIFY. 1010 00:45:23,720 --> 00:45:25,640 THE NIH BUDGET HEARINGS WERE IN 1011 00:45:25,640 --> 00:45:28,320 MAY OF THIS YEAR. 1012 00:45:28,320 --> 00:45:31,920 THE RED X REPRESENTS WHERE WE 1013 00:45:31,920 --> 00:45:32,480 CURRENTLY ARE. 1014 00:45:32,480 --> 00:45:33,920 I SHOWED THIS IN JUNE. 1015 00:45:33,920 --> 00:45:36,200 WE WERE IN THE SAME SPOT THEN. 1016 00:45:36,200 --> 00:45:39,360 IDEALLY STEP 3 WHERE THE 1017 00:45:39,360 --> 00:45:40,280 APPROPRIATIONS COMMITTEES 1018 00:45:40,280 --> 00:45:42,120 CONFERENCE AND HAVE BIPARTISAN 1019 00:45:42,120 --> 00:45:43,000 NEGOTIATIONS, THEY FINALIZE 1020 00:45:43,000 --> 00:45:44,520 SPENDING BILLS, AND THEY ARE 1021 00:45:44,520 --> 00:45:46,520 ABLE TO BE READY TO BE ENACTED, 1022 00:45:46,520 --> 00:45:48,680 THAT HAPPENS IN THE SUMMER 1023 00:45:48,680 --> 00:45:49,640 IDEALLY AND WE CAN GET 1024 00:45:49,640 --> 00:45:50,880 APPROPRIATION BEFORE THE START 1025 00:45:50,880 --> 00:45:52,560 OF THE FISCAL YEAR. 1026 00:45:52,560 --> 00:45:54,040 IN REALITY, THIS ALMOST NEVER 1027 00:45:54,040 --> 00:45:54,840 HAPPENS. 1028 00:45:54,840 --> 00:45:58,720 IT'S HAPPENED IN THE PAST 26 1029 00:45:58,720 --> 00:46:00,480 YEARS, IT'S HAPPENED TWICE, FOR 1030 00:46:00,480 --> 00:46:01,280 NIH. 1031 00:46:01,280 --> 00:46:03,440 IN 1996 AND IN 2018. 1032 00:46:03,440 --> 00:46:06,080 IN 2018, IT HAPPENED BECAUSE OUR 1033 00:46:06,080 --> 00:46:08,760 FY 19 BILL WAS PAIRED WITH THE 1034 00:46:08,760 --> 00:46:10,680 DEFENSE BILL SO THAT REALLY 1035 00:46:10,680 --> 00:46:12,760 RECRUITED ALL THE MEMBERS WHO 1036 00:46:12,760 --> 00:46:15,920 WANTED TO VOTE FOR DEFENSE BUT 1037 00:46:15,920 --> 00:46:17,640 NOT LABOR H HAD NO CHOICE, THAT 1038 00:46:17,640 --> 00:46:19,600 SPARED US FROM BEING PART OF THE 1039 00:46:19,600 --> 00:46:21,400 LONGEST GOVERNMENT SHUTDOWN IN 1040 00:46:21,400 --> 00:46:21,800 HISTORY. 1041 00:46:21,800 --> 00:46:22,680 MANY PARTS OF THE FEDERAL 1042 00:46:22,680 --> 00:46:24,040 GOVERNMENT WERE SHUT DOWN FOR AN 1043 00:46:24,040 --> 00:46:25,600 EXTENDED PERIOD OF TIME AND WE 1044 00:46:25,600 --> 00:46:27,520 WERE VERY GRATEFUL TO HAVE 1045 00:46:27,520 --> 00:46:28,080 AVOIDED THAT. 1046 00:46:28,080 --> 00:46:32,080 SO WHAT YOU NEED TO UNDERSTAND 1047 00:46:32,080 --> 00:46:33,880 THERE'S VIRTUALLY NO CHANCE OF 1048 00:46:33,880 --> 00:46:35,160 APPROPRIATIONS BEING COMPLETED 1049 00:46:35,160 --> 00:46:37,080 BEFORE THE MIDTERM ELECTIONS IN 1050 00:46:37,080 --> 00:46:38,240 NOVEMBER. 1051 00:46:38,240 --> 00:46:38,840 PROBABLY WELL INTO DECEMBER, 1052 00:46:38,840 --> 00:46:42,920 HOPEFULLY NOT TOO MUCH LONGER 1053 00:46:42,920 --> 00:46:43,760 THAN THAT. 1054 00:46:43,760 --> 00:46:45,960 IT IS NOT LIKELY BUT NOT 1055 00:46:45,960 --> 00:46:46,960 IMPOSSIBLE APPROPRIATIONS COULD 1056 00:46:46,960 --> 00:46:48,160 BE PUNTED INTO THE NEXT 1057 00:46:48,160 --> 00:46:48,800 CONGRESS. 1058 00:46:48,800 --> 00:46:50,440 I THINK THIS IS UNLIKELY FOR A 1059 00:46:50,440 --> 00:46:52,000 FEW REASONS. 1060 00:46:52,000 --> 00:46:53,080 ONE IS THERE'S STRONG MOTIVATION 1061 00:46:53,080 --> 00:46:55,040 TO GET THIS DONE IN THIS 1062 00:46:55,040 --> 00:46:57,440 CONGRESS FOR THE RETIRING 1063 00:46:57,440 --> 00:46:59,600 MEMBERS, SEVERAL SENIOR 1064 00:46:59,600 --> 00:47:01,080 APPROPRIATORS RETIRING IN THE 1065 00:47:01,080 --> 00:47:04,360 SENATE, SENATOR ROY BLUNT 1066 00:47:04,360 --> 00:47:05,760 RANKING MEMBER, RICHARD SHELBY 1067 00:47:05,760 --> 00:47:07,160 FROM ALABAMA THE RANKING MEMBER 1068 00:47:07,160 --> 00:47:09,480 OF THE FULL COMMITTEE, AND 1069 00:47:09,480 --> 00:47:10,440 SENATOR PATRICK LEAHY, CHAIR OF 1070 00:47:10,440 --> 00:47:11,000 THE FULL COMMITTEE. 1071 00:47:11,000 --> 00:47:13,200 THEY WOULD LIKE TO GET THEIR 1072 00:47:13,200 --> 00:47:14,120 EARMARKS INTO THESE BILLS, GET 1073 00:47:14,120 --> 00:47:15,320 THEM DONE AND PUT THEIR MARK ON 1074 00:47:15,320 --> 00:47:17,640 THIS AS THEY HAVE BEEN DOING 1075 00:47:17,640 --> 00:47:18,800 THIS WORK FOR DECADES. 1076 00:47:18,800 --> 00:47:20,560 ON THIS NEXT SLIDE THESE ARE 1077 00:47:20,560 --> 00:47:22,800 SOME PHOTOS FROM OUR 1078 00:47:22,800 --> 00:47:24,160 APPROPRIATIONS HEARINGS IN MAY. 1079 00:47:24,160 --> 00:47:28,880 ON THE LEFT DR. LOWY TESTIFIED 1080 00:47:28,880 --> 00:47:31,960 REPRESENTING NCI AT THE MAY 1081 00:47:31,960 --> 00:47:34,360 HEARING IN THE HOUSE. 1082 00:47:34,360 --> 00:47:35,640 CHAIRMAN DELAURO WANTED TO MAKE 1083 00:47:35,640 --> 00:47:38,080 A POINT, THEY CONTINUED THE FY 1084 00:47:38,080 --> 00:47:39,160 22 OMNIBUS A FEW WEEKS BEFORE 1085 00:47:39,160 --> 00:47:40,080 THIS HEARING AND SHE WANTED TO 1086 00:47:40,080 --> 00:47:42,000 MAKE THE POINT THEY WERE ABLE TO 1087 00:47:42,000 --> 00:47:45,520 COME TOGETHER AND INCREASE THE 1088 00:47:45,520 --> 00:47:46,920 NCI BUDGET BY $353 MILLION, 1089 00:47:46,920 --> 00:47:48,320 WE'RE VERY FORTUNATE THESE 1090 00:47:48,320 --> 00:47:51,160 MEMBERS HAVE TAKEN A PERSONAL 1091 00:47:51,160 --> 00:47:52,320 INTEREST IN CANCER RESEARCH. 1092 00:47:52,320 --> 00:47:55,080 THEY HAVE COME TOGETHER EVEN IN 1093 00:47:55,080 --> 00:47:57,440 VERY PARTISAN TIMES TO SUPPORT 1094 00:47:57,440 --> 00:47:59,600 INCREASES FOR NIH AND NCI, A 1095 00:47:59,600 --> 00:48:00,800 GREAT BENEFIT TO US. 1096 00:48:00,800 --> 00:48:03,360 THE PICTURES ON THE RIGHT SHOW 1097 00:48:03,360 --> 00:48:05,240 ACTING NIH DIRECTOR DR. LARRY 1098 00:48:05,240 --> 00:48:06,360 TABAK AND NIAID DIRECTOR DR. 1099 00:48:06,360 --> 00:48:08,120 TONY FAUCI AT THE SENATE 1100 00:48:08,120 --> 00:48:09,040 HEARING. 1101 00:48:09,040 --> 00:48:10,600 THE COUNTERPARTS IN THE SENATE 1102 00:48:10,600 --> 00:48:12,240 CHAIRWOMAN PATTY MURRAY OF 1103 00:48:12,240 --> 00:48:18,400 WASHINGTON STATE AND SENATOR ROY 1104 00:48:18,400 --> 00:48:22,200 BLUNT RANKING MEMBER OF MISSOURI 1105 00:48:22,200 --> 00:48:26,960 AR COLLEGIAL AND HAD A SHARED 1106 00:48:26,960 --> 00:48:27,200 PLIGHTER. 1107 00:48:27,200 --> 00:48:30,440 I LIKE THIS PICTURE. 1108 00:48:30,440 --> 00:48:33,080 OVER THE TIME THEY HAVE GOTTEN 1109 00:48:33,080 --> 00:48:35,880 TO KNOW HIM PERSONALLY, KNEW DR. 1110 00:48:35,880 --> 00:48:39,280 SHARPLESS, WE'RE LOOKING FORWARD 1111 00:48:39,280 --> 00:48:40,440 TO INTRODUCING DR. BERTAGNOLLI. 1112 00:48:40,440 --> 00:48:42,720 IT'S GREAT TO HAVE DIRECT 1113 00:48:42,720 --> 00:48:43,200 COMMUNICATION. 1114 00:48:43,200 --> 00:48:44,800 WE'RE ABLE TO UNDERSTAND THEIR 1115 00:48:44,800 --> 00:48:46,440 CONCERNS AND BE RESPONSIVE TO 1116 00:48:46,440 --> 00:48:49,120 QUESTIONS THEY HAVE. 1117 00:48:49,120 --> 00:48:50,080 NEXT SLIDE PLEASE. 1118 00:48:50,080 --> 00:48:52,720 SO WHAT I WANT TO SHOW HERE, 1119 00:48:52,720 --> 00:48:53,960 BEFORE I START TALKING ABOUT THE 1120 00:48:53,960 --> 00:48:55,720 NUMBERS I WANT TO BE CLEAR ABOUT 1121 00:48:55,720 --> 00:48:57,360 WHAT THESE MEAN AND WHAT THEY 1122 00:48:57,360 --> 00:48:58,040 DON'T MEAN. 1123 00:48:58,040 --> 00:49:00,000 THESE NUMBERS THAT I'M GOING TO 1124 00:49:00,000 --> 00:49:05,080 SHOW YOU DO NOT REFLECT 1125 00:49:05,080 --> 00:49:06,160 BIPARTISAN NEGOTIATED SPENDING 1126 00:49:06,160 --> 00:49:06,400 PROPOSALS. 1127 00:49:06,400 --> 00:49:08,760 AND THAT'S NOT TO SAY THIS IS 1128 00:49:08,760 --> 00:49:09,720 NOT AN IMPORTANT START, AN 1129 00:49:09,720 --> 00:49:12,280 IMPORTANT PART OF THE PROGRESS, 1130 00:49:12,280 --> 00:49:14,440 BUT SERIOUS NEGOTIATIONS ABOUT 1131 00:49:14,440 --> 00:49:16,640 FY23 WON'T REALLY START UNTIL 1132 00:49:16,640 --> 00:49:17,640 AFTER THE MIDTERMS AND 1133 00:49:17,640 --> 00:49:19,880 LEADERSHIP ON BOTH SIDES OF THE 1134 00:49:19,880 --> 00:49:21,480 AISLE KNOW WHAT HANDS THEY ARE 1135 00:49:21,480 --> 00:49:22,000 PLAYING. 1136 00:49:22,000 --> 00:49:24,440 THE PARTIES HAVE ALSO NOT 1137 00:49:24,440 --> 00:49:26,680 ADDRESSED THE BIGGEST THRESHOLD 1138 00:49:26,680 --> 00:49:28,800 ISSUE THIS YEAR AND LAST YEAR, 1139 00:49:28,800 --> 00:49:29,920 FUNDING FOR DEFENSE VERSUS 1140 00:49:29,920 --> 00:49:30,240 NON-DEFENSE. 1141 00:49:30,240 --> 00:49:32,640 THIS IS A TOP LINE 1142 00:49:32,640 --> 00:49:33,080 DETERMINATION. 1143 00:49:33,080 --> 00:49:34,800 IT WAS A BIG OBSTACLE TO THE 1144 00:49:34,800 --> 00:49:37,040 PRESSES LAST YEAR. 1145 00:49:37,040 --> 00:49:38,000 WASN'T RESOLVED UNTIL FEBRUARY. 1146 00:49:38,000 --> 00:49:39,600 HOPEFULLY IT WON'T TAKE THAT 1147 00:49:39,600 --> 00:49:40,400 LONG THIS YEAR. 1148 00:49:40,400 --> 00:49:43,240 BUT I WILL SAY LAST YEAR WHEN IT 1149 00:49:43,240 --> 00:49:45,600 WAS RESOLVED THE OMNIBUS WAS 1150 00:49:45,600 --> 00:49:47,280 COMPLETED AND ENACTED WITHIN SIX 1151 00:49:47,280 --> 00:49:47,640 WEEKS. 1152 00:49:47,640 --> 00:49:51,560 SO ONCE THAT DOMINO FELL, THINGS 1153 00:49:51,560 --> 00:49:52,120 PROGRESSED QUICKLY. 1154 00:49:52,120 --> 00:49:54,480 ALSO LIKE LAST YEAR, THERE ARE 1155 00:49:54,480 --> 00:50:01,560 EVERGREEN POLICY DISPUTES ABOUT 1156 00:50:01,560 --> 00:50:02,160 IMMIGRATION, BORDER SECURITY, 1157 00:50:02,160 --> 00:50:03,080 IMMIGRATION, PLAYING OUT WHEN 1158 00:50:03,080 --> 00:50:04,520 THE SIDES BEGIN TO NEGOTIATE. 1159 00:50:04,520 --> 00:50:06,920 SO LOOKING AT THESE NUMBERS, THE 1160 00:50:06,920 --> 00:50:07,840 HOUSE HAD THE VOTES TO MOVE 1161 00:50:07,840 --> 00:50:09,320 THEIR BILLS OUT OF COMMITTEE. 1162 00:50:09,320 --> 00:50:10,280 THEY HAVE SLIGHTLY LARGER 1163 00:50:10,280 --> 00:50:12,360 MARGINS THAN THE SENATE. 1164 00:50:12,360 --> 00:50:13,240 SO THE APPROPRIATIONS COMMITTEES 1165 00:50:13,240 --> 00:50:15,480 WERE ABLE TO PASS THESE BILLS 1166 00:50:15,480 --> 00:50:18,160 OUT OF COMMITTEE, WHAT THEY 1167 00:50:18,160 --> 00:50:19,440 PROPOSED WAS A $466 MILLION 1168 00:50:19,440 --> 00:50:20,840 INCREASE FOR THE NCI. 1169 00:50:20,840 --> 00:50:24,320 WE WERE VERY GRATEFUL TO SEE 1170 00:50:24,320 --> 00:50:24,520 THAT. 1171 00:50:24,520 --> 00:50:26,920 THE SENATE, 50-50 SENATE DID NOT 1172 00:50:26,920 --> 00:50:30,520 HAVE THOSE VOTES SO CHAIRMAN 1173 00:50:30,520 --> 00:50:31,840 LEAHY, SAME SITUATION, POSTED 1174 00:50:31,840 --> 00:50:33,040 DRAFT BILLS, REFLECTING THE 1175 00:50:33,040 --> 00:50:34,800 MAJORITY VIEWPOINT IN THE 1176 00:50:34,800 --> 00:50:35,040 SENATE. 1177 00:50:35,040 --> 00:50:36,920 AND IT'S THE MAJORITY 1178 00:50:36,920 --> 00:50:38,320 PREROGATIVE TO DO THIS. 1179 00:50:38,320 --> 00:50:40,080 WHAT WE SAW WHEN THE SENATE BILL 1180 00:50:40,080 --> 00:50:43,160 WAS POSTED IN LATE JULY WAS 1181 00:50:43,160 --> 00:50:44,720 PROPOSED $290 MILLION INCREASE 1182 00:50:44,720 --> 00:50:46,040 FOR THE NCI. 1183 00:50:46,040 --> 00:50:48,000 SO, THESE NUMBERS ARE REALLY 1184 00:50:48,000 --> 00:50:49,200 IMPORTANT INDICATORS ABOUT WHERE 1185 00:50:49,200 --> 00:50:51,440 THE CONVERSATION IS GOING TO 1186 00:50:51,440 --> 00:50:54,200 START WHEN THEY BEGIN 1187 00:50:54,200 --> 00:50:54,640 NEGOTIATIONS. 1188 00:50:54,640 --> 00:50:55,920 NEXT SLIDE PLEASE. 1189 00:50:55,920 --> 00:50:59,320 SO I KNOW THERE'S A LOT OF 1190 00:50:59,320 --> 00:51:00,320 INTEREST IN ARPA-H, STILL EARLY 1191 00:51:00,320 --> 00:51:01,880 STAGES, THERE MAY BE MORE 1192 00:51:01,880 --> 00:51:02,960 QUESTIONS THAN ANSWERS. 1193 00:51:02,960 --> 00:51:04,800 BUT I THOUGHT IT WOULD BE 1194 00:51:04,800 --> 00:51:06,560 HELPFUL TO POINT THE BOARD TO 1195 00:51:06,560 --> 00:51:07,760 THE MOST RECENT PRESENTATION, 1196 00:51:07,760 --> 00:51:10,200 THIS IS THE MOST COMPREHENSIVE 1197 00:51:10,200 --> 00:51:13,560 INFORMATION THAT WE HAVE. 1198 00:51:13,560 --> 00:51:14,160 DR. TARA SCHWETZ PRESENTED AT 1199 00:51:14,160 --> 00:51:16,200 THE ADVISORY COMMITTEE TO THE 1200 00:51:16,200 --> 00:51:18,360 DIRECTOR IN JUNE. 1201 00:51:18,360 --> 00:51:19,480 AND INTERESTING PRESENTATION, 1202 00:51:19,480 --> 00:51:21,160 AND THE DISCUSSION WAS 1203 00:51:21,160 --> 00:51:22,240 ILLUMINATING I THINK. 1204 00:51:22,240 --> 00:51:24,440 I THOUGHT WE WOULD FOCUS ON WHAT 1205 00:51:24,440 --> 00:51:26,280 WE DO KNOW. 1206 00:51:26,280 --> 00:51:28,440 ARPA-H RECEIVED $1 BILLION 1207 00:51:28,440 --> 00:51:33,000 APPROPRIATION IN FY 22 OMNIBUS, 1208 00:51:33,000 --> 00:51:35,280 INCLUDED WAS AUTHORIZATION FOR 1209 00:51:35,280 --> 00:51:38,280 THE HHS SECRETARY TO TRANSFER 1210 00:51:38,280 --> 00:51:40,920 ARPA-H ANYWHERE WITHIN HHS, AND 1211 00:51:40,920 --> 00:51:41,520 SPECIFICALLY NOTED INCLUDING 1212 00:51:41,520 --> 00:51:41,800 NIH. 1213 00:51:41,800 --> 00:51:43,480 AND THAT IS WHAT HE DID. 1214 00:51:43,480 --> 00:51:46,520 HE DID THAT IN APRIL. 1215 00:51:46,520 --> 00:51:50,040 SO, I THINK PEOPLE ARE PROBABLY 1216 00:51:50,040 --> 00:51:54,360 PRETTY WELL AWARE THAT THERE IS 1217 00:51:54,360 --> 00:51:56,480 AUTHORIZING LEGISLATION THAT 1218 00:51:56,480 --> 00:51:58,200 REALLY REFLECTS SORT OF A 1219 00:51:58,200 --> 00:51:59,600 DISAGREEMENT WITHIN THE 1220 00:51:59,600 --> 00:52:01,200 SCIENTIFIC COMMUNITY, A LARGER 1221 00:52:01,200 --> 00:52:03,560 DEBATE WHERE SHOULD ARPA-H BE 1222 00:52:03,560 --> 00:52:04,600 AND INTERACT WITHIN NIH, IS IT 1223 00:52:04,600 --> 00:52:05,120 IMPORTANT IT'S OUTSIDE THE 1224 00:52:05,120 --> 00:52:09,840 STRUCK YOU -- STRUCTURE OF NIH 1225 00:52:09,840 --> 00:52:11,800 AGENCY OR CAN IT WORK 1226 00:52:11,800 --> 00:52:13,440 INDEPENDENTLY AND MAINTAIN THIS 1227 00:52:13,440 --> 00:52:14,400 WAY OF OPERATION. 1228 00:52:14,400 --> 00:52:15,960 I DON'T KNOW THE ANSWERS, I'M 1229 00:52:15,960 --> 00:52:18,160 NOT SURE IF THERE'S GOING TO BE 1230 00:52:18,160 --> 00:52:18,800 AUTHORIZING LEGISLATION. 1231 00:52:18,800 --> 00:52:21,680 THERE'S THREE BILLS. 1232 00:52:21,680 --> 00:52:23,640 ONE HAS PASSED THE HOUSE, ONE 1233 00:52:23,640 --> 00:52:25,080 INTRODUCED IN THE HOUSE, ONE 1234 00:52:25,080 --> 00:52:27,000 INTRODUCED IN THE SENATE. 1235 00:52:27,000 --> 00:52:28,160 THESE ARE PENDING. 1236 00:52:28,160 --> 00:52:28,960 THEY HAVE DIFFERENT APPROACHES. 1237 00:52:28,960 --> 00:52:33,240 THE ONE IN THE HOUSE THAT PASSED 1238 00:52:33,240 --> 00:52:35,440 THAT IS SPONSORED BY ANNA ESCHEW 1239 00:52:35,440 --> 00:52:36,880 OF CALIFORNIA WOULD PUT ARPA-H 1240 00:52:36,880 --> 00:52:40,800 IN HHS BUT NOT WITHIN NIH. 1241 00:52:40,800 --> 00:52:42,120 SENATE BILL INTRODUCED BY 1242 00:52:42,120 --> 00:52:50,040 SENATOR PATTY MURRAY AND RICHARD 1243 00:52:50,040 --> 00:52:52,320 BURR OF NORTH CAROLINA PREVENT 1244 00:52:52,320 --> 00:52:55,040 IT IN BEING LOCATE IN THE D.C. 1245 00:52:55,040 --> 00:52:57,360 AREA, IN THE NIH, PROHIBITED 1246 00:52:57,360 --> 00:52:58,560 FROM HIGHING ANYONE EMPLOYED BY 1247 00:52:58,560 --> 00:53:01,440 NIH IN THE PRIOR THREE YEARS. 1248 00:53:01,440 --> 00:53:03,280 WE DON'T KNOW WHAT'S GOING TO 1249 00:53:03,280 --> 00:53:04,600 HAPPEN OR WHO THE DIRECTOR WILL 1250 00:53:04,600 --> 00:53:04,800 BE. 1251 00:53:04,800 --> 00:53:05,880 THERE'S A LOT OF INTEREST IN 1252 00:53:05,880 --> 00:53:08,440 FIGURING OUT WHO WILL BE 1253 00:53:08,440 --> 00:53:09,400 APPOINTED TO LEAD THIS 1254 00:53:09,400 --> 00:53:09,720 ORGANIZATION. 1255 00:53:09,720 --> 00:53:11,280 IN MAY THERE WAS APPOINTMENT OF 1256 00:53:11,280 --> 00:53:13,920 DR. ADAM RUSSELL AS ACTING 1257 00:53:13,920 --> 00:53:14,880 DEPUTY DIRECTOR. 1258 00:53:14,880 --> 00:53:17,000 ONE OTHER THING I WANTED TO KNOW 1259 00:53:17,000 --> 00:53:18,760 ABOUT THE $1 BILLION 1260 00:53:18,760 --> 00:53:20,360 APPROPRIATION THAT ARPA-H 1261 00:53:20,360 --> 00:53:23,240 RECEIVED IN FY 22 THAT WAS GIVEN 1262 00:53:23,240 --> 00:53:24,880 TO THEM WITH THREE-YEAR BUDGET 1263 00:53:24,880 --> 00:53:27,080 AUTHORITY SO THEY CAN SPENT THAT 1264 00:53:27,080 --> 00:53:30,160 MONEY IN FY 22, 23, AND 24. 1265 00:53:30,160 --> 00:53:30,760 REALLY HELPFUL FLEXIBILITY FOR 1266 00:53:30,760 --> 00:53:35,240 THEM AS THEY ARE JUST GETTING 1267 00:53:35,240 --> 00:53:37,360 STARTED. 1268 00:53:37,360 --> 00:53:38,520 NEXT SLIDE PLEASE. 1269 00:53:38,520 --> 00:53:39,800 CAPITOL HILL IS A GHOST TOWN IN 1270 00:53:39,800 --> 00:53:45,720 AUGUST BUT NOT THIS YEAR. 1271 00:53:45,720 --> 00:53:49,280 ADMINISTRATION AND CONGRESSIONAL 1272 00:53:49,280 --> 00:53:51,160 DEMOCRATS HAD A GOOD AUGUST, 1273 00:53:51,160 --> 00:53:52,920 ADVANCING ALONG PARTY LINE 1274 00:53:52,920 --> 00:53:54,400 VOTES, THE FIRST CHIPS IN 1275 00:53:54,400 --> 00:53:56,160 SCIENCE ACT, YOU'VE HEARD OF 1276 00:53:56,160 --> 00:53:57,440 THIS WITH MANY NAMES. 1277 00:53:57,440 --> 00:54:00,640 IT STARTED TWO YEARS AGO BEING 1278 00:54:00,640 --> 00:54:02,920 CALLED THE ENDLESS FRONTIERS 1279 00:54:02,920 --> 00:54:03,320 ACT. 1280 00:54:03,320 --> 00:54:05,880 CHIPS IN SCIENCE ACT WILL INVEST 1281 00:54:05,880 --> 00:54:08,520 $52 BILLION IN U.S. PRODUCTION 1282 00:54:08,520 --> 00:54:11,760 OF SEMICONDUCTOR CHIPS AND 1283 00:54:11,760 --> 00:54:13,880 AUTHORIZED NOT APPROPRIATES A 1284 00:54:13,880 --> 00:54:16,520 FIVE-YEAR $81 BILLION INCREASE 1285 00:54:16,520 --> 00:54:17,280 IN FUNDING FOR THE NATIONAL 1286 00:54:17,280 --> 00:54:19,280 SCIENCE FOUNDATION. 1287 00:54:19,280 --> 00:54:21,680 INFLATION REDUCTION ACT ENACTED 1288 00:54:21,680 --> 00:54:24,600 AUGUST 16 IS REALLY ADVANCES IN 1289 00:54:24,600 --> 00:54:26,360 KEY DOMESTIC PRIORITIES FOR THE 1290 00:54:26,360 --> 00:54:27,480 ADMINISTRATION, HEALTH CARE, 1291 00:54:27,480 --> 00:54:28,800 ALLOWS MEDICARE TO NEGOTIATE 1292 00:54:28,800 --> 00:54:31,280 PRICES FOR SOME PRESCRIPTION 1293 00:54:31,280 --> 00:54:32,800 DRUGS, INVESTS IN CLIMATE CHANGE 1294 00:54:32,800 --> 00:54:34,680 AND CLEAN ENERGY, A REALLY 1295 00:54:34,680 --> 00:54:37,800 IMPORTANT PROVISION TO WORK TRUE 1296 00:54:37,800 --> 00:54:41,600 AND GET SENATOR MANCHIN'S 1297 00:54:41,600 --> 00:54:43,520 SUPPORT TO GET THROUGH THE 1298 00:54:43,520 --> 00:54:45,120 SENATE AND TAX OVERALL 1299 00:54:45,120 --> 00:54:45,880 PROVISION, TAXES FOR 1300 00:54:45,880 --> 00:54:46,640 CORPORATIONS, A BIG VICTORY. 1301 00:54:46,640 --> 00:54:50,160 THEY HAVE A LOT MORE WORK TO DO 1302 00:54:50,160 --> 00:54:51,280 THOUGH. 1303 00:54:51,280 --> 00:54:52,680 THERE ARE SOME MUST-PASS PIECES 1304 00:54:52,680 --> 00:54:53,560 OF LEGISLATION THAT HAVE TO BE 1305 00:54:53,560 --> 00:54:58,200 DEALT WITH IN THE NEXT MONTH. 1306 00:54:58,200 --> 00:54:59,520 THE USER FEES AUTHORIZATION FOR 1307 00:54:59,520 --> 00:55:02,160 FDA IS EXPIRING BY THE END OF 1308 00:55:02,160 --> 00:55:03,320 THE MONTH. 1309 00:55:03,320 --> 00:55:05,720 ALSO THE AUTHORIZATION FOR THE 1310 00:55:05,720 --> 00:55:07,360 SMALL BUSINESS INNOVATION 1311 00:55:07,360 --> 00:55:08,840 RESEARCH PROGRAM, AND NATIONAL 1312 00:55:08,840 --> 00:55:10,000 DEFENSE ANNUAL AUTHORIZATION. 1313 00:55:10,000 --> 00:55:11,400 SO WE EXPECT TO SEE ACTION ON 1314 00:55:11,400 --> 00:55:14,400 ALL OF THOSE BILLS IN THE NEXT 1315 00:55:14,400 --> 00:55:15,400 MONTH. 1316 00:55:15,400 --> 00:55:17,240 OTHER LEGISLATION WE'RE WATCHING 1317 00:55:17,240 --> 00:55:18,760 INCLUDES THERE WAS PANDEMIC 1318 00:55:18,760 --> 00:55:21,440 PREPAREDNESS LEGISLATION IN THE 1319 00:55:21,440 --> 00:55:22,800 SENATE, OBVIOUSLY ARPA-H 1320 00:55:22,800 --> 00:55:24,520 AUTHORIZATION, THERE WAS ALSO 1321 00:55:24,520 --> 00:55:25,200 COVID SUPPLEMENTAL BILL 1322 00:55:25,200 --> 00:55:26,960 INTRODUCED IN THE SENATE IN 1323 00:55:26,960 --> 00:55:27,200 JULY. 1324 00:55:27,200 --> 00:55:28,240 WE DON'T KNOW WHAT'S HAPPENING 1325 00:55:28,240 --> 00:55:30,800 WITH THAT OR WHAT MIGHT HAPPEN. 1326 00:55:30,800 --> 00:55:32,880 WE'VE SEEN REAL INTEREST IN THIS 1327 00:55:32,880 --> 00:55:34,280 CONGRESS, I'M SURE YOU'RE AWARE, 1328 00:55:34,280 --> 00:55:35,600 IN TELEHEALTH. 1329 00:55:35,600 --> 00:55:37,560 THERE'S BEEN OVER 50 BILLS 1330 00:55:37,560 --> 00:55:38,200 INTRODUCED, WE'RE WATCHING 1331 00:55:38,200 --> 00:55:40,080 SEVERAL OF THE BILLS, THE ONE 1332 00:55:40,080 --> 00:55:41,640 WITH THE MOST SPONSORS IS THE 1333 00:55:41,640 --> 00:55:42,160 CONNECT ACT. 1334 00:55:42,160 --> 00:55:45,200 THERE'S A LOT OF INTEREST IN 1335 00:55:45,200 --> 00:55:47,400 CONTINUING AND EXPANDING 1336 00:55:47,400 --> 00:55:48,520 TELEHEALTH FLEXIBILITY, SOME 1337 00:55:48,520 --> 00:55:49,480 THINGS THAT BECAME REALLY WELL 1338 00:55:49,480 --> 00:55:51,040 UNDERSTOOD DURING THE FIRST TWO 1339 00:55:51,040 --> 00:55:52,680 YEARS OF THE PANDEMIC. 1340 00:55:52,680 --> 00:55:54,560 ALSO CONGRESS HAS BEGUN TO PAY A 1341 00:55:54,560 --> 00:55:57,600 LOT OF ATTENTION TO CLINICAL 1342 00:55:57,600 --> 00:55:58,880 TRIALS, TO ACCESS AND INCLUSION, 1343 00:55:58,880 --> 00:55:59,880 NOT JUST FOR CANCER CLINICAL 1344 00:55:59,880 --> 00:56:01,760 TRIALS, FOR ALL CLINICAL TRIALS. 1345 00:56:01,760 --> 00:56:02,680 SO WE'RE TRACKING SOME 1346 00:56:02,680 --> 00:56:04,720 LEGISLATION IN THOSE AREAS AND 1347 00:56:04,720 --> 00:56:08,280 THAT DETAIL IS IN THE UPDATE 1348 00:56:08,280 --> 00:56:08,520 DOCUMENT. 1349 00:56:08,520 --> 00:56:09,080 NEXT SLIDE PLEASE. 1350 00:56:09,080 --> 00:56:11,800 SO THIS IS THE CONGRESSIONAL 1351 00:56:11,800 --> 00:56:12,760 CALENDAR. 1352 00:56:12,760 --> 00:56:15,360 ALWAYS SUBJECT TO CHANGE. 1353 00:56:15,360 --> 00:56:16,960 THEY RETURN, SOME RETURN, ON THE 1354 00:56:16,960 --> 00:56:20,600 6th OF NEXT WEEK WITH THREE 1355 00:56:20,600 --> 00:56:22,240 WEEKS TO PASS A CONTINUING 1356 00:56:22,240 --> 00:56:23,760 RESOLUTION TO AVOID GOVERNMENT 1357 00:56:23,760 --> 00:56:25,200 SHUTDOWN AND ADDRESS MUST-PASS 1358 00:56:25,200 --> 00:56:28,240 LEGISLATION THAT I REFERENCED 1359 00:56:28,240 --> 00:56:28,840 EARLIER. 1360 00:56:28,840 --> 00:56:30,280 THERE'S REALLY ONLY 11 DAYS 1361 00:56:30,280 --> 00:56:32,640 BETWEEN THEM COMING BACK AND THE 1362 00:56:32,640 --> 00:56:34,160 NOVEMBER MIDTERMS THAT BOTH 1363 00:56:34,160 --> 00:56:35,480 CHAMBERS ARE IN SESSION. 1364 00:56:35,480 --> 00:56:36,720 THE SENATE MAY BE BACK IN 1365 00:56:36,720 --> 00:56:37,960 OCTOBER FOR THESE TWO WEEKS THAT 1366 00:56:37,960 --> 00:56:40,080 ARE SLATED ON THE CALENDAR. 1367 00:56:40,080 --> 00:56:41,880 REALLY ALL MEMBERS OF THE HOUSE 1368 00:56:41,880 --> 00:56:43,960 WHO ARE UP FOR REELECTION AND A 1369 00:56:43,960 --> 00:56:45,680 THIRD OF THE SENATE, THAT'S UP 1370 00:56:45,680 --> 00:56:46,960 FOR REELECTION, WOULD LIKE TO BE 1371 00:56:46,960 --> 00:56:48,880 CAMPAIGNING IN THEIR DISTRICTS 1372 00:56:48,880 --> 00:56:49,720 AND STATES. 1373 00:56:49,720 --> 00:56:52,520 BUT THERE ARE 90 PENDING 1374 00:56:52,520 --> 00:56:53,200 NOMINATIONS FOR THE 1375 00:56:53,200 --> 00:56:54,800 ADMINISTRATION, NOT ALL ON THE 1376 00:56:54,800 --> 00:56:56,400 ARE GOING TO MOVE BUT THEY MAY 1377 00:56:56,400 --> 00:56:58,120 COME BACK TO WORK ON NOMINATIONS 1378 00:56:58,120 --> 00:57:00,080 IF IT'S SOMETHING THEY CAN'T GET 1379 00:57:00,080 --> 00:57:00,840 TO IN SEPTEMBER. 1380 00:57:00,840 --> 00:57:02,040 BECAUSE THERE MAY BE SOME THAT 1381 00:57:02,040 --> 00:57:04,560 THEY WANT TO GET DONE BEFORE 1382 00:57:04,560 --> 00:57:04,960 MIDTERMS. 1383 00:57:04,960 --> 00:57:08,440 AND WE'LL SEE WHAT HAPPENS WITH 1384 00:57:08,440 --> 00:57:08,680 THAT. 1385 00:57:08,680 --> 00:57:09,680 NEXT SLIDE PLEASE. 1386 00:57:09,680 --> 00:57:12,200 SO HISTORY TELLS US THAT THE 1387 00:57:12,200 --> 00:57:14,360 PRESIDENT'S PARTY LOSES SEATS IN 1388 00:57:14,360 --> 00:57:15,320 THE MIDTERMS. 1389 00:57:15,320 --> 00:57:16,720 THIS COVERAGE IS ON EVERY NEWS 1390 00:57:16,720 --> 00:57:18,160 REPORT ABOUT WHAT'S GOING TO 1391 00:57:18,160 --> 00:57:19,200 HAPPEN IN THE ELECTIONS. 1392 00:57:19,200 --> 00:57:20,680 I THOUGHT IT WAS INTERESTING TO 1393 00:57:20,680 --> 00:57:22,600 LOOK AT THESE DATA THAT SHOW 1394 00:57:22,600 --> 00:57:26,560 THERE'S ONLY BEEN TWO EXCEPTIONS 1395 00:57:26,560 --> 00:57:29,640 SINCE 1946 TO THAT HISTORICAL 1396 00:57:29,640 --> 00:57:31,000 LESSON. 1397 00:57:31,000 --> 00:57:32,640 FIRST WAS PRESIDENT CLINTON'S 1398 00:57:32,640 --> 00:57:35,120 SECOND TERM DEMOCRATS PICKED UP 1399 00:57:35,120 --> 00:57:36,400 FIVE SEATS AND PRESIDENT GEORGE 1400 00:57:36,400 --> 00:57:37,560 BUSH'S FIRST TERM WHERE 1401 00:57:37,560 --> 00:57:38,920 REPUBLICANS PICKED UP EIGHT 1402 00:57:38,920 --> 00:57:39,120 SEATS. 1403 00:57:39,120 --> 00:57:40,320 THAT WAS RIGHT AFTER 9/11, AND 1404 00:57:40,320 --> 00:57:41,800 SO THAT'S MAYBE LESS OF AN 1405 00:57:41,800 --> 00:57:43,960 OUTLIER THAN IT WOULD APPEAR 1406 00:57:43,960 --> 00:57:44,640 HERE. 1407 00:57:44,640 --> 00:57:47,480 NOT ONLY DO ELECTIONS MATTER BUT 1408 00:57:47,480 --> 00:57:47,960 ALSO MAJORITIES MATTER. 1409 00:57:47,960 --> 00:57:49,960 IT'S MUCH EASIER TO MOVE YOUR 1410 00:57:49,960 --> 00:57:52,400 PARTY'S AGENDA IF YOU HAVE A 1411 00:57:52,400 --> 00:57:53,400 HEALTHY MAJORITY AS OPPOSED TO 1412 00:57:53,400 --> 00:57:55,560 ONE OF THE SLIMMEST MAJORITIES 1413 00:57:55,560 --> 00:57:57,080 IN HISTORY THAT SPEAKER PELOSI 1414 00:57:57,080 --> 00:57:58,200 HAS BEEN DEALING WITH IN THE 1415 00:57:58,200 --> 00:57:59,760 HOUSE OVER THE PAST TWO YEARS, 1416 00:57:59,760 --> 00:58:01,400 FOR EXAMPLE, WHEN YOU CAN ONLY 1417 00:58:01,400 --> 00:58:02,880 LOSE A HANDFUL OF VOTES IT'S A 1418 00:58:02,880 --> 00:58:04,760 BIG CHALLENGE TO KEEP YOUR 1419 00:58:04,760 --> 00:58:06,840 CAUCUS TOGETHER AND BE ABLE TO 1420 00:58:06,840 --> 00:58:07,840 MOVE LEGISLATION. 1421 00:58:07,840 --> 00:58:11,080 SO WE'RE ALL INTERESTED I THINK 1422 00:58:11,080 --> 00:58:11,840 POLITICAL JUNKIES ARE INTERESTED 1423 00:58:11,840 --> 00:58:12,960 TO SEE WHAT HAPPENS. 1424 00:58:12,960 --> 00:58:14,400 IT APPEARS AS THOUGH THE 1425 00:58:14,400 --> 00:58:15,360 REPUBLICANS ARE STILL FAVORED 1426 00:58:15,360 --> 00:58:16,560 THROUGH MOST OF THE POLLING, 1427 00:58:16,560 --> 00:58:18,680 I'VE BEEN READING, TO RETAKE THE 1428 00:58:18,680 --> 00:58:21,320 HOUSE BUT PERHAPS WITH FAR 1429 00:58:21,320 --> 00:58:23,000 SMALLER MAJORITIES THAN EXPECTED 1430 00:58:23,000 --> 00:58:24,120 SO THE MAGNITUDE OF THE SHIFT IS 1431 00:58:24,120 --> 00:58:26,560 GOING TO BE IMPORTANT AS WELL AS 1432 00:58:26,560 --> 00:58:29,240 THE SHIFT ITSELF. 1433 00:58:29,240 --> 00:58:29,800 NEXT SLIDE PLEASE. 1434 00:58:29,800 --> 00:58:33,120 I WANTED TO SHOW YOU MY LAST 1435 00:58:33,120 --> 00:58:34,400 SLIDE, TURNOUT WILL BE REALLY 1436 00:58:34,400 --> 00:58:40,480 IMPORTANT IN THESE MIDTERMS, 1437 00:58:40,480 --> 00:58:43,440 MUCH HIGHER IN 2018, A LOT OF 1438 00:58:43,440 --> 00:58:45,880 PEOPLE -- MANY MORE SHOW UP FOR 1439 00:58:45,880 --> 00:58:46,920 PRESIDENTIAL ELECTIONS THAN 1440 00:58:46,920 --> 00:58:47,960 MIDTERMS SO IT'S INTERESTING TO 1441 00:58:47,960 --> 00:58:50,880 LOOK AT THIS AND SEE, WE SAW 1442 00:58:50,880 --> 00:58:52,320 THIS REALLY BIG INCREASE FROM 1443 00:58:52,320 --> 00:58:59,440 2014 TO 2018 AND WE'LL SEE HOW 1444 00:58:59,440 --> 00:59:03,360 GALVANIZING SUPREME COURT EVENTS 1445 00:59:03,360 --> 00:59:04,640 HAVE BEEN, I'M HAPPY TO TAKE 1446 00:59:04,640 --> 00:59:07,320 QUESTIONS NOW OR OFFLINE. 1447 00:59:07,320 --> 00:59:09,440 REACH OUT, I WOULD LOVE TO HEAR 1448 00:59:09,440 --> 00:59:10,800 FROM YOU. 1449 00:59:10,800 --> 00:59:11,120 THANKS. 1450 00:59:11,120 --> 00:59:12,880 >> THANKS, M.K. 1451 00:59:12,880 --> 00:59:20,120 THE FLOOR IS NOW OPEN FOR 1452 00:59:20,120 --> 00:59:21,000 QUESTIONS. 1453 00:59:21,000 --> 00:59:22,480 I'LL TAKE THE CHAIR'S 1454 00:59:22,480 --> 00:59:23,560 PREROGATIVE WHILE WE WAIT FOR 1455 00:59:23,560 --> 00:59:24,320 OTHER QUESTIONS. 1456 00:59:24,320 --> 00:59:28,840 AS WE THINK ABOUT THE MOONSHOT, 1457 00:59:28,840 --> 00:59:34,040 WILL IT SORT OF BUDGETARILY 1458 00:59:34,040 --> 00:59:34,560 OPERATE UNDER PREVIOUS 1459 00:59:34,560 --> 00:59:35,560 LEGISLATION OR REQUIRE NO 1460 00:59:35,560 --> 00:59:38,680 LEGISLATION TO FUND IT? 1461 00:59:38,680 --> 00:59:40,920 >> IT WOULD REQUIRE -- IT 1462 00:59:40,920 --> 00:59:44,240 WOULDN'T HAVE TO BE NEW 1463 00:59:44,240 --> 00:59:44,840 AUTHORIZATIONING LEGISLATION, 1464 00:59:44,840 --> 00:59:47,120 COULD BE APPROPRIATIONS BILL BUT 1465 00:59:47,120 --> 00:59:50,160 1.0 MOONSHOT WAS AUTHORIZED BY 1466 00:59:50,160 --> 00:59:51,960 THE 21ST CENTURY CURES. 1467 00:59:51,960 --> 00:59:52,280 >> RIGHT. 1468 00:59:52,280 --> 00:59:54,280 >> AND THEN APPROPRIATED. 1469 00:59:54,280 --> 00:59:54,560 >> RIGHT. 1470 00:59:54,560 --> 00:59:57,040 >> YEAH, IF IT WAS GOING TO BE 1471 00:59:57,040 --> 00:59:59,120 DONE IN THAT WAY, THROUGH -- 1472 00:59:59,120 --> 01:00:02,000 THOSE WERE -- THEY CREATED 1473 01:00:02,000 --> 01:00:04,840 SET-ASIDES AND CREATED MANDATORY 1474 01:00:04,840 --> 01:00:05,560 FUNDING FOR THOSE PROGRAMS, 1475 01:00:05,560 --> 01:00:07,240 APPROPRIATORS CAN FUND NEW 1476 01:00:07,240 --> 01:00:09,440 PROJECTS AND INITIATIVES AND DO 1477 01:00:09,440 --> 01:00:10,000 FREQUENTLY. 1478 01:00:10,000 --> 01:00:11,840 BUT THAT WAS A DIFFERENT AND 1479 01:00:11,840 --> 01:00:13,600 SORT OF UNIQUE MODEL. 1480 01:00:13,600 --> 01:00:16,400 IT REALLY -- WE'LL SEE WHAT'S 1481 01:00:16,400 --> 01:00:18,000 PROPOSED FOR FY 24 BUT AS CAME 1482 01:00:18,000 --> 01:00:21,320 UP IN THE BUDGET SUBCOMMITTEE 1483 01:00:21,320 --> 01:00:22,840 HEARING, EARLIER IN DR. LOWY'S 1484 01:00:22,840 --> 01:00:24,440 PRESENTATION, I'M SORRY, THAT'S 1485 01:00:24,440 --> 01:00:26,640 A NEXT BUDGET YEAR LET'S SEE HOW 1486 01:00:26,640 --> 01:00:27,840 THEY HANDLING IT. 1487 01:00:27,840 --> 01:00:29,920 I CAN TELL YOU THERE'S AN 1488 01:00:29,920 --> 01:00:32,840 AWARENESS AMONG MEMBERS OF 1489 01:00:32,840 --> 01:00:33,920 APPROPRIATIONS STAFF AND 1490 01:00:33,920 --> 01:00:35,640 COMMITTEE MEMBERS THAT THIS END 1491 01:00:35,640 --> 01:00:37,200 OF THAT FUNDING IS COMING, AND 1492 01:00:37,200 --> 01:00:38,800 THAT THERE'S GOING TO HAVE TO BE 1493 01:00:38,800 --> 01:00:41,640 SOME CHOICES MADE AND WE WANT TO 1494 01:00:41,640 --> 01:00:45,640 CONTINUE THIS IMPORTANT WORK. 1495 01:00:45,640 --> 01:00:48,000 >> THANKS. 1496 01:00:48,000 --> 01:00:50,400 I SEE CHRIS' HAND. 1497 01:00:50,400 --> 01:00:51,640 >> M.K., THANKS, AS ALWAYS. 1498 01:00:51,640 --> 01:00:53,680 APPRECIATE YOUR TIME AND 1499 01:00:53,680 --> 01:00:54,440 THOUGHTFUL REPORT. 1500 01:00:54,440 --> 01:00:55,400 THIS IS PROBABLY MORE JUST TO 1501 01:00:55,400 --> 01:00:57,920 THE OF A STATEMENT AS OPPOSED TO 1502 01:00:57,920 --> 01:01:00,360 A QUESTION BUT MAYBE YOU HAD 1503 01:01:00,360 --> 01:01:00,680 CONVERSATION. 1504 01:01:00,680 --> 01:01:03,480 SEVERAL OF US ARE DEEPLY 1505 01:01:03,480 --> 01:01:05,800 CONCERNED THAT THE ADDITIONAL 1506 01:01:05,800 --> 01:01:07,200 COVID RELIEF PACKAGES HAVE 1507 01:01:07,200 --> 01:01:07,600 STALLED. 1508 01:01:07,600 --> 01:01:08,920 I THINK IT'S JUST IMPORTANT TO 1509 01:01:08,920 --> 01:01:12,840 BE ON THE RECORD TO SAY THAT, 1510 01:01:12,840 --> 01:01:14,760 YOU KNOW, SHOULD UNFORTUNATELY 1511 01:01:14,760 --> 01:01:17,160 THE COUNTRY HAVE MORE SURGES, WE 1512 01:01:17,160 --> 01:01:19,800 HAVE TO UNDERSTAND THAT A SURGE 1513 01:01:19,800 --> 01:01:22,760 OF COVID WILL HINDER OUR ABILITY 1514 01:01:22,760 --> 01:01:25,320 IN THE CANCER COMMUNITY TO 1515 01:01:25,320 --> 01:01:26,800 ENROLL PATIENTS TO TRIALS, TO 1516 01:01:26,800 --> 01:01:27,760 CONTINUE THE DISCOVERY WORK 1517 01:01:27,760 --> 01:01:28,640 THAT'S SO ESSENTIAL. 1518 01:01:28,640 --> 01:01:30,920 I HAVEN'T REALLY SEEN THAT 1519 01:01:30,920 --> 01:01:32,400 CONVERSATION AT THE NATIONAL 1520 01:01:32,400 --> 01:01:32,600 LEVEL. 1521 01:01:32,600 --> 01:01:35,680 I DON'T KNOW IF CONGRESS IS 1522 01:01:35,680 --> 01:01:38,280 AWARE OF THOSE CONNECTIONS, THAT 1523 01:01:38,280 --> 01:01:40,160 COVID MAKES CANCER CARE AND 1524 01:01:40,160 --> 01:01:42,680 CLINICAL TRIALS EXCEEDINGLY 1525 01:01:42,680 --> 01:01:43,560 DIFFICULT. 1526 01:01:43,560 --> 01:01:45,400 AND WE HAVE DOCUMENTED EXCESS 1527 01:01:45,400 --> 01:01:46,640 MORTALITY DURING THE COVID 1528 01:01:46,640 --> 01:01:47,960 PERIOD FOR PATIENTS WITH CANCER, 1529 01:01:47,960 --> 01:01:49,560 WHETHER THEY HAD COVID OR NOT 1530 01:01:49,560 --> 01:01:51,400 SIMPLY BECAUSE THEY CAN'T GET 1531 01:01:51,400 --> 01:01:51,600 CARE. 1532 01:01:51,600 --> 01:01:53,600 I GUESS THAT'S MY STATEMENT. 1533 01:01:53,600 --> 01:01:57,200 THE QUESTION FOR YOU IS, HAS 1534 01:01:57,200 --> 01:01:59,680 THAT CONNECTION BETWEEN COVID 1535 01:01:59,680 --> 01:02:02,640 RELIEF FUNDS AND ITS IMPACT ON 1536 01:02:02,640 --> 01:02:04,440 EITHER CANCER CARE DELIVERY OR 1537 01:02:04,440 --> 01:02:05,120 CLINICAL TRIAL ENTERPRISE, HAS 1538 01:02:05,120 --> 01:02:06,720 THAT BEEN A CONVERSATION THAT 1539 01:02:06,720 --> 01:02:07,760 YOU'VE HEARD ABOUT? 1540 01:02:07,760 --> 01:02:09,280 >> YOU KNOW, IT'S A REALLY 1541 01:02:09,280 --> 01:02:10,040 INTERESTING QUESTION. 1542 01:02:10,040 --> 01:02:12,160 I'M NOT SURE IT'S HAPPENED IN 1543 01:02:12,160 --> 01:02:15,440 QUITE THAT WAY. 1544 01:02:15,440 --> 01:02:18,080 WE HAVE RECEIVED SINCE THE 1545 01:02:18,080 --> 01:02:22,200 BEGINNING WHEN NCI RECEIVED A 1546 01:02:22,200 --> 01:02:25,560 $306 MILLION PIECE OF THE COVID 1547 01:02:25,560 --> 01:02:28,000 FUNDING AS PART OF AN NIH 1548 01:02:28,000 --> 01:02:29,440 PACKAGE, THERE'S BEEN INTEREST 1549 01:02:29,440 --> 01:02:31,200 IN HOW COVID AFFECTED THE QUICK 1550 01:02:31,200 --> 01:02:32,040 ADJUSTMENTS MADE TO CLINICAL 1551 01:02:32,040 --> 01:02:33,840 TRIALS, SO WE WERE ABLE TO 1552 01:02:33,840 --> 01:02:35,160 CONTINUE SOME REALLY IMPORTANT 1553 01:02:35,160 --> 01:02:39,000 PROGRAMS AND ACCESS FOR 1554 01:02:39,000 --> 01:02:39,400 PATIENTS. 1555 01:02:39,400 --> 01:02:40,800 NCI'S WORKED WITH SEROLOGY AND 1556 01:02:40,800 --> 01:02:41,600 EXCESS MORTALITY. 1557 01:02:41,600 --> 01:02:42,880 BUT I DON'T THINK IT'S BEEN 1558 01:02:42,880 --> 01:02:44,840 LOOKED AT IN SORT OF THAT 1559 01:02:44,840 --> 01:02:46,760 HOLISTIC WAY BECAUSE THAT MUST 1560 01:02:46,760 --> 01:02:49,720 ALSO BE TRUE FOR OTHER DISEASE 1561 01:02:49,720 --> 01:02:50,280 AREAS AS WELL. 1562 01:02:50,280 --> 01:02:52,840 AND, YOU KNOW, I THINK THAT'S 1563 01:02:52,840 --> 01:02:55,160 ACTUALLY A REALLY IMPORTANT 1564 01:02:55,160 --> 01:02:55,840 POINT. 1565 01:02:55,840 --> 01:02:57,240 AND I DON'T KNOW, I THINK WE'LL 1566 01:02:57,240 --> 01:02:59,120 SEE THE RUBBER WILL MEET THE 1567 01:02:59,120 --> 01:03:00,200 ROAD AFTER MIDTERMS IN TERMS OF 1568 01:03:00,200 --> 01:03:02,400 WHO IS WILLING TO GO TO BAT AND 1569 01:03:02,400 --> 01:03:04,760 SAY, LOOK, YOU MAY BE TIRED OF 1570 01:03:04,760 --> 01:03:06,200 TALKING ABOUT IT BUT COVID IS 1571 01:03:06,200 --> 01:03:07,120 NOT TIRED OF BEING HERE. 1572 01:03:07,120 --> 01:03:12,840 WE NEED TO ADDRESS IT AND BE 1573 01:03:12,840 --> 01:03:13,080 PREPARED. 1574 01:03:13,080 --> 01:03:20,120 AND PERHAPS SOME CONCERN ABOUT 1575 01:03:20,120 --> 01:03:22,480 MONKEYPOX WILL STIR THE FUNDING 1576 01:03:22,480 --> 01:03:23,920 BUT HELPFUL TO COME FROM PATIENT 1577 01:03:23,920 --> 01:03:29,160 GROUPS AND RESEARCHERS AS WELL. 1578 01:03:29,160 --> 01:03:31,360 >> GREAT COMMENT, CHRIS. 1579 01:03:31,360 --> 01:03:34,200 THANKS FOR THAT PERSPECTIVE, 1580 01:03:34,200 --> 01:03:34,360 M.K. 1581 01:03:34,360 --> 01:03:37,120 I THINK IT'S TIME TO MOVE ON TO 1582 01:03:37,120 --> 01:03:39,680 THE NEXT AGENDA ITEM WHICH WILL 1583 01:03:39,680 --> 01:03:41,960 BE A SCIENTIFIC PRESENTATION 1584 01:03:41,960 --> 01:03:49,280 FROM THE INTRAMURAL PROGRAM ON 1585 01:03:49,280 --> 01:03:53,040 HPV EPIDEMIOLOGY AND PREDICTING 1586 01:03:53,040 --> 01:03:54,680 COST EFFECTIVE CERVICAL 1587 01:03:54,680 --> 01:03:56,080 SCREENING FROM DR. SHIFFMAN, 1588 01:03:56,080 --> 01:03:57,640 DIVISION OF CANCER EPIDEMIOLOGY 1589 01:03:57,640 --> 01:04:06,360 AND CANCER GENETICS. 1590 01:04:06,360 --> 01:04:06,920 MARK? 1591 01:04:06,920 --> 01:04:08,320 >> HELLO. 1592 01:04:08,320 --> 01:04:14,840 >> PLEASE PUT UP MARK'S SLIDES. 1593 01:04:14,840 --> 01:04:18,680 >> I'VE BEEN ASKED TO TALK ABOUT 1594 01:04:18,680 --> 01:04:21,680 HOW EPIDEMIOLOGY IS PREDICTING 1595 01:04:21,680 --> 01:04:23,280 COST EFFECTIVE CERVICAL 1596 01:04:23,280 --> 01:04:26,120 SCREENING SOLUTIONS, JOINED BY 1597 01:04:26,120 --> 01:04:30,800 NICOLE CAMPOS FROM HARVARD TO 1598 01:04:30,800 --> 01:04:33,760 WORK ON THIS QUESTION. 1599 01:04:33,760 --> 01:04:36,200 WE HAVE NO CONFLICTS INTEREST. 1600 01:04:36,200 --> 01:04:38,400 TO AVOID CONFLICTS OF INTEREST 1601 01:04:38,400 --> 01:04:47,040 OVER MY CAREER WE PAY FOR 1602 01:04:47,040 --> 01:04:47,640 COMMERCIAL PRODUCTS, PUBLISH 1603 01:04:47,640 --> 01:04:48,320 INDEPENDENTLY. 1604 01:04:48,320 --> 01:04:49,840 THIS IS A PERSONAL PERSPECTIVE 1605 01:04:49,840 --> 01:04:52,320 I'D LIKE TO POINT OUT. 1606 01:04:52,320 --> 01:04:57,960 WE WANT TO SHOW HOW 1607 01:04:57,960 --> 01:04:58,720 EPIDEMIOLOGIC UNDERSTANDING OF 1608 01:04:58,720 --> 01:05:02,720 HPV AND CARCINOGENESIS CAN 1609 01:05:02,720 --> 01:05:03,520 GUIDE STRATEGIES. 1610 01:05:03,520 --> 01:05:05,280 OF ALL THE MAJOR CANCERS WE KNOW 1611 01:05:05,280 --> 01:05:07,640 MORE I THINK ABOUT CERVICAL 1612 01:05:07,640 --> 01:05:09,960 CANCER AND HPV THAN ANY OF THE 1613 01:05:09,960 --> 01:05:10,760 OTHERS. 1614 01:05:10,760 --> 01:05:13,200 WE HAVE A UNIQUE OPPORTUNITY TO 1615 01:05:13,200 --> 01:05:15,640 KNOW THE CAUSAL AGENT AND HOW TO 1616 01:05:15,640 --> 01:05:17,320 STOP IT. 1617 01:05:17,320 --> 01:05:20,040 AND THEN TO FIGURE OUT HOW TO 1618 01:05:20,040 --> 01:05:21,240 GET IT DONE. 1619 01:05:21,240 --> 01:05:23,320 MY FOCUS HAS BEEN ON 1620 01:05:23,320 --> 01:05:24,640 LOW-RESOURCE SETTINGS SINCE THE 1621 01:05:24,640 --> 01:05:26,840 START OF MY CAREER WHEN I LIVED 1622 01:05:26,840 --> 01:05:29,760 IN AFRICA AND WENT TO MED SCHOOL 1623 01:05:29,760 --> 01:05:34,160 AND THEN CAME TO NCI TO WORK ON 1624 01:05:34,160 --> 01:05:36,440 WHAT EVENTUALLY WAS A WHOLE 1625 01:05:36,440 --> 01:05:38,080 CAREER IN CERVICAL CANCER. 1626 01:05:38,080 --> 01:05:38,920 THIS SHORT PRESENTATION SHOWS 1627 01:05:38,920 --> 01:05:40,440 KEY PRINCIPLES OF WHAT WE'VE 1628 01:05:40,440 --> 01:05:41,600 LEARNED AND GIVES EXAMPLE OF 1629 01:05:41,600 --> 01:05:44,160 WHAT WE'VE COME UP WITH. 1630 01:05:44,160 --> 01:05:47,000 WITH THE MOONSHOT BEING THE MAIN 1631 01:05:47,000 --> 01:05:49,800 FUNDING, I'D LIKE TO POINT OUT, 1632 01:05:49,800 --> 01:05:51,840 SOME GREAT GRATITUDE AND OFFICE 1633 01:05:51,840 --> 01:05:55,840 OF AIDS RESEARCH AND INTRAMURAL 1634 01:05:55,840 --> 01:05:56,880 RESEARCH. 1635 01:05:56,880 --> 01:05:57,640 THE DISPARITIES IN CERVICAL 1636 01:05:57,640 --> 01:06:00,040 CANCER HAVE BEEN GREAT AND JUST 1637 01:06:00,040 --> 01:06:00,360 GETTING WORSE. 1638 01:06:00,360 --> 01:06:02,760 WE'RE DOING SO WELL BECAUSE OF 1639 01:06:02,760 --> 01:06:05,680 OUR NEW KNOWLEDGE OF HPV. 1640 01:06:05,680 --> 01:06:06,720 IN CERTAIN PLACES. 1641 01:06:06,720 --> 01:06:09,120 BUT FAILING TO REACH OTHER 1642 01:06:09,120 --> 01:06:13,920 PLACES SO THAT IT'S EXACERBATING 1643 01:06:13,920 --> 01:06:15,480 THE RELATIVE DISPARITY AND 1644 01:06:15,480 --> 01:06:17,760 BECOMING A DISEASE OF HEALTH 1645 01:06:17,760 --> 01:06:20,240 DISPARITY, BOTH NATIONALLY AND 1646 01:06:20,240 --> 01:06:20,600 INTERNATIONALLY. 1647 01:06:20,600 --> 01:06:22,640 PRACTICE LAGS BEHIND SCIENCE BY 1648 01:06:22,640 --> 01:06:24,800 DECADES IN CERTAIN PLACES. 1649 01:06:24,800 --> 01:06:26,880 IN CONTEXT OF W.H.O. CALL FOR 1650 01:06:26,880 --> 01:06:28,640 ACTION FOR ELIMINATION, WE HAVE 1651 01:06:28,640 --> 01:06:32,200 TO REALIZE THAT THERE'S A VERY 1652 01:06:32,200 --> 01:06:33,880 UNEVEN PATH TO ELIMINATION 1653 01:06:33,880 --> 01:06:35,280 DEPENDING WHERE YOU'RE AT. 1654 01:06:35,280 --> 01:06:37,480 THIS IS A REALLY NEW AND 1655 01:06:37,480 --> 01:06:38,440 FASCINATING GRAPH. 1656 01:06:38,440 --> 01:06:40,480 IT'S WORTH SPENDING A MINUTE ON. 1657 01:06:40,480 --> 01:06:42,520 IT'S IN MILLIONS OF PEOPLE. 1658 01:06:42,520 --> 01:06:45,000 IT'S SHOWING WHERE PEOPLE HAVE 1659 01:06:45,000 --> 01:06:47,760 NEVER BEEN SCREENED. 1660 01:06:47,760 --> 01:06:50,080 NOW, IF YOU IGNORE VACCINE AGES 1661 01:06:50,080 --> 01:06:52,000 AND JUST SAY SOMEBODY OVER 20 1662 01:06:52,000 --> 01:06:54,800 AND WHETHER THEY ARE IN A LOW 1663 01:06:54,800 --> 01:06:56,200 INCOME, LOWER MIDDLE, UPPER 1664 01:06:56,200 --> 01:07:00,120 MIDDLE, OR HIGH INCOME SETTING, 1665 01:07:00,120 --> 01:07:02,120 THE SCREENING KEY AGES WE'LL 1666 01:07:02,120 --> 01:07:03,920 TALK ABOUT IS BETWEEN 30 AND 49 1667 01:07:03,920 --> 01:07:05,080 OR 30 AND 45. 1668 01:07:05,080 --> 01:07:07,160 THOSE ARE THE BEST SCREENING 1669 01:07:07,160 --> 01:07:07,480 YEARS. 1670 01:07:07,480 --> 01:07:10,480 WHERE YOU CAN CATCH PRE-CANCER 1671 01:07:10,480 --> 01:07:11,720 AND PREVENT CANCER. 1672 01:07:11,720 --> 01:07:13,320 AND BECAUSE OF THAT, YOU WONDER 1673 01:07:13,320 --> 01:07:15,200 WHERE ARE THE MILLIONS OF PEOPLE 1674 01:07:15,200 --> 01:07:17,280 WHO ARE TOO OLD TO BE 1675 01:07:17,280 --> 01:07:20,200 VACCINATED, AND ARE GOING TO BE 1676 01:07:20,200 --> 01:07:22,560 AT RISK BECAUSE OF LACK OF ANY 1677 01:07:22,560 --> 01:07:24,120 SCREENING EVER, AND WHERE ARE 1678 01:07:24,120 --> 01:07:26,080 THE DEATHS GOING TO COME FROM? 1679 01:07:26,080 --> 01:07:29,000 YOU SEE IN TERMS OF SHEER 1680 01:07:29,000 --> 01:07:30,480 MILLIONS AND MILLIONS, MAINLY 1681 01:07:30,480 --> 01:07:33,560 THEY ARE IN LOWER, MIDDLE, SOME 1682 01:07:33,560 --> 01:07:34,760 OF THE UPPER MIDDLE, MEANING 1683 01:07:34,760 --> 01:07:36,960 THERE ARE SOME RESOURCES TO BE 1684 01:07:36,960 --> 01:07:37,200 HAD. 1685 01:07:37,200 --> 01:07:40,320 THE QUESTION IS, WILL THEY BE 1686 01:07:40,320 --> 01:07:42,400 ALLOCATED TO WHAT'S INCREASINGLY 1687 01:07:42,400 --> 01:07:46,000 EFFECTIVE VACCINE AND SCREENING 1688 01:07:46,000 --> 01:07:46,280 PROGRAMS. 1689 01:07:46,280 --> 01:07:48,160 MOST PEOPLE I THINK DON'T HAVE A 1690 01:07:48,160 --> 01:07:50,160 CLUE AS TO HOW COST 1691 01:07:50,160 --> 01:07:51,480 EFFECTIVENESS ANALYSES ARE 1692 01:07:51,480 --> 01:07:53,560 REALLY PERFORMED. 1693 01:07:53,560 --> 01:07:55,480 I DIDN'T. 1694 01:07:55,480 --> 01:07:57,680 AND I KNOW IT WAS COST VERSUS 1695 01:07:57,680 --> 01:08:00,520 BENEFIT BUT IT TURNS OUT THAT 1696 01:08:00,520 --> 01:08:02,120 THE FIRST THING AND ESSENTIAL 1697 01:08:02,120 --> 01:08:04,600 THING YOU DO IS TO DEVELOP A 1698 01:08:04,600 --> 01:08:05,560 NATURAL HISTORY MODEL. 1699 01:08:05,560 --> 01:08:07,160 YOU HAVE TO DETERMINE WHAT THE 1700 01:08:07,160 --> 01:08:09,520 HEALTH STATES ARE THAT LEAD TO 1701 01:08:09,520 --> 01:08:12,440 THAT CANCER OR OTHER DISEASE. 1702 01:08:12,440 --> 01:08:17,280 , DEFINE THE TRANSITIONS, DEVINE 1703 01:08:17,280 --> 01:08:20,520 VARIABLES AND MODIFY, ESTIMATE 1704 01:08:20,520 --> 01:08:21,320 TRANSITION RISK, CALIBRATE 1705 01:08:21,320 --> 01:08:21,800 ANYTHING YOU DON'T KNOW. 1706 01:08:21,800 --> 01:08:23,520 IF YOU DON'T KNOW A TRANSITION, 1707 01:08:23,520 --> 01:08:25,960 YOU NEED TO ESTIMATE IT. 1708 01:08:25,960 --> 01:08:27,560 YOU VALIDATE THE MODEL AGAINST 1709 01:08:27,560 --> 01:08:30,240 KNOWN DATA AND THEN YOU TAKE 1710 01:08:30,240 --> 01:08:31,440 WHATEVER YOUR PREVENTION 1711 01:08:31,440 --> 01:08:34,000 STRATEGY IS, ESTIMATE ITS 1712 01:08:34,000 --> 01:08:44,520 EFFICACY, APPLY TO A COHORT, 1713 01:08:46,480 --> 01:08:48,080 THERE'S MANY WAYS TO CALIBRATION 1714 01:08:48,080 --> 01:08:50,360 AND OFTEN UNCERTAIN KNOWLEDGE OF 1715 01:08:50,360 --> 01:08:52,480 A NATURAL HISTORY. 1716 01:08:52,480 --> 01:08:58,040 A LOT OF TIMES, PEOPLE CONSIDER 1717 01:08:58,040 --> 01:09:00,240 HEALTH DECISION ANALYSES TO BE 1718 01:09:00,240 --> 01:09:02,960 NOT AS IMPORTANT RESEARCH 1719 01:09:02,960 --> 01:09:04,160 FINDINGS AS DIRECT OBSERVATION. 1720 01:09:04,160 --> 01:09:06,680 WHAT WE'VE DONE IS WIDENING THE 1721 01:09:06,680 --> 01:09:13,160 SCOPE OVER THE YEARS IN THE NCI. 1722 01:09:13,160 --> 01:09:14,360 WE HAVE DONE INCREASINGLY 1723 01:09:14,360 --> 01:09:17,360 APPLICABLE THINGS ABOUT COST 1724 01:09:17,360 --> 01:09:18,240 EFFECTIVENESS. 1725 01:09:18,240 --> 01:09:19,880 FIRST WE STARTED WITH ETIOLOGY 1726 01:09:19,880 --> 01:09:22,560 AND PATHOGENESIS, WHEN WE DIDN'T 1727 01:09:22,560 --> 01:09:24,440 KNOW. 1728 01:09:24,440 --> 01:09:27,280 I STARTED IN 1975, IN THE FIELD, 1729 01:09:27,280 --> 01:09:30,120 AND I'VE BEEN WORKING 40 YEARS 1730 01:09:30,120 --> 01:09:32,240 FOR THE IRP, AND WE STARTED WITH 1731 01:09:32,240 --> 01:09:37,360 ODDS RATIOS LOOKING FOR THE 1732 01:09:37,360 --> 01:09:39,520 CAUSE AND SPENT THAT TIME 1733 01:09:39,520 --> 01:09:42,040 LOOKING FOR THE HPV TYPES THAT 1734 01:09:42,040 --> 01:09:44,440 WERE INVOLVED, THEN WE HAD 1735 01:09:44,440 --> 01:09:45,440 PREVENTION METHODS PERIOD, AND 1736 01:09:45,440 --> 01:09:47,800 NOW WE'RE VERY MUCH IN THE HEART 1737 01:09:47,800 --> 01:09:51,080 OF CLINICAL EPIDEMIOLOGY WHERE 1738 01:09:51,080 --> 01:09:52,760 WE'RE ESTIMATING RISK, 1739 01:09:52,760 --> 01:09:53,280 ARTIFICIAL INTELLIGENCE 1740 01:09:53,280 --> 01:09:54,320 GUIDELINES, PREVENTIVE 1741 01:09:54,320 --> 01:09:55,440 STRATEGIES, AND COST 1742 01:09:55,440 --> 01:09:55,960 EFFECTIVENESS. 1743 01:09:55,960 --> 01:09:58,360 BUT ALL OF THESE CONTINUE ON. 1744 01:09:58,360 --> 01:10:00,520 IT'S JUST WE'VE ADDED THE SCOPE 1745 01:10:00,520 --> 01:10:02,080 AS WE'VE GONE. 1746 01:10:02,080 --> 01:10:04,600 I WANTED TO SAY ONLY THAT THIS 1747 01:10:04,600 --> 01:10:06,480 IS ONE OF THE BEST UNDERSTOOD 1748 01:10:06,480 --> 01:10:08,200 NATURAL HISTORIES OF ANY MAJOR 1749 01:10:08,200 --> 01:10:08,960 CANCER. 1750 01:10:08,960 --> 01:10:10,480 AND IT LOOKS LIKE A CARTOON BUT 1751 01:10:10,480 --> 01:10:11,560 IT'S NOT. 1752 01:10:11,560 --> 01:10:15,200 IT'S ACTUALLY STOOD UP QUITE 1753 01:10:15,200 --> 01:10:15,760 WELL. 1754 01:10:15,760 --> 01:10:21,920 THE USUAL PATTERN IS HEALTHY 1755 01:10:21,920 --> 01:10:24,520 TISSUE, MINOR, SEVERE, DEATH. 1756 01:10:24,520 --> 01:10:26,280 FOR CERVIX 13 TYPES, THEY APPEAR 1757 01:10:26,280 --> 01:10:27,880 AND IF THEY DON'T GO AWAY WHICH 1758 01:10:27,880 --> 01:10:29,880 THEY USUALLY DO IT'S VERY 1759 01:10:29,880 --> 01:10:32,440 DYNAMIC AND COMMON, THERE'S A 1760 01:10:32,440 --> 01:10:34,400 PROGRESSION TO PRE-CANCER, 1761 01:10:34,400 --> 01:10:36,280 USUALLY SQUAMOUS, WHICH OVER 1762 01:10:36,280 --> 01:10:38,640 TIME CAN HAVE A GENETIC 1763 01:10:38,640 --> 01:10:39,920 MUTATION, INVADE AND CAUSE 1764 01:10:39,920 --> 01:10:40,200 DEATH. 1765 01:10:40,200 --> 01:10:42,320 THESE TERMS WHICH DON'T SEEM 1766 01:10:42,320 --> 01:10:44,560 LIKE SCIENTIFIC TERMS GIVEN WHAT 1767 01:10:44,560 --> 01:10:48,440 WE KNOW IS CIN OR OTHER TERMS 1768 01:10:48,440 --> 01:10:50,040 ARE BETTER TERMS BECAUSE THEY 1769 01:10:50,040 --> 01:10:52,720 ARE EXACT AND BASED ON MOLECULAR 1770 01:10:52,720 --> 01:10:56,400 AND OTHER EXACT MEASUREMENTS. 1771 01:10:56,400 --> 01:11:00,440 WE KNOW HPVs EXACTLY, WHERE IN 1772 01:11:00,440 --> 01:11:02,280 THE GENETICS AND PHYLOGENY 1773 01:11:02,280 --> 01:11:05,480 ONCOGENIC ARE, WE KNOW BY TYPE, 1774 01:11:05,480 --> 01:11:07,000 CAN MEASURE RELIABLY AND 1775 01:11:07,000 --> 01:11:09,720 ACCURATELY, AND PAY ATTENTION 1776 01:11:09,720 --> 01:11:13,360 ONLY TO THOSE THAT CAUSE 1777 01:11:13,360 --> 01:11:14,760 CERVICAL CANCER, WE KNOW THEIR 1778 01:11:14,760 --> 01:11:16,400 ORDER OF IMPORTANCE WHEN WE 1779 01:11:16,400 --> 01:11:18,160 STUDY TENS OF THOUSANDS OF 1780 01:11:18,160 --> 01:11:19,480 CERVICAL CANCERS. 1781 01:11:19,480 --> 01:11:23,760 SO WE KNOW TYPE 16 IS THE WORST. 1782 01:11:23,760 --> 01:11:27,200 1845 LESS. 1783 01:11:27,200 --> 01:11:30,120 NEXT THE 16 RELATED, AND OTHERS 1784 01:11:30,120 --> 01:11:32,200 CONSIDERED CARCINOGENIC BUT VERY 1785 01:11:32,200 --> 01:11:32,520 RARELY. 1786 01:11:32,520 --> 01:11:33,920 CANCER SERIES AND COHORTS SAY 1787 01:11:33,920 --> 01:11:35,200 THE SAME THING. 1788 01:11:35,200 --> 01:11:37,040 THERE'S NO COUNTER DATA. 1789 01:11:37,040 --> 01:11:38,480 WE KNOW EXACTLY WHICH TYPES AND 1790 01:11:38,480 --> 01:11:42,360 WHICH ONES ARE THE MOST 1791 01:11:42,360 --> 01:11:42,760 IMPORTANT. 1792 01:11:42,760 --> 01:11:44,320 ACCURACY IS REALLY IMPORTANT IN 1793 01:11:44,320 --> 01:11:46,760 CAUSAL CHANGE AND SO THAT LED 1794 01:11:46,760 --> 01:11:48,440 NATURALLY TO PREVENTIVE METHODS. 1795 01:11:48,440 --> 01:11:50,840 THOSE ARE MAINLY COHORT STUDIES 1796 01:11:50,840 --> 01:11:53,440 AND TRIALS WE DID IN THE '90s 1797 01:11:53,440 --> 01:11:57,320 AND 2000s, STILL ONGOING. 1798 01:11:57,320 --> 01:11:58,720 THE EPIDEMIOLOGISTS PIVOTED, AND 1799 01:11:58,720 --> 01:12:02,080 WE WERE WORKING WITH 1800 01:12:02,080 --> 01:12:03,080 IMMUNOLOGISTS, VIROLOGISTS, DNA 1801 01:12:03,080 --> 01:12:04,400 DIAGNOSTIC FOLKS, AND THROUGH 1802 01:12:04,400 --> 01:12:07,080 THOSE WE GOT VERY GOOD IDEAS OF 1803 01:12:07,080 --> 01:12:09,520 WHAT THE RELATIVE RISKS WERE AND 1804 01:12:09,520 --> 01:12:10,320 REDUCTIONS IN VACCINE EFFICACY 1805 01:12:10,320 --> 01:12:13,760 SO WE KNOW WHAT THE 1806 01:12:13,760 --> 01:12:15,120 INTERVENTIONS CAN DO, SCREENING, 1807 01:12:15,120 --> 01:12:18,720 AND VACCINE. 1808 01:12:18,720 --> 01:12:22,840 NOW WE'RE ON TO VACCINATION 1809 01:12:22,840 --> 01:12:26,680 BREAKING THAT FIRST EXPOSURE AND 1810 01:12:26,680 --> 01:12:32,680 WE HAVE ALSO SCREENING WHICH IS 1811 01:12:32,680 --> 01:12:33,280 FINDING PRE-CANCER BEFORE 1812 01:12:33,280 --> 01:12:35,440 CANCER, THE GOAL IS TO FIND 1813 01:12:35,440 --> 01:12:36,880 PRE-CANCER AND WE HELPED 1814 01:12:36,880 --> 01:12:40,080 VALIDATE MANY METHODS. 1815 01:12:40,080 --> 01:12:43,080 RIGHT NOW, WE'RE GOING TO 1816 01:12:43,080 --> 01:12:44,840 STRATEGIES BECAUSE BY 2005 WE 1817 01:12:44,840 --> 01:12:46,640 KNEW ALL THIS STUFF ABOVE. 1818 01:12:46,640 --> 01:12:49,120 AND IT'S STILL ALL THESE YEARS 1819 01:12:49,120 --> 01:12:50,120 LATER, WE'RE LOOKING TO HOW TO 1820 01:12:50,120 --> 01:12:52,400 GET IT TO THE PEOPLE WHO NEED IT 1821 01:12:52,400 --> 01:12:52,960 MOST. 1822 01:12:52,960 --> 01:12:55,880 THERE'S BEEN A STAGNATION OF THE 1823 01:12:55,880 --> 01:12:59,280 DECLINE IN THE UNITED STATES. 1824 01:12:59,280 --> 01:13:01,400 THERE'S A CONTINUED INCREASE IN 1825 01:13:01,400 --> 01:13:03,320 NUMBERS OF DEATHS, PLACES AROUND 1826 01:13:03,320 --> 01:13:05,840 THE WORLD, AGE THAT ARE HIGH 1827 01:13:05,840 --> 01:13:06,040 RISK. 1828 01:13:06,040 --> 01:13:07,400 WE'RE NOW TALKING VERY MUCH 1829 01:13:07,400 --> 01:13:10,080 ABOUT WHAT ARE THE WAYS TO MAKE 1830 01:13:10,080 --> 01:13:12,120 THESE INTERVENTIONS THAT ARE SO 1831 01:13:12,120 --> 01:13:15,200 ACCURATE SIMPLE ENOUGH AND COST 1832 01:13:15,200 --> 01:13:16,600 EFFECTIVE THAT THEY CAN COMPETE 1833 01:13:16,600 --> 01:13:18,480 FOR ATTENTION IN A WORLD THAT 1834 01:13:18,480 --> 01:13:20,320 HAS SO MANY DIFFERENT 1835 01:13:20,320 --> 01:13:20,840 PRIORITIES. 1836 01:13:20,840 --> 01:13:23,240 THE EMPHASIS IS ALWAYS ON 1837 01:13:23,240 --> 01:13:23,680 ABSOLUTE RISK. 1838 01:13:23,680 --> 01:13:25,640 SO, IF YOU THINK ABOUT THE 1839 01:13:25,640 --> 01:13:27,360 BEGINNING, WE JUST DIDN'T KNOW 1840 01:13:27,360 --> 01:13:28,600 PEOPLE GOT CERVICAL CANCER, 1841 01:13:28,600 --> 01:13:29,440 DIDN'T KNOW WHY. 1842 01:13:29,440 --> 01:13:31,880 AND WE'VE BEEN ABLE LIKE PLAYING 1843 01:13:31,880 --> 01:13:35,040 THE GAME OF TWENTY QUESTIONS TO 1844 01:13:35,040 --> 01:13:36,240 DERIVE QUESTIONS THAT ARE VERY 1845 01:13:36,240 --> 01:13:38,800 EXACT TO GET TO WHO IS AT RISK. 1846 01:13:38,800 --> 01:13:41,440 WE CAN DO IT QUITE WELL. 1847 01:13:41,440 --> 01:13:42,840 TAKE A SCREENING POPULATION. 1848 01:13:42,840 --> 01:13:44,920 AND THEN YOU JUST ASK PEOPLE, 1849 01:13:44,920 --> 01:13:46,320 ARE YOU HPV POSITIVE TODAY OR 1850 01:13:46,320 --> 01:13:46,680 NOT? 1851 01:13:46,680 --> 01:13:50,360 THAT'S ONE OF THE GOOD TESTS. 1852 01:13:50,360 --> 01:13:52,280 IF YOU'RE NEGATIVE, REASSURED. 1853 01:13:52,280 --> 01:13:52,920 INCREDIBLY PREDICTIVE. 1854 01:13:52,920 --> 01:13:56,400 IF YOU HAVE TWO NEGATIVES, VERY, 1855 01:13:56,400 --> 01:13:57,320 VERY REASSURING. 1856 01:13:57,320 --> 01:13:58,560 HPV POSITIVE YOU'RE ALERTED BUT 1857 01:13:58,560 --> 01:14:00,880 STILL DON'T KNOW WHO HAS 1858 01:14:00,880 --> 01:14:02,040 PRE-CANCER BECAUSE INFECTION IS 1859 01:14:02,040 --> 01:14:03,760 MUCH MORE COMMON AND OFTEN GOES 1860 01:14:03,760 --> 01:14:04,400 AWAY. 1861 01:14:04,400 --> 01:14:06,560 THEN IF YOU HAVE THAT, YOU NEED 1862 01:14:06,560 --> 01:14:08,080 A TRIAGE TEST, WHICH IF PERFECT 1863 01:14:08,080 --> 01:14:11,680 WOULD FIND ONLY THE PRE-CANCERS, 1864 01:14:11,680 --> 01:14:13,640 AMONG HPV POSITIVES, TURNS OUT 1865 01:14:13,640 --> 01:14:16,000 USUALLY YOU CAN HAVE THE NUMBER 1866 01:14:16,000 --> 01:14:17,760 AND GET CLOSER TO KNOWING 1867 01:14:17,760 --> 01:14:19,360 EXACTLY THAT THE PEOPLE YOU NEED 1868 01:14:19,360 --> 01:14:20,520 TO BE TREATING ARE WITHIN THAT 1869 01:14:20,520 --> 01:14:23,680 GROUP AND YOU DON'T WANT TO MISS 1870 01:14:23,680 --> 01:14:26,560 THEM BECAUSE THEY MOTIVATE THE 1871 01:14:26,560 --> 01:14:28,680 ENTIRE EXERCISE. 1872 01:14:28,680 --> 01:14:30,520 ACCURACY EQUALS EFFICACY. 1873 01:14:30,520 --> 01:14:31,760 OLDER TECHNOLOGIES NEED 1874 01:14:31,760 --> 01:14:33,360 REPETITION TO OVERCOME ERROR. 1875 01:14:33,360 --> 01:14:34,640 BUT HIGHLY ACCURATE TEST 1876 01:14:34,640 --> 01:14:36,640 PERFORMED LESS OFTEN IS 1877 01:14:36,640 --> 01:14:36,960 PREFERABLE. 1878 01:14:36,960 --> 01:14:42,000 WE DON'T WANT TO DO ACCURATE 1879 01:14:42,000 --> 01:14:43,800 TESTS TOO OFTEN, THE PRINCIPLE 1880 01:14:43,800 --> 01:14:46,040 IS TRUE IN HIGHER RESOURCE 1881 01:14:46,040 --> 01:14:47,600 SETTINGS, IN LOWER FOR 1882 01:14:47,600 --> 01:14:48,560 AFFORDABILITY AND 1883 01:14:48,560 --> 01:14:48,920 SUSTAINABILITY. 1884 01:14:48,920 --> 01:14:50,760 YOU ONLY NEED A COUPLE REALLY 1885 01:14:50,760 --> 01:14:52,600 GOOD SCREENINGS IN A LIFETIME TO 1886 01:14:52,600 --> 01:14:55,320 GREATLY REDUCE RISK. 1887 01:14:55,320 --> 01:14:59,600 AND THE OLD TERMS SO WHAT I DID 1888 01:14:59,600 --> 01:15:01,480 IN MED SCHOOL ARE ANTIQUATED, 1889 01:15:01,480 --> 01:15:03,120 STILL USED ALL THE TIME, USEFUL 1890 01:15:03,120 --> 01:15:06,600 AS A WAY OF COMMUNICATING BUT 1891 01:15:06,600 --> 01:15:08,240 PROXIES FOR THE REAL MOLECULAR 1892 01:15:08,240 --> 01:15:12,000 PROCESSES WE UNDERSTAND AT THE 1893 01:15:12,000 --> 01:15:13,960 HEART OF THE CARCINOGENESIS. 1894 01:15:13,960 --> 01:15:15,400 SIMILARLY ANYBODY WHO THINKS 1895 01:15:15,400 --> 01:15:18,600 THAT YOU CAN LOOK AT A CERVIX 1896 01:15:18,600 --> 01:15:20,000 AND TELL WHAT IT IS, IT'S HARD 1897 01:15:20,000 --> 01:15:22,240 TO KNOW THE DIFFERENCE BETWEEN 1898 01:15:22,240 --> 01:15:25,280 INFECTION, WHICH IS HERE, AND 1899 01:15:25,280 --> 01:15:25,800 PRE-CANCER. 1900 01:15:25,800 --> 01:15:27,800 SO, WHAT WE'VE DONE IN THE 1901 01:15:27,800 --> 01:15:31,480 MOONSHOT IS TO TRY TO ACCELERATE 1902 01:15:31,480 --> 01:15:37,360 THE TAKING UP OF HPV-BASED 1903 01:15:37,360 --> 01:15:40,640 THERAPIES, AND BASICALLY 1904 01:15:40,640 --> 01:15:42,720 THERAPIES PREVENTIVE THERAPIES, 1905 01:15:42,720 --> 01:15:44,600 LIKE PAVE, HUMAN PAPILLOMAVIRUS 1906 01:15:44,600 --> 01:15:46,440 AND AUTOMATED VISUAL EVALUATION. 1907 01:15:46,440 --> 01:15:48,600 I'M GOING TO USE THIS AS JUST AN 1908 01:15:48,600 --> 01:15:48,800 EXAMPLE. 1909 01:15:48,800 --> 01:15:52,160 THIS IS WHO WE ARE, RIGHT NOW, 1910 01:15:52,160 --> 01:15:54,200 THERE'S LOTS OF US. 1911 01:15:54,200 --> 01:15:57,440 THIS IS MOONSHOT-SUPPORTED 1912 01:15:57,440 --> 01:15:58,680 INITIATIVE, PEOPLE VOLUNTEERED 1913 01:15:58,680 --> 01:16:00,440 AND THEY GOES AWAY. 1914 01:16:00,440 --> 01:16:02,280 BASICALLY WE'RE DOING IT IN THE 1915 01:16:02,280 --> 01:16:05,320 UNITED STATES AND WE HAVE A 1916 01:16:05,320 --> 01:16:09,640 MISSISSIPPI GROUP THAT MEGAN 1917 01:16:09,640 --> 01:16:11,680 CLARK IS RUNNING AND ALL THESE 1918 01:16:11,680 --> 01:16:12,920 DIFFERENT COUNTRIES. 1919 01:16:12,920 --> 01:16:15,520 AFTER A PANDEMIC DELAY WE'RE UP 1920 01:16:15,520 --> 01:16:18,560 TO GETTING READY TO START THE 1921 01:16:18,560 --> 01:16:21,200 SCREENING, A VALIDATION OF THIS 1922 01:16:21,200 --> 01:16:22,200 COST EFFECTIVE DESIGNED 1923 01:16:22,200 --> 01:16:22,440 STRATEGY. 1924 01:16:22,440 --> 01:16:23,400 SO WHAT WE WANT TO DO IS THE 1925 01:16:23,400 --> 01:16:24,920 RIGHT THING FOR THE GREATEST 1926 01:16:24,920 --> 01:16:25,560 NUMBER OF WOMEN. 1927 01:16:25,560 --> 01:16:26,880 AND HOW DO WE DO THAT? 1928 01:16:26,880 --> 01:16:29,040 WE DO IT THROUGH ACCURACY, 1929 01:16:29,040 --> 01:16:30,840 PUTTING THEM ON THEIR RIGHT 1930 01:16:30,840 --> 01:16:32,520 PLACE IN THE CAUSAL DIAGRAM. 1931 01:16:32,520 --> 01:16:34,880 IN OTHER WORDS, AS YOU GET 1932 01:16:34,880 --> 01:16:35,880 INCREASING RISK TOWARDS CERVICAL 1933 01:16:35,880 --> 01:16:38,040 CANCER, YOU DO MORE FOR PEOPLE. 1934 01:16:38,040 --> 01:16:40,120 AND IT'S EQUAL MANAGEMENT OF 1935 01:16:40,120 --> 01:16:40,640 EQUAL RISK. 1936 01:16:40,640 --> 01:16:42,880 THE FIRST THING YOU DO IS GO 1937 01:16:42,880 --> 01:16:44,000 WHERE THERE'S A DISEASE. 1938 01:16:44,000 --> 01:16:45,760 IF YOU'RE A PLACE LIKE BRAZIL, 1939 01:16:45,760 --> 01:16:46,960 YOU KNOW WHERE THERE'S BEEN 1940 01:16:46,960 --> 01:16:49,320 CANCER IN THE LAST FIVE YEARS. 1941 01:16:49,320 --> 01:16:51,560 GO TO THOSE PLACES. 1942 01:16:51,560 --> 01:16:52,840 DON'T GO TO PEOPLE SCREENED A 1943 01:16:52,840 --> 01:16:53,000 LOT. 1944 01:16:53,000 --> 01:16:54,600 GO WHERE THEY HAVEN'T BEEN. 1945 01:16:54,600 --> 01:16:56,440 IF YOU CAN DO THAT, YOU CAN THEN 1946 01:16:56,440 --> 01:17:00,640 FIND WHO IS AT RISK. 1947 01:17:00,640 --> 01:17:02,840 THROUGH A SELF-SWAB TECHNIQUE 1948 01:17:02,840 --> 01:17:05,800 YOU CAN SELF-SAMPLE SOMEBODY, 1949 01:17:05,800 --> 01:17:07,360 THEY SELF-SAMPLE THEMSELVES, THE 1950 01:17:07,360 --> 01:17:08,760 IMPORTANT POINT, THEY 1951 01:17:08,760 --> 01:17:09,800 SELF-SAMPLE. 1952 01:17:09,800 --> 01:17:12,840 WOMEN HELPING WOMEN. 1953 01:17:12,840 --> 01:17:14,720 AND BASICALLY THAT SELF-SAMPLE 1954 01:17:14,720 --> 01:17:16,280 IS ANALOGOUS, ALMOST THE SAME 1955 01:17:16,280 --> 01:17:18,120 SENSITIVITY OF A CLINICIAN 1956 01:17:18,120 --> 01:17:18,360 SAMPLE. 1957 01:17:18,360 --> 01:17:21,040 IT'S THEN PUT INTO A HIGH-RISK 1958 01:17:21,040 --> 01:17:24,120 HPV TEST WHICH WE WORKED HARD TO 1959 01:17:24,120 --> 01:17:27,920 GET TO THE $5 RANGE AND IT 1960 01:17:27,920 --> 01:17:29,680 REASSURES EVERYONE NEGATIVE AND 1961 01:17:29,680 --> 01:17:33,760 THEY GO HOME. 1962 01:17:33,760 --> 01:17:35,360 IF POSITIVE, THEY NEED TRIAGE. 1963 01:17:35,360 --> 01:17:38,160 YOU PUT THEM IN TYPE GROUPS TO 1964 01:17:38,160 --> 01:17:39,320 DICTATE RISK, ADD TO THEIR 1965 01:17:39,320 --> 01:17:39,720 APPEARANCE. 1966 01:17:39,720 --> 01:17:41,000 APPEARANCES ARE VERY HARD FOR 1967 01:17:41,000 --> 01:17:43,080 HUMANS TO TELL APART. 1968 01:17:43,080 --> 01:17:45,160 FORTUNATELY, THEY CAN WITH SOME 1969 01:17:45,160 --> 01:17:50,560 RELIABILITY AT THE EXTREMES BE 1970 01:17:50,560 --> 01:17:52,560 PUT INTO VERY SUSPICIOUS, INTO 1971 01:17:52,560 --> 01:17:54,800 BAD OR GOOD OR DON'T KNOW, BY 1972 01:17:54,800 --> 01:17:56,720 MACHINE LEARNING, DEEP LEARNING. 1973 01:17:56,720 --> 01:17:58,040 THAT'S CALLED AUTOMATED VISUAL 1974 01:17:58,040 --> 01:18:00,640 EVALUATION WHICH WE'VE BEEN 1975 01:18:00,640 --> 01:18:05,720 WORKING ON FOR SEVERAL YEARS 1976 01:18:05,720 --> 01:18:05,880 NOW. 1977 01:18:05,880 --> 01:18:10,920 THE COMBINATION OF COMMENT 1978 01:18:10,920 --> 01:18:11,600 ELEMENT -- COMPLEMENTARY 1979 01:18:11,600 --> 01:18:15,560 BIOMARKERS DO THE BEST JOB, 1980 01:18:15,560 --> 01:18:16,400 AGAINST HISTOPATHOLOGY AND 1981 01:18:16,400 --> 01:18:18,480 VIROLOGY CAN KNOW WHO NEEDS TO 1982 01:18:18,480 --> 01:18:20,600 BE TREATED USING NEW TOOLS, 1983 01:18:20,600 --> 01:18:22,880 THERMAL ABLATION, 20 TO 40 1984 01:18:22,880 --> 01:18:26,520 SECONDS, OR IF NEEDED EXCISIONAL 1985 01:18:26,520 --> 01:18:27,280 TREATMENT OR REFERRAL. 1986 01:18:27,280 --> 01:18:28,600 I'M NOT SAYING THIS IS THE WAY 1987 01:18:28,600 --> 01:18:29,400 TO GO. 1988 01:18:29,400 --> 01:18:31,040 THIS IS PRE-PANDEMIC. 1989 01:18:31,040 --> 01:18:32,760 YOU CAN SCREEN HUNDREDS OF 1990 01:18:32,760 --> 01:18:34,720 PEOPLE IN A CLINIC ROOM PER DAY. 1991 01:18:34,720 --> 01:18:37,200 AND IT'S JUST BECAUSE IT'S 1992 01:18:37,200 --> 01:18:37,520 SELF-SAMPLED. 1993 01:18:37,520 --> 01:18:39,760 AND THERE'S MANY DIFFERENT 1994 01:18:39,760 --> 01:18:40,680 APPLICATIONS OF IT. 1995 01:18:40,680 --> 01:18:43,760 NOW, I WANT TO SAY A WORD ABOUT 1996 01:18:43,760 --> 01:18:44,840 ARTIFICIAL INTELLIGENCE AS THE 1997 01:18:44,840 --> 01:18:46,480 NEXT PART BEFORE I END. 1998 01:18:46,480 --> 01:18:48,840 THIS IS A TREMENDOUS IMAGE 1999 01:18:48,840 --> 01:18:49,600 RECOGNITION APPROACH FOR 2000 01:18:49,600 --> 01:18:50,800 CLINICIANS BECAUSE YOU GOT TO 2001 01:18:50,800 --> 01:18:55,680 LOOK AT THE CERVIX TO TREAT, WHY 2002 01:18:55,680 --> 01:18:59,000 NOT TAKE A PICTURE AND HAVE IT 2003 01:18:59,000 --> 01:18:59,280 ANALYZED. 2004 01:18:59,280 --> 01:19:00,960 DON'T BE TAKEN IF IN IT LOOKS 2005 01:19:00,960 --> 01:19:05,040 GOOD TO TO BE TRUE. 2006 01:19:05,040 --> 01:19:09,480 BE SKEPTICAL OF CLAIMS, 2007 01:19:09,480 --> 01:19:10,960 PERFORMANCE DECLINES FROM THE 2008 01:19:10,960 --> 01:19:12,560 TRAINING SETTING AND WE'VE 2009 01:19:12,560 --> 01:19:14,760 GOTTEN BACK TO GOOD A.I. IMAGE 2010 01:19:14,760 --> 01:19:15,640 RECOGNITION FOR PRE-CANCER. 2011 01:19:15,640 --> 01:19:18,360 DEEP LEARNING IS NOT MAGIC, JUST 2012 01:19:18,360 --> 01:19:20,520 WHAT YOU LABEL THINGS. 2013 01:19:20,520 --> 01:19:23,680 HOW WE'RE DOING IT, WE COMBINE 2014 01:19:23,680 --> 01:19:25,640 USING DEVICES EITHER DEDICATED 2015 01:19:25,640 --> 01:19:28,440 OR NOT, WE HAVE MANY DIFFERENT 2016 01:19:28,440 --> 01:19:28,920 ALGORITHMS. 2017 01:19:28,920 --> 01:19:34,080 AND WE PUT TOGETHER THE RISK 2018 01:19:34,080 --> 01:19:35,160 ESTIMATES FROM THE HPV 2019 01:19:35,160 --> 01:19:37,120 16 IS THE WORST, THAT VARIABLE 2020 01:19:37,120 --> 01:19:38,600 IS CROSSED AGAINST APPEARANCE 2021 01:19:38,600 --> 01:19:41,920 VARIABLE, YOU GET A RISK 2022 01:19:41,920 --> 01:19:43,880 STRATIFICATION SCORE WHICH CAN 2023 01:19:43,880 --> 01:19:48,600 BE USED BY THE LOCAL NLH OR 2024 01:19:48,600 --> 01:19:52,280 WHATEVER TO DECIDES WHO THEY 2025 01:19:52,280 --> 01:19:53,840 WILL TREAT, WITH ABLATION, 2026 01:19:53,840 --> 01:19:55,640 REFERRED, SUSPECT CANCER. 2027 01:19:55,640 --> 01:19:57,000 SOUNDS COMPLICATED BUT IT REALLY 2028 01:19:57,000 --> 01:20:00,840 IS AN APP THAT TAKES THE BEST OF 2029 01:20:00,840 --> 01:20:03,360 OUR KNOWLEDGE AND PRESENTS EASY 2030 01:20:03,360 --> 01:20:03,800 CHOICES. 2031 01:20:03,800 --> 01:20:05,120 AND IT JUST BASICALLY WORKS LIKE 2032 01:20:05,120 --> 01:20:07,840 THIS KIND OF A CURVE, WHERE YOU 2033 01:20:07,840 --> 01:20:10,000 TAKE THE WORST AND DEFINITELY 2034 01:20:10,000 --> 01:20:12,440 TREAT THEM AND FIND FOR YOUR OWN 2035 01:20:12,440 --> 01:20:13,560 SETTING HOW YOU'RE GOING TO 2036 01:20:13,560 --> 01:20:16,520 TREAT AND YOU PUT THAT INTO THE 2037 01:20:16,520 --> 01:20:16,720 APP. 2038 01:20:16,720 --> 01:20:18,880 AND THAT'S A LOCAL USE. 2039 01:20:18,880 --> 01:20:21,320 SO, WHEN WE TALK ABOUT HOW DOES 2040 01:20:21,320 --> 01:20:23,320 THIS ALL AFFECT HEALTH DECISION 2041 01:20:23,320 --> 01:20:26,080 ANALYSIS, BASED ON ALL OF OUR 2042 01:20:26,080 --> 01:20:26,680 IMPROVED TRANSITION 2043 01:20:26,680 --> 01:20:29,160 PROBABILITIES, WE ARE NO LONGER 2044 01:20:29,160 --> 01:20:30,280 CALIBRATING MUCH. 2045 01:20:30,280 --> 01:20:33,120 WE'VE OBSERVED THINGS FOR 20 2046 01:20:33,120 --> 01:20:33,320 YEARS. 2047 01:20:33,320 --> 01:20:36,320 SO 20-YEAR COHORTS OVER THE LIFE 2048 01:20:36,320 --> 01:20:37,600 COURSE GIVES US VERY GOOD 2049 01:20:37,600 --> 01:20:38,520 TRANSITION RISKS. 2050 01:20:38,520 --> 01:20:42,560 WHICH MEANS IT'S HIGHLY RELIABLE 2051 01:20:42,560 --> 01:20:44,080 AND CAN DO COUNTER-FACTUALS OF 2052 01:20:44,080 --> 01:20:45,800 PREDICTING WHAT WOULD BE OF THIS 2053 01:20:45,800 --> 01:20:48,880 OR THAT WITH A FAIR DEGREE OF 2054 01:20:48,880 --> 01:20:51,160 CONFIDENCE THAT IT'S TRUE. 2055 01:20:51,160 --> 01:20:53,160 AND SO, AS OPPOSED TO GUESS 2056 01:20:53,160 --> 01:20:55,720 WORK, IT BECOMES A VERY USEFUL 2057 01:20:55,720 --> 01:20:58,640 ALMOST ACCOUNTING TOOL AS WE 2058 01:20:58,640 --> 01:20:59,960 PLAN HEALTH DECISIONS. 2059 01:20:59,960 --> 01:21:02,480 BY DIRECT MEASUREMENT OF THESE 2060 01:21:02,480 --> 01:21:04,840 WE NEED LESS CALIBRATION, AND 2061 01:21:04,840 --> 01:21:05,520 GET INCREASED TRUST AND 2062 01:21:05,520 --> 01:21:08,720 INCREASED VALUE FOR HEALTH 2063 01:21:08,720 --> 01:21:08,960 DECISIONS. 2064 01:21:08,960 --> 01:21:11,360 IT TURNS OUT THAT VALUE OF 2065 01:21:11,360 --> 01:21:12,480 HEALTH DECISION MODELING DEPENDS 2066 01:21:12,480 --> 01:21:13,560 HOW MUCH YOU ALREADY KNOW AND 2067 01:21:13,560 --> 01:21:15,120 THEN IT'S JUST A MATTER OF THE 2068 01:21:15,120 --> 01:21:18,840 MATH WHICH IS A VERY GOOD MATH 2069 01:21:18,840 --> 01:21:21,120 TECHNIQUE OF INTEGRATING RISKS 2070 01:21:21,120 --> 01:21:23,200 OVER TIME FOR THINGS WE CAN'T DO 2071 01:21:23,200 --> 01:21:27,840 TRIALS ON. 2072 01:21:27,840 --> 01:21:28,960 IN CONCLUSION, WE'VE HAD A 2073 01:21:28,960 --> 01:21:31,040 WONDERFUL RUN OF LUCK AND WE'VE 2074 01:21:31,040 --> 01:21:31,680 ALSO HAVE DOUG. 2075 01:21:31,680 --> 01:21:33,480 I WANT TO HAVE THIS OCCASION TO 2076 01:21:33,480 --> 01:21:34,080 THANK HIM. 2077 01:21:34,080 --> 01:21:37,400 THIS IS THE THIRD TIME I'VE 2078 01:21:37,400 --> 01:21:39,640 PRESENTED, EACH OF THOSE PHASES 2079 01:21:39,640 --> 01:21:40,920 I PRESENTED ONCE. 2080 01:21:40,920 --> 01:21:43,160 WE'RE NOW AT THIS POINT 40 YEARS 2081 01:21:43,160 --> 01:21:44,840 IN, THE REASON I HAVE 40 YEARS 2082 01:21:44,840 --> 01:21:46,920 IS BECAUSE WE HAVE SOMEBODY WITH 2083 01:21:46,920 --> 01:21:48,320 CONTINUITY WHO HAS SEEN A VISION 2084 01:21:48,320 --> 01:21:50,680 OVER THAT TIME. 2085 01:21:50,680 --> 01:21:53,240 HE'S HAD ALL THE PRAISE HE 2086 01:21:53,240 --> 01:21:55,400 NEEDS, DOESN'T NEED MINE BUT I'M 2087 01:21:55,400 --> 01:21:58,040 NO NONSENSE, HE DESERVES MY 2088 01:21:58,040 --> 01:21:59,040 THANKS AS WELL. 2089 01:21:59,040 --> 01:22:04,240 WE'VE DONE ENOUGH WITH CERVIX 2090 01:22:04,240 --> 01:22:06,120 THAT IT'S A MODEL. 2091 01:22:06,120 --> 01:22:07,200 KAISER PERMANENTE NORTHERN 2092 01:22:07,200 --> 01:22:11,680 CALIFORNIA, OR LIVING IN 2093 01:22:11,680 --> 01:22:13,240 AUSTRALIA WE'VE MADE CERVICAL 2094 01:22:13,240 --> 01:22:15,320 CANCER A RARE DISEASE, THAT 2095 01:22:15,320 --> 01:22:16,720 COULD BE EVERYWHERE, IT'S 2096 01:22:16,720 --> 01:22:19,560 ACHIEVABLE, A MATTER OF 2097 01:22:19,560 --> 01:22:20,560 IMPLEMENTATION OF WILL. 2098 01:22:20,560 --> 01:22:22,960 BECAUSE IT'S SUCH A RISK MAINLY 2099 01:22:22,960 --> 01:22:26,320 TO PEOPLE AT RISK, IT'S AN ISSUE 2100 01:22:26,320 --> 01:22:26,600 OF JUSTICE. 2101 01:22:26,600 --> 01:22:28,760 IT'S ALWAYS BEEN THAT NOW, NOW 2102 01:22:28,760 --> 01:22:29,640 INCREASINGLY THAT WAY. 2103 01:22:29,640 --> 01:22:31,360 I THANK HIM AND THANK YOU FOR 2104 01:22:31,360 --> 01:22:33,840 YOUR ATTENTION AND IF YOU HAVE 2105 01:22:33,840 --> 01:22:38,760 ANY TECHNICAL QUESTIONS, NICOLE 2106 01:22:38,760 --> 01:22:41,480 IS HERE FOR THE COST 2107 01:22:41,480 --> 01:22:44,760 EFFECTIVENESS STUFF. 2108 01:22:44,760 --> 01:22:52,120 THANKS. 2109 01:22:52,120 --> 01:22:53,000 >> THANK YOU, MARK. 2110 01:22:53,000 --> 01:22:55,840 THE FLOOR IS OPEN FOR QUESTIONS 2111 01:22:55,840 --> 01:22:56,720 OF MARK. 2112 01:22:56,720 --> 01:23:01,240 I'M ALWAYS INTERESTED IN SEEING 2113 01:23:01,240 --> 01:23:04,560 THE MATH, HAVING GROWN UP IN THE 2114 01:23:04,560 --> 01:23:07,880 MISSISSIPPI DELTA WONDERING WHY 2115 01:23:07,880 --> 01:23:13,680 IT PERSISTS AS SUCH A REGION 2116 01:23:13,680 --> 01:23:15,520 WITH HIGH RATES, AND CAN THIS 2117 01:23:15,520 --> 01:23:22,600 MODEL OR A MODEL LIKE THIS MOVE 2118 01:23:22,600 --> 01:23:23,560 THE NEEDLE WHERE THERE'S ISSUES 2119 01:23:23,560 --> 01:23:27,240 RELATIVE TO EDUCATION, WHAT IS 2120 01:23:27,240 --> 01:23:28,480 HPV, CERVICAL CANCER, HOW WILL 2121 01:23:28,480 --> 01:23:30,720 IT IMPACT ME AND MY FAMILY 2122 01:23:30,720 --> 01:23:32,800 MEMBERS. 2123 01:23:32,800 --> 01:23:35,760 I THINK THERE'S A HUGE GAP, 2124 01:23:35,760 --> 01:23:37,040 TRYING TO IMPLEMENT THESE 2125 01:23:37,040 --> 01:23:38,000 APPROACHES MAY BE MORE DIFFICULT 2126 01:23:38,000 --> 01:23:44,040 IN THOSE TYPES OF SETTINGS. 2127 01:23:44,040 --> 01:23:44,640 >> COMPLETELY TRUE. 2128 01:23:44,640 --> 01:23:46,600 WHEN WE GO AROUND THE WORLD IN 2129 01:23:46,600 --> 01:23:48,200 AFRICA OR WHATEVER AND SAY TRUST 2130 01:23:48,200 --> 01:23:52,680 ME, WE'RE GOING TO BE USING HPV 2131 01:23:52,680 --> 01:23:53,560 SCIENCE AND ARTIFICIAL 2132 01:23:53,560 --> 01:23:55,200 INTELLIGENCE TO PREDICT WHETHER 2133 01:23:55,200 --> 01:23:58,520 YOU'RE AT RISK AND NEED SURGICAL 2134 01:23:58,520 --> 01:23:59,720 PROCEDURE OR NOT. 2135 01:23:59,720 --> 01:24:03,000 YOU FEEL FINE BUT YOU NEED 2136 01:24:03,000 --> 01:24:03,360 SOMETHING. 2137 01:24:03,360 --> 01:24:04,760 WE'VE BEEN IN NIGERIA AND HAD 2138 01:24:04,760 --> 01:24:08,640 THE WHOLE TOWN SAY NO THANKS. 2139 01:24:08,640 --> 01:24:13,040 WE HAVE A REALLY ACTIVE HEALTH 2140 01:24:13,040 --> 01:24:13,360 COMMUNICATION. 2141 01:24:13,360 --> 01:24:13,960 PAUL HAHN AND OTHERS. 2142 01:24:13,960 --> 01:24:15,480 WE'VE GOT TO BE ABLE TO 2143 01:24:15,480 --> 01:24:17,520 COMMUNICATE THE GIST OF WHAT 2144 01:24:17,520 --> 01:24:19,240 WE'RE DOING FOR FAIRNESS AND WE 2145 01:24:19,240 --> 01:24:20,720 HAVE TO UNDERSTAND HOW MUCH 2146 01:24:20,720 --> 01:24:22,280 PEOPLE WANT TO KNOW. 2147 01:24:22,280 --> 01:24:25,680 SINCE THIS IS BASICALLY TAKING 2148 01:24:25,680 --> 01:24:29,200 VERY COMPLEX SCIENCE, BOILING IT 2149 01:24:29,200 --> 01:24:31,080 DOWN, MAKING IT SIMPLE IN 2150 01:24:31,080 --> 01:24:31,320 OUTCOME. 2151 01:24:31,320 --> 01:24:33,280 BUT IF PEOPLE WANT TO KNOW WHAT 2152 01:24:33,280 --> 01:24:36,960 IT IS, QUITE A TASK. 2153 01:24:36,960 --> 01:24:40,400 SO NUMERACY FOR RISK ESTIMATION 2154 01:24:40,400 --> 01:24:41,440 IS NOBODY'S FAVORITE. 2155 01:24:41,440 --> 01:24:43,480 EVERYONE WOULD RATHER NAME 2156 01:24:43,480 --> 01:24:48,120 SOMETHING THAN SAY I HAVE X PER 2157 01:24:48,120 --> 01:24:50,640 CORRECT -- X% THIS OR THAT. 2158 01:24:50,640 --> 01:24:52,920 WE HAVE A LOT TO DO EVEN WITH A 2159 01:24:52,920 --> 01:24:54,800 VERY EFFECTIVE ANSWER, AND I 2160 01:24:54,800 --> 01:25:03,000 KNOW THAT'S THE WHOLE THING FOR 2161 01:25:03,000 --> 01:25:03,400 IMPLEMENTATION. 2162 01:25:03,400 --> 01:25:05,800 PATTY GRAVITT IS DOING WORK ON 2163 01:25:05,800 --> 01:25:07,720 THIS PARTICULARLY, HOW MUCH 2164 01:25:07,720 --> 01:25:10,360 SHARED DECISION MAKING IS TO BE 2165 01:25:10,360 --> 01:25:12,320 EXPECTED AND DESIRED, AND HOW 2166 01:25:12,320 --> 01:25:14,160 FLEXIBLE CAN WE MAKE THIS SO 2167 01:25:14,160 --> 01:25:22,720 THAT PEOPLE CAN TRUST IN THEIR 2168 01:25:22,720 --> 01:25:22,960 CONTEXT. 2169 01:25:22,960 --> 01:25:30,000 >> FRANCIS, I SEE YOUR HAND. 2170 01:25:30,000 --> 01:25:30,640 >> THAT'S WONDERFUL. 2171 01:25:30,640 --> 01:25:32,000 THE CASE IN AFRICA, AND 2172 01:25:32,000 --> 01:25:34,600 MARGARET, YOU CAN HELP ME OUT 2173 01:25:34,600 --> 01:25:38,720 HERE, IS THAT IT HAPPENED WITH 2174 01:25:38,720 --> 01:25:42,600 MAMMOGRAPHY, ALL THESE TESTS 2175 01:25:42,600 --> 01:25:46,800 THAT IDENTIFY HIGH RISK AND 2176 01:25:46,800 --> 01:25:50,800 POTENTIALLY HIGH RISK IS THE 2177 01:25:50,800 --> 01:25:51,120 CONTINUUM. 2178 01:25:51,120 --> 01:25:53,560 s YOU COULD THE TEST, IT'S 2179 01:25:53,560 --> 01:25:53,840 POSITIVE. 2180 01:25:53,840 --> 01:25:55,800 IT ENDS THERE. 2181 01:25:55,800 --> 01:25:57,200 UNTIL EFFORTS ARE MADE INTO 2182 01:25:57,200 --> 01:26:03,960 INTERVENTION, THERE'S GOING TO 2183 01:26:03,960 --> 01:26:06,320 BE AN -- (INDISCERNIBLE) TO 2184 01:26:06,320 --> 01:26:07,400 SETTLE IN THESE COUNTRIES, 2185 01:26:07,400 --> 01:26:08,800 POSSIBLY EVEN THE MISSISSIPPI 2186 01:26:08,800 --> 01:26:11,320 DELTA THAT JOHN WAS TALKING 2187 01:26:11,320 --> 01:26:12,640 ABOUT, EITHER WORKING WITH THE 2188 01:26:12,640 --> 01:26:16,160 GOVERNMENTS OR WHATEVER TO MAKE 2189 01:26:16,160 --> 01:26:18,120 SURE THAT PEOPLE ARE FOUND TO BE 2190 01:26:18,120 --> 01:26:19,360 HIGH RISK OR POSITIVE THAT THERE 2191 01:26:19,360 --> 01:26:21,400 IS AN OPTION FOR THEM. 2192 01:26:21,400 --> 01:26:22,840 IF THAT'S NOT THERE, I THINK 2193 01:26:22,840 --> 01:26:24,400 THERE'S GOING TO BE 2194 01:26:24,400 --> 01:26:25,240 CONTINUING -- THE QUESTION IS 2195 01:26:25,240 --> 01:26:27,040 HOW DOES THAT HELP MY LIFE. 2196 01:26:27,040 --> 01:26:29,800 HOW DOES IT CHANGE ANYTHING FOR 2197 01:26:29,800 --> 01:26:30,160 ME? 2198 01:26:30,160 --> 01:26:33,680 >> NOTICE THE DEVICE THAT IS THE 2199 01:26:33,680 --> 01:26:36,280 ABLATION DEVICE IS THE DEVICE 2200 01:26:36,280 --> 01:26:37,840 THAT TAKES THE HPV TYPE, 2201 01:26:37,840 --> 01:26:39,440 INTEGRATES THE INFORMATION OF 2202 01:26:39,440 --> 01:26:41,760 WHAT IT SEES, HAS A CAMERA, AND 2203 01:26:41,760 --> 01:26:44,960 SAYS WILL THIS DEVICE WORK FOR 2204 01:26:44,960 --> 01:26:46,560 THIS, FOR YOU, OR DO YOU NEED 2205 01:26:46,560 --> 01:26:52,720 REFERRAL. 2206 01:26:52,720 --> 01:27:03,080 WE TIE THEM TOGETHER. 2207 01:27:16,400 --> 01:27:22,160 >> MAMMOGRAPHY DIDN'T PICK UP, 2208 01:27:22,160 --> 01:27:23,960 TO HAVE DONE POTENTIALLY. 2209 01:27:23,960 --> 01:27:25,080 >> MARGARET? 2210 01:27:25,080 --> 01:27:29,720 >> THANK YOU. 2211 01:27:29,720 --> 01:27:32,920 >> EXCELLENT PRESENTATION, MARK. 2212 01:27:32,920 --> 01:27:34,800 ALL REFERRING CANCERS, LIKEWISE 2213 01:27:34,800 --> 01:27:37,440 CERTAIN ARE ASSOCIATED WITH HPV, 2214 01:27:37,440 --> 01:27:45,080 WONDERING SOMEONE HAS CONSIDERED 2215 01:27:45,080 --> 01:27:47,040 A SIMILAR APPROACH, THERE WERE 2216 01:27:47,040 --> 01:27:47,680 PRE-CANCER LESIONS. 2217 01:27:47,680 --> 01:27:49,000 SUCH AN APPROACH COULD BE TAKEN 2218 01:27:49,000 --> 01:27:57,360 WITH THIS DISEASE AS WELL, ALSO 2219 01:27:57,360 --> 01:27:58,440 A VERY EXCITING OPPORTUNITY. 2220 01:27:58,440 --> 01:27:59,920 >> THAT'S A SPECIAL AREA OF 2221 01:27:59,920 --> 01:28:00,560 INTEREST. 2222 01:28:00,560 --> 01:28:06,560 I WOULD POINT OUT THERE IS NO 2223 01:28:06,560 --> 01:28:08,840 PRE-CANCEROUS STATE WELL 2224 01:28:08,840 --> 01:28:11,000 IDENTIFIED, WE HAVE A VERY LONG 2225 01:28:11,000 --> 01:28:13,000 SOJOURN TIME WHERE WE CAN CATCH 2226 01:28:13,000 --> 01:28:15,720 AND DESTROY A PRE-CANCER OF THE 2227 01:28:15,720 --> 01:28:16,280 CERVIX. 2228 01:28:16,280 --> 01:28:19,400 AND WE'RE WORKING ALSO ON THE 2229 01:28:19,400 --> 01:28:20,120 ADENOS, GLANDULARES, LEARNING 2230 01:28:20,120 --> 01:28:22,120 MORE ABOUT RIGHT NOW. 2231 01:28:22,120 --> 01:28:24,520 WE DON'T HAVE WHAT WE'RE 2232 01:28:24,520 --> 01:28:28,120 TARGETING, OFTEN THE FIRST SIGN 2233 01:28:28,120 --> 01:28:36,480 OF OROPHARYNGEAL, EXTENSION OF 2234 01:28:36,480 --> 01:28:39,080 THE NECK, OFTEN NOTHING SEEN SO 2235 01:28:39,080 --> 01:28:47,400 FINDING THAT SURROGATE ENDPOINT 2236 01:28:47,400 --> 01:28:49,760 PRECURSOR WOULD BE A STEP UP FOR 2237 01:28:49,760 --> 01:28:52,480 THAT SCREENING EFFORT. 2238 01:28:52,480 --> 01:28:54,200 2239 01:28:54,200 --> 01:28:57,640 >> THANKS, MARK. 2240 01:28:57,640 --> 01:28:59,000 ONE LAST QUESTION, AS WE 2241 01:28:59,000 --> 01:29:03,480 CONTINUE TO SEE DEVELOPMENT OF 2242 01:29:03,480 --> 01:29:05,800 NEW NON-INVASIVE APPROACHES FOR 2243 01:29:05,800 --> 01:29:06,800 CANCER DETECTION, PRE-CANCEROUS 2244 01:29:06,800 --> 01:29:09,520 AS WELL FOR VARIOUS FORMS OF 2245 01:29:09,520 --> 01:29:11,560 CANCER, WHERE ARE WE WITH 2246 01:29:11,560 --> 01:29:12,800 CERVICAL CANCER? 2247 01:29:12,800 --> 01:29:16,080 DO WE SEE NOVEL APPROACHES 2248 01:29:16,080 --> 01:29:18,920 COMING ONLINE THAT MIGHT BE EVEN 2249 01:29:18,920 --> 01:29:28,520 MORE NON-INVASIVE TO DETECT 2250 01:29:28,520 --> 01:29:29,600 THESE CANCERS? 2251 01:29:29,600 --> 01:29:31,040 AS WE THINK ABOUT MICROBIOME AND 2252 01:29:31,040 --> 01:29:32,520 OTHER APPROACHES TO COME UP WITH 2253 01:29:32,520 --> 01:29:37,720 NEW AND BETTER WAYS TO DETECT 2254 01:29:37,720 --> 01:29:38,720 THESE PRE-CANCERS. 2255 01:29:38,720 --> 01:29:40,600 >> FIRST OF ALL, THE REASSURANCE 2256 01:29:40,600 --> 01:29:44,720 GIVEN TO 90% OF PEOPLE BY A 2257 01:29:44,720 --> 01:29:45,400 SELF-SWAB, A BACKGROUND, YOU 2258 01:29:45,400 --> 01:29:47,560 KNOW, I MEAN IT'S A SPECIAL 2259 01:29:47,560 --> 01:29:50,640 PLASTIC BUT IT'S A BEAUTIFUL 2260 01:29:50,640 --> 01:29:55,280 LITTLE SWAB THAT'S BEING MADE, 2261 01:29:55,280 --> 01:29:56,440 CUSTOM MADE, IT'S -- THE 2262 01:29:56,440 --> 01:30:04,520 POSITIVES COME UP IN TEN 2263 01:30:04,520 --> 01:30:04,720 MINUTES. 2264 01:30:04,720 --> 01:30:08,640 WEAKEST SIGNALS TO 50 MINUTES. 2265 01:30:08,640 --> 01:30:12,160 A 10-MINUTE TEST FOR $5, 10 TO 2266 01:30:12,160 --> 01:30:14,720 50 MINUTES, DONE BY A WOMAN AND 2267 01:30:14,720 --> 01:30:15,560 HANDED IN. 2268 01:30:15,560 --> 01:30:16,880 THAT REASSURANCE TWICE IN A 2269 01:30:16,880 --> 01:30:18,640 LIFETIME IS A BIG ADVANCE. 2270 01:30:18,640 --> 01:30:21,240 THEN THE FACT THAT WE NOW HAVE A 2271 01:30:21,240 --> 01:30:26,480 VARIETY OF REALLY GOOD TRIAGE 2272 01:30:26,480 --> 01:30:28,120 TOOLS, METHYLATION, DUAL STAIN, 2273 01:30:28,120 --> 01:30:30,320 HPV TYPING, A HOST. 2274 01:30:30,320 --> 01:30:31,960 IT'S JUST A MATTER OF GETTING 2275 01:30:31,960 --> 01:30:33,720 THEM -- IF YOU GIVE ME ENOUGH 2276 01:30:33,720 --> 01:30:35,920 MONEY I CAN TELL IF SOMEONE HAS 2277 01:30:35,920 --> 01:30:36,240 PRE-CANCER. 2278 01:30:36,240 --> 01:30:38,680 IT'S A MATTER OF SCALING AND 2279 01:30:38,680 --> 01:30:40,560 ENGINEERING AND GETTING IT TO 2280 01:30:40,560 --> 01:30:41,960 PEOPLE WHICH TURNS OUT TO BE 2281 01:30:41,960 --> 01:30:44,200 MAJOR CHALLENGES TO GET THINGS 2282 01:30:44,200 --> 01:30:44,600 AFFORDABLE. 2283 01:30:44,600 --> 01:30:46,760 AND ACCEPTED. 2284 01:30:46,760 --> 01:30:50,800 2285 01:30:50,800 --> 01:30:51,600 >> YES, KAREN? 2286 01:30:51,600 --> 01:30:53,200 >> THANKS YOU SO MUCH. 2287 01:30:53,200 --> 01:30:58,040 THIS WAS SUCH A GREAT TALK. 2288 01:30:58,040 --> 01:31:00,200 THIS IS ONE WE REALLY CAN CURE, 2289 01:31:00,200 --> 01:31:02,120 PREVENT AND IT'S ONE OF THOSE 2290 01:31:02,120 --> 01:31:03,800 THAT REMINDS ME OF COLORECTAL 2291 01:31:03,800 --> 01:31:05,800 CANCER SCREENING BUT TO JOHN'S 2292 01:31:05,800 --> 01:31:06,600 POINT WHEN I LOOK AT FOR 2293 01:31:06,600 --> 01:31:08,080 INSTANCE A LOT OF EFFORTS THAT 2294 01:31:08,080 --> 01:31:10,200 HAVE BEEN MADE AROUND HEALTH 2295 01:31:10,200 --> 01:31:13,680 EDUCATION THINKING SPECIFICALLY 2296 01:31:13,680 --> 01:31:15,840 OF THE PROGRAMS THE NCI HAS 2297 01:31:15,840 --> 01:31:17,960 FUNDED MANY ARE NOT IN THAT 2298 01:31:17,960 --> 01:31:19,600 BLACK BELT IN THE MISSISSIPPI, 2299 01:31:19,600 --> 01:31:21,040 ALABAMA, THEY ARE ALL IN THE 2300 01:31:21,040 --> 01:31:21,960 NORTHEAST REGION. 2301 01:31:21,960 --> 01:31:24,280 MAYBE PERHAPS THERE'S AN 2302 01:31:24,280 --> 01:31:24,960 OPPORTUNITY TO THINK ABOUT 2303 01:31:24,960 --> 01:31:27,800 CREATING SOME OF THOSE 2304 01:31:27,800 --> 01:31:28,320 EDUCATIONAL OPPORTUNITIES. 2305 01:31:28,320 --> 01:31:29,640 THIS IS NOT ROCKET SCIENCE. 2306 01:31:29,640 --> 01:31:31,320 IN FACT A LOT OF THE 2307 01:31:31,320 --> 01:31:32,480 TECHNOLOGIES THAT YOU'RE TALKING 2308 01:31:32,480 --> 01:31:34,800 ABOUT, NOT WITH THE A.I. BUT 2309 01:31:34,800 --> 01:31:37,680 WITH THE POINT OF SERVICE CARE, 2310 01:31:37,680 --> 01:31:38,720 IT'S REVERSE INNOVATION. 2311 01:31:38,720 --> 01:31:40,120 THEY HAVE BEEN DOING IT IN 2312 01:31:40,120 --> 01:31:41,920 BOTSWANA FOR YEARS, A PROVIDER 2313 01:31:41,920 --> 01:31:43,120 IS LOOKING, NOT EVEN A PHYSICIAN 2314 01:31:43,120 --> 01:31:45,720 PROVIDER, SOMEONE WHO IS A 2315 01:31:45,720 --> 01:31:48,040 LAYPERSON TRAINED TO LOOK AT IT, 2316 01:31:48,040 --> 01:31:51,120 THERE'S A PHYSICIAN SOMEWHERE 2317 01:31:51,120 --> 01:31:53,520 ELSE LOOKING THAT SAYS OKAY THIS 2318 01:31:53,520 --> 01:31:57,160 PERSON NEEDS SOME VINEGAR WHICH 2319 01:31:57,160 --> 01:31:58,600 IS ESSENTIALLY TREATMENT, RIGHT? 2320 01:31:58,600 --> 01:32:01,480 TO YOUR POINT, LOW COST 2321 01:32:01,480 --> 01:32:02,240 INTERVENTIONS THAT REALLY WORK, 2322 01:32:02,240 --> 01:32:03,800 THE BIGGEST THING THAT WE CAN 2323 01:32:03,800 --> 01:32:06,040 THINK ABOUT IS HOW TO DO THE 2324 01:32:06,040 --> 01:32:07,520 EDUCATION, HOW DO WE LEVERAGE 2325 01:32:07,520 --> 01:32:11,040 THE RESOURCES THAT ARE ALREADY 2326 01:32:11,040 --> 01:32:11,600 OUT THERE PARTICULARLY THE 2327 01:32:11,600 --> 01:32:14,120 NON-CHI PROGRAM BECAUSE THAT WAS 2328 01:32:14,120 --> 01:32:17,320 ONE OF THE BIG PUSHES. 2329 01:32:17,320 --> 01:32:19,200 NCI SAID HPV, GET THE WORD OUT 2330 01:32:19,200 --> 01:32:20,120 ABOUT PREVENTION AND SCREENING. 2331 01:32:20,120 --> 01:32:24,720 I THINK THIS IS A WONDERFUL, 2332 01:32:24,720 --> 01:32:26,640 WONDERFUL EXAMPLE OF INNOVATIONS 2333 01:32:26,640 --> 01:32:27,680 THAT UNFORTUNATELY MAY BYPASS 2334 01:32:27,680 --> 01:32:30,080 THOSE COMMUNITIES THAT HAVE BEEN 2335 01:32:30,080 --> 01:32:30,960 TRADITIONALLY UNDERSERVED AND WE 2336 01:32:30,960 --> 01:32:33,120 NEED TO PUT OUR MINDS TOGETHER 2337 01:32:33,120 --> 01:32:34,000 TO LEVERAGE OUR CURRENT 2338 01:32:34,000 --> 01:32:34,960 RESOURCES TO ADDRESS SOME OF 2339 01:32:34,960 --> 01:32:35,520 THOSE ISSUES. 2340 01:32:35,520 --> 01:32:40,080 THANK YOU FOR A GREAT TALK. 2341 01:32:40,080 --> 01:32:43,440 >> TO TARGET THEM SPECIFICALLY, 2342 01:32:43,440 --> 01:32:45,200 GO TO THE HIGHEST BECAUSE THESE 2343 01:32:45,200 --> 01:32:45,520 WORK ANYWHERE. 2344 01:32:45,520 --> 01:32:47,320 AS SOON AS YOU KNOW A PLACE IS 2345 01:32:47,320 --> 01:32:49,160 HIGH RISK TREAT IT LIKE THE 2346 01:32:49,160 --> 01:32:50,640 EPIDEMIC THAT IT IS. 2347 01:32:50,640 --> 01:32:51,320 GO THERE. 2348 01:32:51,320 --> 01:32:53,840 AND BREAK IT DOWN FROM THERE 2349 01:32:53,840 --> 01:32:55,360 BECAUSE REDUCING SOMETHING 10% 2350 01:32:55,360 --> 01:32:58,640 FROM A HIGH RATE SAVES A LOT 2351 01:32:58,640 --> 01:32:59,320 MORE LIVES THAN REDUCING 2352 01:32:59,320 --> 01:33:03,160 SOMETHING 10% FROM A LOW RATE. 2353 01:33:03,160 --> 01:33:06,760 >> I COULDN'T AGREE MORE, KAREN. 2354 01:33:06,760 --> 01:33:08,440 I THINK THERE'S A GRASSROOTS 2355 01:33:08,440 --> 01:33:10,560 EFFORT THAT WILL BE NEEDED TO 2356 01:33:10,560 --> 01:33:11,000 ADDRESS THIS. 2357 01:33:11,000 --> 01:33:13,440 AND SOME OF THESE PLACES LIKE 2358 01:33:13,440 --> 01:33:17,080 THE MISSISSIPPI DELTA. 2359 01:33:17,080 --> 01:33:17,600 SUSAN? 2360 01:33:17,600 --> 01:33:19,440 >> JUST BECAUSE I SO AGREE, THIS 2361 01:33:19,440 --> 01:33:24,520 IS AN IMPORTANT POINT, IN 2362 01:33:24,520 --> 01:33:28,560 THINKING ABOUT PARTNERS WHEN YOU 2363 01:33:28,560 --> 01:33:38,880 WERE WORKING IN THESE 2364 01:33:38,880 --> 01:33:40,040 LOW-RESOURCE SETTINGS 2365 01:33:40,040 --> 01:33:41,680 COMMUNITY SETTINGS, THE FOLKS 2366 01:33:41,680 --> 01:33:43,040 SERVING THOSE COMMUNITIES, NICE 2367 01:33:43,040 --> 01:33:46,120 TO SEE LIKE I'VE SEEN IN 2368 01:33:46,120 --> 01:33:47,840 LEGISLATION WITH A PUSH TO HAVE 2369 01:33:47,840 --> 01:33:51,080 THOSE CENTERS ACTUALLY BE ABLE 2370 01:33:51,080 --> 01:33:52,280 TO RECEIVE THOSE TYPES OF FUNDS 2371 01:33:52,280 --> 01:33:55,520 TO DO SOME OF THE HEALTH 2372 01:33:55,520 --> 01:33:56,240 EDUCATION AND OUTREACH BECAUSE 2373 01:33:56,240 --> 01:33:59,440 THEY ARE THE TRUSTED PARTNERS IN 2374 01:33:59,440 --> 01:34:01,880 THE COMMUNITY ALREADY THERE. 2375 01:34:01,880 --> 01:34:05,120 SO, I WOULD LOVE TO SEE THIS 2376 01:34:05,120 --> 01:34:10,640 ADVANCE IN THE U.S. AND IN 2377 01:34:10,640 --> 01:34:12,400 UNDERSERVED AREAS. 2378 01:34:12,400 --> 01:34:13,080 >> THAT'S TRUE. 2379 01:34:13,080 --> 01:34:14,880 >> I AGREE TOTALLY. 2380 01:34:14,880 --> 01:34:15,680 ELECTRA? 2381 01:34:15,680 --> 01:34:16,360 >> THANKS, MARK. 2382 01:34:16,360 --> 01:34:16,840 HI, MARK. 2383 01:34:16,840 --> 01:34:17,600 GOOD TO SEE YOU. 2384 01:34:17,600 --> 01:34:20,360 THANKS FOR ALL YOU DO. 2385 01:34:20,360 --> 01:34:21,880 SO, SOMEBODY WHO HAS WORKED FOR 2386 01:34:21,880 --> 01:34:24,600 OVER 30 YEARS IN THIS AREA OF 2387 01:34:24,600 --> 01:34:26,440 CERVICAL CANCER, I CAN TELL YOU 2388 01:34:26,440 --> 01:34:33,120 IT'S GOING TO TAKE MORE THAN 2389 01:34:33,120 --> 01:34:34,600 JUST EDUCATION. 2390 01:34:34,600 --> 01:34:35,520 EVEN ACCESS. 2391 01:34:35,520 --> 01:34:37,160 W.H.O., SEVERAL YEARS AGO SAID 2392 01:34:37,160 --> 01:34:46,000 THERE'S THREE PILLARS THAT LED 2393 01:34:46,000 --> 01:34:51,960 LEAD TO ELIMINATION, SCREENING 2394 01:34:51,960 --> 01:34:52,840 AND TIMELY FOLLOW-UP. 2395 01:34:52,840 --> 01:34:55,080 IN THE UNITED STATES WE'RE 2396 01:34:55,080 --> 01:34:56,880 FALLING SHORT, BIG TIME, OF THE 2397 01:34:56,880 --> 01:34:57,760 LAST ONE. 2398 01:34:57,760 --> 01:35:01,320 WHEN I GOT MY DISSERTATION 2399 01:35:01,320 --> 01:35:06,120 FINISHED IN 1989, THE RATE OF 2400 01:35:06,120 --> 01:35:08,240 FOLLOW-UP OF ABNORMAL PAPS WAS 2401 01:35:08,240 --> 01:35:08,400 60%. 2402 01:35:08,400 --> 01:35:09,800 WENT TO A MEETING A COUPLE 2403 01:35:09,800 --> 01:35:12,560 MONTHS AGO, THE RATE IS STILL 2404 01:35:12,560 --> 01:35:17,400 60% FOR WOMEN WITH ABNORMALS. 2405 01:35:17,400 --> 01:35:19,920 THAT'S JUST UNACCEPTABLE. 2406 01:35:19,920 --> 01:35:22,720 AND UNTIL WE UNDERSTAND THAT 2407 01:35:22,720 --> 01:35:25,120 THESE WOMEN ALL COUNT, THAT WE 2408 01:35:25,120 --> 01:35:28,000 HEALTH CARE PROVIDERS ARE 2409 01:35:28,000 --> 01:35:29,080 RESPONSIBLE FOR FOLLOW-UP, 2410 01:35:29,080 --> 01:35:30,760 TIMELY AND PROPER FOLLOW-UP OF 2411 01:35:30,760 --> 01:35:36,600 THE WOMEN, THAT WE NEED TO FOCUS 2412 01:35:36,600 --> 01:35:39,560 ON THIS. 2413 01:35:39,560 --> 01:35:43,440 WE'RE NOT 2414 01:35:43,440 --> 01:35:45,120 WE'RE NOT GOING TO GET ANYWHERE, 2415 01:35:45,120 --> 01:35:46,800 DOESN'T HELP TO SCREEN WITHOUT 2416 01:35:46,800 --> 01:35:47,080 FOLLOW-UP. 2417 01:35:47,080 --> 01:35:48,720 UNFORTUNATELY WOMEN WHO DON'T 2418 01:35:48,720 --> 01:35:53,920 SPEAK ENGLISH ARE EXPERIENCING A 2419 01:35:53,920 --> 01:35:56,560 HUGE DISPARITY BECAUSE A LOT OF 2420 01:35:56,560 --> 01:35:58,760 INFORMATION IS IN ENGLISH, NO 2421 01:35:58,760 --> 01:36:03,480 HELP TO GET THE APPROPRIATE 2422 01:36:03,480 --> 01:36:04,120 FOLLOW-UP SERVICES. 2423 01:36:04,120 --> 01:36:05,880 I THINK WE CAN ELIMINATE 2424 01:36:05,880 --> 01:36:08,120 CERVICAL CANCER BUT THERE HAS TO 2425 01:36:08,120 --> 01:36:12,440 BE A WILL AND EVERYBODY HAS TO 2426 01:36:12,440 --> 01:36:13,960 THINK ABOUT IT, AND WANT TO DO 2427 01:36:13,960 --> 01:36:17,720 IT, AND NOT THINK OF CERVICAL 2428 01:36:17,720 --> 01:36:19,480 CANCER AS SOMETHING THAT ONLY 2429 01:36:19,480 --> 01:36:24,800 CERTAIN WOMEN GET. 2430 01:36:24,800 --> 01:36:26,280 AND I HAVE HEARD THAT AND WE'VE 2431 01:36:26,280 --> 01:36:31,040 GOT TO CHANGE WAIT WE THINK 2432 01:36:31,040 --> 01:36:34,600 ABOUT IT. ALSO HELP TO INCREASE 2433 01:36:34,600 --> 01:36:36,720 HPV VACCINATION RATES WHICH 2434 01:36:36,720 --> 01:36:38,960 SUFFERED DON'T COVID AND 2435 01:36:38,960 --> 01:36:39,400 CONTINUE TO SUFFER. 2436 01:36:39,400 --> 01:36:40,920 WE WANT TO MAKE A DIFFERENCE IN 2437 01:36:40,920 --> 01:36:42,560 CANCER, START WITH THE ONE WE 2438 01:36:42,560 --> 01:36:44,320 CAN, PERHAPS A FEW OTHER CANCERS 2439 01:36:44,320 --> 01:36:47,680 ALONG THE WAY. 2440 01:36:47,680 --> 01:36:50,960 BUT THANK YOU, MARK AND DOUG, 2441 01:36:50,960 --> 01:36:53,360 FOR YOUR WORK ON THIS. 2442 01:36:53,360 --> 01:36:55,120 IT'S REALLY SPECTACULAR AND 2443 01:36:55,120 --> 01:36:57,320 WE'VE JUST GOT TO NOW IMPLEMENT 2444 01:36:57,320 --> 01:36:59,840 IT BUT IMPLEMENT IT ON THE 2445 01:36:59,840 --> 01:37:03,760 MULTI-LEVEL FOCUS AND NOT JUST 2446 01:37:03,760 --> 01:37:07,280 THINK ABOUT ACCESS AND EDUCATION 2447 01:37:07,280 --> 01:37:08,680 BECAUSE THERE'S CULTURE, THERE'S 2448 01:37:08,680 --> 01:37:10,480 FEAR, THERE'S A WHOLE LOT OF 2449 01:37:10,480 --> 01:37:12,080 THINGS THAT WE NEED TO FOCUS ON 2450 01:37:12,080 --> 01:37:13,320 AND WE'RE DOING IT. 2451 01:37:13,320 --> 01:37:16,320 WE'VE BEEN DOING IT NOW IN 2452 01:37:16,320 --> 01:37:20,520 APPALACHIA FOR MANY YEARS, IT'S 2453 01:37:20,520 --> 01:37:22,680 NICE THEY DON'T HAVE THE HIGHEST 2454 01:37:22,680 --> 01:37:23,920 RATES ANY LONGER, STILL IN THE 2455 01:37:23,920 --> 01:37:26,360 MID, BUT WE HAVE A LONG WAY TO 2456 01:37:26,360 --> 01:37:27,960 GO TO ELIMINATE THIS CANCER. 2457 01:37:27,960 --> 01:37:29,560 ACHIEVABLE BUT WE HAVE TO WORK 2458 01:37:29,560 --> 01:37:33,800 TOGETHER. 2459 01:37:33,800 --> 01:37:34,400 >> YEAH, EXCELLENT PERSPECTIVE 2460 01:37:34,400 --> 01:37:35,600 FROM SOMEONE WHO HAS BEEN DOING 2461 01:37:35,600 --> 01:37:37,240 THIS A LONG TIME. 2462 01:37:37,240 --> 01:37:37,440 THANKS. 2463 01:37:37,440 --> 01:37:39,280 I STILL THINK EDUCATION AS WE 2464 01:37:39,280 --> 01:37:42,280 TALK ABOUT FEAR AND TRUST, YOU 2465 01:37:42,280 --> 01:37:43,640 KNOW, CULTURE, RIGHT? 2466 01:37:43,640 --> 01:37:45,360 YOU KNOW, PEOPLE HAVE NO IDEA 2467 01:37:45,360 --> 01:37:47,800 WHAT HPV IS IN THE FIRST PLACE, 2468 01:37:47,800 --> 01:37:51,120 YOU KNOW, WE HAD PEOPLE WHO 2469 01:37:51,120 --> 01:37:53,280 DON'T -- VACCINATION CHALLENGES 2470 01:37:53,280 --> 01:37:56,040 WITH COVID, AND EVERYONE, IT WAS 2471 01:37:56,040 --> 01:37:56,640 EVERYWHERE, RIGHT? 2472 01:37:56,640 --> 01:37:59,760 AND FOR A VIRUS THAT CAUSES 2473 01:37:59,760 --> 01:38:01,000 CANCER, SO FEW PEOPLE IN THE 2474 01:38:01,000 --> 01:38:02,720 MISSISSIPPI DELTA HAVE ANY CLUE 2475 01:38:02,720 --> 01:38:06,400 WHAT IT IS IN THE FIRST PLACE. 2476 01:38:06,400 --> 01:38:07,640 THERE'S PERSISTENT EXPOSURE TO 2477 01:38:07,640 --> 01:38:08,520 THE VIRUS. 2478 01:38:08,520 --> 01:38:10,360 SO GREAT POINTS. 2479 01:38:10,360 --> 01:38:12,800 AND THEN YOUR COMMENT, ELECTRA, 2480 01:38:12,800 --> 01:38:15,720 ABOUT FOLLOW-UP IS SIMILAR TO 2481 01:38:15,720 --> 01:38:16,920 COLORECTAL CANCER AND SCREENING 2482 01:38:16,920 --> 01:38:18,040 AND LUNG CANCER SCREENING, ALL 2483 01:38:18,040 --> 01:38:18,680 THESE THINGS. 2484 01:38:18,680 --> 01:38:20,480 IF YOU CAN FIND IT, GREAT. 2485 01:38:20,480 --> 01:38:22,000 BUT WHAT HAPPENS IF YOU CAN'T DO 2486 01:38:22,000 --> 01:38:23,080 ANYTHING ABOUT IT LATER? 2487 01:38:23,080 --> 01:38:24,680 SO THESE ARE ALL GREAT POINTS. 2488 01:38:24,680 --> 01:38:26,640 BUT THANK YOU AGAIN, MARK. 2489 01:38:26,640 --> 01:38:29,360 THAT WAS SUCH A FABULOUS 2490 01:38:29,360 --> 01:38:29,760 PRESENTATION. 2491 01:38:29,760 --> 01:38:31,760 AND THE BOARD THANKS YOU FOR 2492 01:38:31,760 --> 01:38:34,800 YOUR TIME AND YOUR EFFORTS. 2493 01:38:34,800 --> 01:38:38,600 I THINK WE'RE RIGHT ON TIME, 2494 01:38:38,600 --> 01:38:39,040 PAULETTE. 2495 01:38:39,040 --> 01:38:42,600 I THINK WE'RE SUPPOSED TO GO 2496 01:38:42,600 --> 01:38:46,920 INTO BREAK NOW. 2497 01:38:46,920 --> 01:38:47,880 >> YES. 2498 01:38:47,880 --> 01:38:50,120 >> SO, THERE'S A 30-MINUTE BREAK 2499 01:38:50,120 --> 01:38:51,480 FOR THIS OPEN SESSION. 2500 01:38:51,480 --> 01:38:52,920 HOWEVER, THOSE AT THE VIRTUAL 2501 01:38:52,920 --> 01:38:55,360 TABLE CAN TAKE A FIVE-MINUTE 2502 01:38:55,360 --> 01:38:58,640 BREAK, DON'T DISCONNECT, JUST 2503 01:38:58,640 --> 01:39:00,560 TURN OFF YOUR CAMERAS AND MUTE. 2504 01:39:00,560 --> 01:39:03,480 IF YOU'RE NOT MUTED I.T. 2505 01:39:03,480 --> 01:39:04,600 PROFESSIONALS WILL MUTE 2506 01:39:04,600 --> 01:39:05,000 EVERYONE. 2507 01:39:05,000 --> 01:39:08,240 EVERYONE ELSE SHOULD COME BACK 2508 01:39:08,240 --> 01:39:10,240 AT 3:25. 2509 01:39:10,240 --> 01:39:12,000 FOR THOSE AT THE VIRTUAL TABLE 2510 01:39:12,000 --> 01:39:12,720 JUST TAKE A FIVE-MINUTE BREAK. 2511 01:39:12,720 --> 01:39:19,600 >>I THINK WE'RE BACK IN 2512 01:39:19,600 --> 01:39:19,800 SESSION. 2513 01:39:19,800 --> 01:39:24,040 AND WE'RE NOW IN THE SESSION FOR 2514 01:39:24,040 --> 01:39:26,240 ONGOING AND NEW BUSINESS, AMONG 2515 01:39:26,240 --> 01:39:29,840 WHICH THERE WERE TWO NCAB 2516 01:39:29,840 --> 01:39:30,480 SUBCOMMITTEE MEETINGS HELD 2517 01:39:30,480 --> 01:39:31,360 EARLIER TODAY, AND CHAIRS WILL 2518 01:39:31,360 --> 01:39:31,920 GIVE THEIR REPORTS. 2519 01:39:31,920 --> 01:39:42,240 WE'LL HAVE THE FIRST REPORT FROM 2520 01:39:42,240 --> 01:39:50,720 AMY HEIMBERGER ON EXPERIMENTAL 2521 01:39:50,720 --> 01:39:51,440 THERAPEUTICS? 2522 01:39:51,440 --> 01:39:53,480 >> THERAPEUTICS BEGAN BY GIVING 2523 01:39:53,480 --> 01:39:55,200 AN UPDATE WITH REGARDS TO 2524 01:39:55,200 --> 01:39:56,320 PREVIOUS MANDATE UNDER DR. 2525 01:39:56,320 --> 01:39:56,600 SHARPLESS. 2526 01:39:56,600 --> 01:39:58,840 THERE WAS SOME CONCERNS WITH 2527 01:39:58,840 --> 01:40:00,120 REGARDS TO DEVELOPMENT 6 2528 01:40:00,120 --> 01:40:01,040 CELLULAR THERAPEUTICS AND HOW 2529 01:40:01,040 --> 01:40:04,960 THE NCI COULD DO THAT BETTER. 2530 01:40:04,960 --> 01:40:06,920 ROSE ARGININE PRESENTED AN 2531 01:40:06,920 --> 01:40:09,120 UPDATE ON CELLULAR THERAPEUTICS 2532 01:40:09,120 --> 01:40:10,760 FOR SOLID CANCERS, THIS INCLUDED 2533 01:40:10,760 --> 01:40:12,320 A NUMBER OF CONFERENCES AS WELL 2534 01:40:12,320 --> 01:40:15,760 AS A WHITE PAPER THAT WAS 2535 01:40:15,760 --> 01:40:18,240 PUBLISHED THAT IDENTIFIED AREAS 2536 01:40:18,240 --> 01:40:20,720 ON UNMET NEED FOR ADVANCING 2537 01:40:20,720 --> 01:40:26,160 CELLULAR THERAPIES FOR SOLID 2538 01:40:26,160 --> 01:40:26,400 CANCERS. 2539 01:40:26,400 --> 01:40:28,080 THIS ULTIMATELY RESULTED IN 2540 01:40:28,080 --> 01:40:30,480 THREE COMPANION FUNDING 2541 01:40:30,480 --> 01:40:31,680 OPPORTUNITY ANNOUNCEMENTS THAT 2542 01:40:31,680 --> 01:40:37,680 CAME FOR THE CANCER ADOPTIVE 2543 01:40:37,680 --> 01:40:38,840 CELL THERAPY NETWORK, POSTED, 2544 01:40:38,840 --> 01:40:42,480 ONE WILL INCLUDE A COOPERATIVE 2545 01:40:42,480 --> 01:40:44,880 AGREEMENT UG3 AND UH3 THAT WILL 2546 01:40:44,880 --> 01:40:45,920 INCLUDE ADULT AND PEDIATRIC 2547 01:40:45,920 --> 01:40:47,720 CANCERS AND IT'S GOING TO BE 2548 01:40:47,720 --> 01:40:50,760 MANAGED AS A SINGLE U24 2549 01:40:50,760 --> 01:40:52,120 COORDINATING SITE SUPPORTED BY 2550 01:40:52,120 --> 01:40:55,280 THE CELL CORE AT THE FREDERICK 2551 01:40:55,280 --> 01:40:56,680 NATIONAL LABORATORY FOR CANCER 2552 01:40:56,680 --> 01:40:56,960 RESEARCH. 2553 01:40:56,960 --> 01:41:01,920 AND THERE'S A WEBINAR FOR THAT 2554 01:41:01,920 --> 01:41:04,040 ON SEPTEMBER 7. 2555 01:41:04,040 --> 01:41:05,440 THE NEW DISCUSSION POINTS THAT 2556 01:41:05,440 --> 01:41:08,400 WERE BROUGHT UP ON OUR 2557 01:41:08,400 --> 01:41:11,880 SUBCOMMITTEE MEETING THIS 2558 01:41:11,880 --> 01:41:15,360 MORNING WERE A CONSIDERATION FOR 2559 01:41:15,360 --> 01:41:16,480 INCREASING OUR TRANSLATIONAL 2560 01:41:16,480 --> 01:41:18,120 RESEARCH TRAINING. 2561 01:41:18,120 --> 01:41:20,640 AND WE BEGAN BY INTRODUCING THE 2562 01:41:20,640 --> 01:41:21,040 NEED. 2563 01:41:21,040 --> 01:41:23,760 THIS WAS THROUGH THE FACT THAT 2564 01:41:23,760 --> 01:41:27,760 THERE'S A PROGRAM IN THE CANCER 2565 01:41:27,760 --> 01:41:28,520 CENTER THROUGH THE NCI 2566 01:41:28,520 --> 01:41:29,440 DEVELOPMENTAL THERAPEUTICS 2567 01:41:29,440 --> 01:41:32,480 PROGRAM WHERE YOU CAN GET 2568 01:41:32,480 --> 01:41:34,040 CONFIDENTIAL GUIDANCE. 2569 01:41:34,040 --> 01:41:34,920 IT'S BEEN OPERATIONAL FOR 3.5 2570 01:41:34,920 --> 01:41:35,360 YEARS. 2571 01:41:35,360 --> 01:41:39,520 SO FAR THERE'S BEEN A TOTAL OF 2572 01:41:39,520 --> 01:41:46,920 264 REQUESTS, 149 149 2573 01:41:46,920 --> 01:41:52,120 CONSULTATIONS ACROSS EVERY STATE 2574 01:41:52,120 --> 01:41:53,920 FROM PRE-CLINICAL TOXICOLOGY, 2575 01:41:53,920 --> 01:41:54,480 EFFICACY, PROOF-OF-CONCEPT 2576 01:41:54,480 --> 01:41:55,120 STUDIES, ET CETERA. 2577 01:41:55,120 --> 01:41:56,680 THERE'S CLEARLY A NEED BY PEOPLE 2578 01:41:56,680 --> 01:41:59,120 WORKING IN THE TRANSLATIONAL 2579 01:41:59,120 --> 01:41:59,640 CONTINUUM. 2580 01:41:59,640 --> 01:42:00,760 BUT I ALSO PROVIDED SOME 2581 01:42:00,760 --> 01:42:04,080 ANTIDOTES WITH THE FACT THAT 2582 01:42:04,080 --> 01:42:05,880 EVEN AT A MAJOR CANCER CENTER 2583 01:42:05,880 --> 01:42:08,200 THAT THERE'S MANY ISSUES THAT 2584 01:42:08,200 --> 01:42:10,240 ARISE IN THE TRANSLATIONAL 2585 01:42:10,240 --> 01:42:11,880 THERAPEUTIC PIPELINE. 2586 01:42:11,880 --> 01:42:15,200 AND THESE INCLUDE THINGS LIKE 2587 01:42:15,200 --> 01:42:17,080 INVESTIGATORS, EVEN SEASONED 2588 01:42:17,080 --> 01:42:17,720 INVESTIGATORS NOT UNDERSTANDING 2589 01:42:17,720 --> 01:42:21,680 THAT REQUIREMENT FOR FILING 2590 01:42:21,680 --> 01:42:24,120 PROVISIONAL PATENT PRIOR TO 2591 01:42:24,120 --> 01:42:26,040 PUBLIC DISCLOSURE, UNDERSTANDING 2592 01:42:26,040 --> 01:42:26,680 COMPETITIVE LANDSCAPE, CLINICAL 2593 01:42:26,680 --> 01:42:28,040 INDICATIONS, ET CETERA. 2594 01:42:28,040 --> 01:42:30,480 SO THIS MEETING THIS MORNING WAS 2595 01:42:30,480 --> 01:42:34,800 TO EXPLORE IDEAS AROUND 2596 01:42:34,800 --> 01:42:36,400 POTENTIALLY DEVELOPING EARLIER 2597 01:42:36,400 --> 01:42:42,040 STAGE THERAPEUTICS OR 2598 01:42:42,040 --> 01:42:42,640 TRANSLATIONAL THERAPEUTICS, 2599 01:42:42,640 --> 01:42:43,240 EDUCATIONAL CURRICULUM. 2600 01:42:43,240 --> 01:42:44,880 BECAUSE THAT WAS THE 2601 01:42:44,880 --> 01:42:46,520 CONSIDERATION, WE HAD DR. 2602 01:42:46,520 --> 01:42:49,280 BUBBLER, DIRECTOR FOR THE CENTER 2603 01:42:49,280 --> 01:42:53,120 OF CANCER TRAINING, PROVIDED US 2604 01:42:53,120 --> 01:42:57,120 WITH INFORMATION WITH REGARDS TO 2605 01:42:57,120 --> 01:42:57,720 INTRAMURAL INTERAGENCY ONCOLOGY 2606 01:42:57,720 --> 01:42:58,920 TASK FORCE FELLOWSHIP. 2607 01:42:58,920 --> 01:43:00,680 THIS IS AN INTERESTING PROGRAM, 2608 01:43:00,680 --> 01:43:06,600 THE IT'S A COMBINATION, 2609 01:43:06,600 --> 01:43:08,600 TWO-YEAR IN-HOUSE FELLOWSHIP TO 2610 01:43:08,600 --> 01:43:11,640 TRAIN SCIENTISTS IN RESEARCH AND 2611 01:43:11,640 --> 01:43:12,600 RESEARCH-RELATED REGULATORY 2612 01:43:12,600 --> 01:43:13,200 PROCESSES. 2613 01:43:13,200 --> 01:43:15,200 NOW, I'M GOING TO EMPHASIZE THIS 2614 01:43:15,200 --> 01:43:18,240 IS ON THE SORT OF RAPID 2615 01:43:18,240 --> 01:43:19,200 TRANSLATION INTO CLINICAL TRIALS 2616 01:43:19,200 --> 01:43:23,080 SORT OF PART OF THE CONTINUUM. 2617 01:43:23,080 --> 01:43:25,160 SINCE THE INITIATION, HE'S HAD A 2618 01:43:25,160 --> 01:43:26,880 TOTAL OF 70 GRADUATES TO DATE, 2619 01:43:26,880 --> 01:43:30,480 MANY OF THESE HAVE ACTUALLY 2620 01:43:30,480 --> 01:43:32,320 HAD -- WENT ON TO SERVE IN THE 2621 01:43:32,320 --> 01:43:40,280 FDA OR IN THE BIOMEDICAL 2622 01:43:40,280 --> 01:43:42,480 INDUSTRY. 2623 01:43:42,480 --> 01:43:45,320 THERE'S A TOTAL OF 1572 ACTIVE 2624 01:43:45,320 --> 01:43:49,360 CANCER TRAINING AWARDS, IN 2625 01:43:49,360 --> 01:43:52,560 K12s, R25s, K08s, ET 2626 01:43:52,560 --> 01:43:53,640 CETERA. 2627 01:43:53,640 --> 01:43:55,520 AND OF THOSE, 166 SUPPORT 2628 01:43:55,520 --> 01:43:58,680 CLINICAL TRIALS. 2629 01:43:58,680 --> 01:44:01,320 I WOULD LIKE TO NOTE THESE ARE 2630 01:44:01,320 --> 01:44:03,560 TRAINING GRANTS IN CANCER, THEY 2631 01:44:03,560 --> 01:44:05,360 DON'T NECESSARILY INFLUENCE OR 2632 01:44:05,360 --> 01:44:07,320 EDUCATE ON THAT TRANSLATIONAL 2633 01:44:07,320 --> 01:44:08,520 CONTINUUM, AT THE VERY EARLY 2634 01:44:08,520 --> 01:44:08,720 STAGE. 2635 01:44:08,720 --> 01:44:10,560 IN OTHER WORDS, HOW YOU VET 2636 01:44:10,560 --> 01:44:11,720 SOMETHING, HOW YOU PICK LEAD 2637 01:44:11,720 --> 01:44:13,280 TEST ARTICLES, ET CETERA. 2638 01:44:13,280 --> 01:44:15,160 SO, WE'VE GOT A VERY NICE SORT 2639 01:44:15,160 --> 01:44:19,200 OF PROGRAM AT THE NCI ON THE 2640 01:44:19,200 --> 01:44:20,480 RAPID TRANSLATION INTO CLINICAL 2641 01:44:20,480 --> 01:44:22,800 TRIALS STAGE OF THINGS. 2642 01:44:22,800 --> 01:44:25,040 HE ALSO BROUGHT UP THE METHODS 2643 01:44:25,040 --> 01:44:27,120 AND CLINICAL CANCER RESEARCH 2644 01:44:27,120 --> 01:44:27,400 WORKSHOP. 2645 01:44:27,400 --> 01:44:30,080 I WAS ONE OF THE FIRST OR 2646 01:44:30,080 --> 01:44:31,080 PROBABLY SECOND YEAR PARTICIPANT 2647 01:44:31,080 --> 01:44:32,600 WHEN IT WAS INITIATED A WHILE 2648 01:44:32,600 --> 01:44:32,880 AGO. 2649 01:44:32,880 --> 01:44:35,600 AND THIS IS REALLY WHERE AN 2650 01:44:35,600 --> 01:44:37,200 INVESTIGATOR BRINGS TO THIS 2651 01:44:37,200 --> 01:44:39,960 PARTICULAR WORKSHOP, IT'S A 2652 01:44:39,960 --> 01:44:41,320 WEEK-LONG COURSE, CLINICAL TRIAL 2653 01:44:41,320 --> 01:44:42,960 CONCEPT, AND THEN THEY HAVE 2654 01:44:42,960 --> 01:44:44,080 EXPERTS THAT COME IN AND HELP 2655 01:44:44,080 --> 01:44:45,960 WORK THROUGH THE CLINICAL TRIAL. 2656 01:44:45,960 --> 01:44:48,000 AGAIN, IT'S RIGHT AS YOU'RE 2657 01:44:48,000 --> 01:44:50,880 TRANSITIONING INTO CLINICAL 2658 01:44:50,880 --> 01:44:51,200 TRIAL. 2659 01:44:51,200 --> 01:44:53,200 SO, THE SUBCOMMITTEE, WE 2660 01:44:53,200 --> 01:44:55,200 DISCUSSED THE SPECIFIC 2661 01:44:55,200 --> 01:44:56,200 CHALLENGES ASSOCIATED WITH 2662 01:44:56,200 --> 01:44:57,840 TRANSLATIONAL RESEARCH. 2663 01:44:57,840 --> 01:44:59,480 AND THIS INVOLVED EDUCATION 2664 01:44:59,480 --> 01:45:01,720 AROUND THIS SORT OF ENDEAVOR. 2665 01:45:01,720 --> 01:45:03,880 FIRST OF ALL, THERE WAS A 2666 01:45:03,880 --> 01:45:05,040 DISCUSSION WITH REGARDS TO 2667 01:45:05,040 --> 01:45:07,080 INCREASING THE DIVERSITY OF THE 2668 01:45:07,080 --> 01:45:07,960 RESEARCH WORKFORCE WHICH 2669 01:45:07,960 --> 01:45:11,120 EVERYONE ON THIS BOARD AGREES IS 2670 01:45:11,120 --> 01:45:15,640 A KEY ISSUE. 2671 01:45:15,640 --> 01:45:16,320 THE MULTI-FACETED CHALLENGES 2672 01:45:16,320 --> 01:45:17,320 TRANSLATIONAL RESEARCH 2673 01:45:17,320 --> 01:45:18,120 INSTITUTIONAL SUPPORT FOR 2674 01:45:18,120 --> 01:45:21,040 INTELLECTUAL PROPERTY NEEDS FOR 2675 01:45:21,040 --> 01:45:22,240 THE INVESTIGATORS RESEARCHERS 2676 01:45:22,240 --> 01:45:23,960 NOT REALLY UNDERSTANDING THE 2677 01:45:23,960 --> 01:45:25,000 PROCESS, IN OTHER WORDS, YOU 2678 01:45:25,000 --> 01:45:27,920 KNOW, THE ACTUAL SORT OF PROCESS 2679 01:45:27,920 --> 01:45:29,160 YOU GO THROUGH WHEN PHARMA LOOKS 2680 01:45:29,160 --> 01:45:31,240 AL THESE KINDS OF THINGS. 2681 01:45:31,240 --> 01:45:32,200 AND THEN ADDITIONALLY THERE'S A 2682 01:45:32,200 --> 01:45:34,680 LOT OF LACK OF INSTITUTIONAL 2683 01:45:34,680 --> 01:45:36,440 INFRASTRUCTURE TO SUPPORT GOOD 2684 01:45:36,440 --> 01:45:37,600 LABORATORY PRACTICES, GOOD 2685 01:45:37,600 --> 01:45:38,480 MANUFACTURING PRACTICES, ET 2686 01:45:38,480 --> 01:45:38,920 CETERA. 2687 01:45:38,920 --> 01:45:40,840 AND THEN IT ALSO COMES DOWN TO 2688 01:45:40,840 --> 01:45:43,600 LACK OF EXPERTISE IN MULTIPLE 2689 01:45:43,600 --> 01:45:44,880 DOMAINS, THOSE INCLUDE BUSINESS 2690 01:45:44,880 --> 01:45:47,440 UNDERSTANDING, SORT OF WHETHER 2691 01:45:47,440 --> 01:45:50,320 YOU'RE GOING TO REAP YOUR RETURN 2692 01:45:50,320 --> 01:45:51,600 ON INVESTMENT WHEN DEVELOPING 2693 01:45:51,600 --> 01:45:53,320 SOMETHING, LEGAL ASPECTS OF 2694 01:45:53,320 --> 01:45:54,920 INTELLECTUAL PROPERTY, ET 2695 01:45:54,920 --> 01:45:55,920 CETERA. 2696 01:45:55,920 --> 01:45:56,680 AND BUSINESS ASPECTS. 2697 01:45:56,680 --> 01:45:58,000 SO, CERTAINLY THOSE KINDS OF 2698 01:45:58,000 --> 01:45:59,800 THINGS PLAY A ROLE IN PHARMA 2699 01:45:59,800 --> 01:46:02,400 WHEN THEY DEVELOP A DRUG, AND 2700 01:46:02,400 --> 01:46:04,640 THOSE ACADEMIC CENTERS ARE NOT 2701 01:46:04,640 --> 01:46:07,040 AWARE OF THESE KEY COMPONENTS AS 2702 01:46:07,040 --> 01:46:08,040 THEY ARE DEVELOPING THERAPEUTICS 2703 01:46:08,040 --> 01:46:12,320 AND I THINK WE HAVE A VARIETY OF 2704 01:46:12,320 --> 01:46:14,160 LOST INITIATIVES BECAUSE OF THE 2705 01:46:14,160 --> 01:46:15,360 LACK OF UNDERSTANDING. 2706 01:46:15,360 --> 01:46:18,440 SO, WE HAD A NUMBER OF KEY STEPS 2707 01:46:18,440 --> 01:46:19,240 THAT WERE ACTUALLY IDENTIFIED, 2708 01:46:19,240 --> 01:46:22,120 IF THIS IS SOMETHING THAT THE 2709 01:46:22,120 --> 01:46:24,800 GROUP WISHES TO OR IF THERE'S 2710 01:46:24,800 --> 01:46:26,880 SIGNIFICANT INTEREST IN 2711 01:46:26,880 --> 01:46:28,640 DEVELOPING THIS FURTHER. 2712 01:46:28,640 --> 01:46:30,200 THERE COULD BE DEVELOPMENT OF 2713 01:46:30,200 --> 01:46:31,800 NCI CURRICULUM THAT REALLY SORT 2714 01:46:31,800 --> 01:46:34,520 OF IS MORE FOCUSED ON THE EARLY 2715 01:46:34,520 --> 01:46:37,600 PARTS OF THE EDUCATIONAL 2716 01:46:37,600 --> 01:46:40,080 TRANSLATIONAL CONTINUUM. 2717 01:46:40,080 --> 01:46:42,160 WE COULD CERTAINLY ASSAY OR 2718 01:46:42,160 --> 01:46:43,040 ASSESS FROM CANCER CENTERS 2719 01:46:43,040 --> 01:46:44,920 DIRECTORS THE NEEDS OF THE 2720 01:46:44,920 --> 01:46:45,720 VARIOUS CANCER CENTERS, SPECIFIC 2721 01:46:45,720 --> 01:46:47,240 LIVE SORT OF THE AREAS THAT THEY 2722 01:46:47,240 --> 01:46:49,520 FEEL THEY ARE REALLY LACKING. 2723 01:46:49,520 --> 01:46:56,160 ONE OF THE ADVANTAGES OF HAVING 2724 01:46:56,160 --> 01:46:57,280 IT CENTRALIZED, REDUCES 2725 01:46:57,280 --> 01:46:58,240 DUPLICATION OF INFRASTRUCTURE, 2726 01:46:58,240 --> 01:46:59,680 COULD HARMONIZE, COULD BRING IN 2727 01:46:59,680 --> 01:47:01,400 THE LEADING EXPERTS IN THESE 2728 01:47:01,400 --> 01:47:02,800 DOMAINS TO REALLY SORT OF FOSTER 2729 01:47:02,800 --> 01:47:04,400 AND MAKE SURE THAT THE TRAINING 2730 01:47:04,400 --> 01:47:06,600 IS DONE BY THE BEST POSSIBLE 2731 01:47:06,600 --> 01:47:07,720 PERSON. 2732 01:47:07,720 --> 01:47:10,440 THIS COULD BE ARCHIVED, SO THAT 2733 01:47:10,440 --> 01:47:13,640 THESE TALKS OR THESE 2734 01:47:13,640 --> 01:47:15,200 INSTRUCTIONAL ACTIVITIES ARE 2735 01:47:15,200 --> 01:47:18,720 AVAILABLE TO THE TRAINEES. 2736 01:47:18,720 --> 01:47:21,680 WE COULD ALSO CONSIDER THIS 2737 01:47:21,680 --> 01:47:23,120 BEING SUPPORTED BY ARPA-H. 2738 01:47:23,120 --> 01:47:26,080 THIS WAS ACTUALLY A COMMENT MADE 2739 01:47:26,080 --> 01:47:28,600 IN DR. BARKER'S SUBSEQUENT 2740 01:47:28,600 --> 01:47:30,920 SESSION, BUT TRANSLATIONAL 2741 01:47:30,920 --> 01:47:32,320 RESEARCH IS NOT NATIONALLY 2742 01:47:32,320 --> 01:47:36,400 CONFINED TO CANCER, THERE'S 2743 01:47:36,400 --> 01:47:37,360 ALZHEIMER'S, NEUROSCIENCES, MANY 2744 01:47:37,360 --> 01:47:38,680 TYPES OF DISEASE PROCESSES THAT 2745 01:47:38,680 --> 01:47:40,880 WOULD BENEFIT FROM UNDERSTANDING 2746 01:47:40,880 --> 01:47:43,640 HOW TO REALLY OPTIMIZE THE 2747 01:47:43,640 --> 01:47:44,640 SUCCESS OF TRANSLATIONAL 2748 01:47:44,640 --> 01:47:44,880 RESEARCH. 2749 01:47:44,880 --> 01:47:47,640 AND SO I THINK THOSE WERE THE 2750 01:47:47,640 --> 01:47:49,320 KEY SORT OF DISCUSSION POINTS, 2751 01:47:49,320 --> 01:47:50,400 CERTAINLY IF ANYBODY ELSE WOULD 2752 01:47:50,400 --> 01:47:53,280 LIKE TO ADD THINGS THAT I'VE 2753 01:47:53,280 --> 01:47:57,560 MISSED I'M HAPPY TO HAVE YOU 2754 01:47:57,560 --> 01:48:02,320 VOLUNTEER. 2755 01:48:02,320 --> 01:48:03,480 >> GREAT, AMY. 2756 01:48:03,480 --> 01:48:10,120 LOOKS LIKE HOWARD HAS HIS HAND 2757 01:48:10,120 --> 01:48:10,640 UP. 2758 01:48:10,640 --> 01:48:12,480 >> SO, I JUST WANTED TO SHARE 2759 01:48:12,480 --> 01:48:16,080 ANOTHER POINT THAT I'M NOT SURE 2760 01:48:16,080 --> 01:48:17,840 WAS EMPHASIZED. 2761 01:48:17,840 --> 01:48:20,400 AND THAT IS THE -- THERE HAVE 2762 01:48:20,400 --> 01:48:23,240 BEEN OTHER INITIATIVES TRYING 2763 01:48:23,240 --> 01:48:25,680 TO -- MY UNDERSTANDING, TO 2764 01:48:25,680 --> 01:48:29,480 ADVANCE THE SAME GOALS OF 2765 01:48:29,480 --> 01:48:31,560 HELPING TO OPTIMIZE 2766 01:48:31,560 --> 01:48:32,320 TRANSLATIONAL RESEARCH FROM 2767 01:48:32,320 --> 01:48:36,600 ACADEMIA INTO LET'S SAY BROADER 2768 01:48:36,600 --> 01:48:37,880 ACCESS OR COMMERCIALIZATION, 2769 01:48:37,880 --> 01:48:41,200 IMPACT ON PATIENT CARE. 2770 01:48:41,200 --> 01:48:42,880 AND THE LACK OF UNDERSTANDING 2771 01:48:42,880 --> 01:48:46,280 WAS ACTUALLY A SURVEY TOPIC IN 2772 01:48:46,280 --> 01:48:52,120 EUROPE AMONG THE EUROPEAN 2773 01:48:52,120 --> 01:48:53,720 INVESTIGATORS WHO ACTUALLY 2774 01:48:53,720 --> 01:48:55,360 ANSWERED, NUMBER ONE, BEING THE 2775 01:48:55,360 --> 01:48:57,880 UPDATED -- THE NEED FOR TRAINING 2776 01:48:57,880 --> 01:48:59,680 AND UPDATED REGULATORY SCIENCES. 2777 01:48:59,680 --> 01:49:02,800 AND RESPONDING TO THAT, THE 2778 01:49:02,800 --> 01:49:04,560 REGULATORS STARTED SOMETHING 2779 01:49:04,560 --> 01:49:05,720 CALLED THE STARS INITIATIVE 2780 01:49:05,720 --> 01:49:10,240 WHICH IS NOW BEING IMPLEMENTED 2781 01:49:10,240 --> 01:49:11,000 GOING FORWARD. 2782 01:49:11,000 --> 01:49:13,960 AND I DON'T KNOW IF IT'S IN 2783 01:49:13,960 --> 01:49:17,600 RESPONSE BUT THE FDA, THE 2784 01:49:17,600 --> 01:49:19,240 ONCOLOGY CENTER OF EXCELLENCE 2785 01:49:19,240 --> 01:49:19,920 LAUNCHED PROJECT CATALYST, 2786 01:49:19,920 --> 01:49:20,400 SOMETHING SIMILAR. 2787 01:49:20,400 --> 01:49:21,880 I WANT TO BRING THOSE UP TO THE 2788 01:49:21,880 --> 01:49:27,240 GROUP BECAUSE I THINK THESE ARE 2789 01:49:27,240 --> 01:49:30,040 ALSO VERY IMPORTANT APPROACHES 2790 01:49:30,040 --> 01:49:32,080 THAT SHOULD BE, LET'S SAY, 2791 01:49:32,080 --> 01:49:33,880 FOLLOWED OR MAYBE LEARNED FROM 2792 01:49:33,880 --> 01:49:34,520 OR ENGAGED WITH. 2793 01:49:34,520 --> 01:49:36,920 I THINK NCI PEOPLE ARE ALREADY 2794 01:49:36,920 --> 01:49:37,920 ENGAGED IN PROJECT CATALYST 2795 01:49:37,920 --> 01:49:40,200 BECAUSE OF THEIR CLOSENESS WITH 2796 01:49:40,200 --> 01:49:44,280 THE FDA STAFF. 2797 01:49:44,280 --> 01:49:46,160 >> GREAT POINT, HOWARD, IN TERMS 2798 01:49:46,160 --> 01:49:47,560 OF NOT REINVENTING THE WHEEL, 2799 01:49:47,560 --> 01:49:50,720 ARE THERE MODELS THAT WE COULD 2800 01:49:50,720 --> 01:49:55,680 LOOK AT THAT COULD BE TWEAKED. 2801 01:49:55,680 --> 01:49:56,320 AND INTERSECTIONS BETWEEN 2802 01:49:56,320 --> 01:49:57,120 PROGRAMS. 2803 01:49:57,120 --> 01:49:57,440 >> SURE. 2804 01:49:57,440 --> 01:50:00,560 I MEAN, I THINK ESPECIALLY FOR 2805 01:50:00,560 --> 01:50:01,520 UNDERSERVED RARE INDICATIONS, 2806 01:50:01,520 --> 01:50:03,480 PEDIATRICS, ET CETERA, WE HAVE 2807 01:50:03,480 --> 01:50:04,640 TO COLLABORATE. 2808 01:50:04,640 --> 01:50:05,040 >> ABSOLUTELY. 2809 01:50:05,040 --> 01:50:06,400 >> WITH THE EUROPEANS AND OTHERS 2810 01:50:06,400 --> 01:50:07,880 THAT CAN DO QUALITY TRIALS AND 2811 01:50:07,880 --> 01:50:10,600 WANT TO COLLABORATE WITH US. 2812 01:50:10,600 --> 01:50:15,680 AND ON THE TOPICS LIKE 2813 01:50:15,680 --> 01:50:19,920 BIOMARKERS, THERE'S BEEN 2814 01:50:19,920 --> 01:50:20,760 DIVERGENCE, PROVIDING 2815 01:50:20,760 --> 01:50:23,320 OPPORTUNITY FOR HARMONIZATION, A 2816 01:50:23,320 --> 01:50:27,600 WIN-WIN, FOR THE SUPER RARE 2817 01:50:27,600 --> 01:50:28,160 INDICATIONS, HELPING BOTH 2818 01:50:28,160 --> 01:50:30,600 POPULATIONS ACROSS -- YOU KNOW, 2819 01:50:30,600 --> 01:50:32,120 ACROSS THE GLOBE. 2820 01:50:32,120 --> 01:50:33,040 >> GREAT. 2821 01:50:33,040 --> 01:50:34,000 THANKS, HOWARD. 2822 01:50:34,000 --> 01:50:36,400 ANY OTHER QUESTIONS OR COMMENTS 2823 01:50:36,400 --> 01:50:38,200 RELATED TO THE EXPERIMENTAL 2824 01:50:38,200 --> 01:50:40,320 THERAPEUTICS SUBCOMMITTEE? 2825 01:50:40,320 --> 01:50:43,040 >> I THINK IT WAS ONE POINT I 2826 01:50:43,040 --> 01:50:44,960 NEGLECTED TO ADD IN, MY 2827 01:50:44,960 --> 01:50:45,880 APOLOGIES. 2828 01:50:45,880 --> 01:50:48,720 ONE OF THE THINGS THAT DR. 2829 01:50:48,720 --> 01:50:50,520 VOGLER BROUGHT UP, WAS THAT THE 2830 01:50:50,520 --> 01:50:52,960 CLINICAL TRIALS WAS PARTICULARLY 2831 01:50:52,960 --> 01:50:53,960 EFFECTIVE WHEN THE STUDENTS 2832 01:50:53,960 --> 01:50:56,080 BROUGHT IN SORT OF A REAL LIFE 2833 01:50:56,080 --> 01:50:56,400 EXAMPLE. 2834 01:50:56,400 --> 01:50:57,800 SO THE PROGRAM COULD, YOU KNOW, 2835 01:50:57,800 --> 01:51:01,640 IF WE'RE TALKING ABOUT EARLIER 2836 01:51:01,640 --> 01:51:02,840 IN THAT CONTINUUM PIPELINE, WE 2837 01:51:02,840 --> 01:51:04,560 COULD HAVE INVESTIGATORS 2838 01:51:04,560 --> 01:51:06,040 INVOLVED THAT LET'S SAY THE 2839 01:51:06,040 --> 01:51:07,880 TARGET THEY WANT TO DEVELOP AND 2840 01:51:07,880 --> 01:51:09,520 IN OTHER WORDS THEY HAVE, YOU 2841 01:51:09,520 --> 01:51:11,280 KNOW, A REAL EXAMPLE THEY WANT 2842 01:51:11,280 --> 01:51:12,520 TO IMPLEMENT THROUGH THE 2843 01:51:12,520 --> 01:51:14,080 PROGRAM, HE THOUGHT THAT WOULD 2844 01:51:14,080 --> 01:51:15,520 BE MUCH MORE EFFECTIVE STRATEGY 2845 01:51:15,520 --> 01:51:17,840 AS OPPOSED TO JUST A GENERAL 2846 01:51:17,840 --> 01:51:20,360 CURRICULUM JUST STRAIGHT, YOU 2847 01:51:20,360 --> 01:51:22,560 KNOW, FORWARD, WITH NO OTHER 2848 01:51:22,560 --> 01:51:26,160 WORKING EXAMPLE. 2849 01:51:26,160 --> 01:51:32,720 >> YEAH, KIND OF -- THERE'S 2850 01:51:32,720 --> 01:51:34,240 DIDACTIC AND PRACTICAL. 2851 01:51:34,240 --> 01:51:35,000 THAT'S GREAT. 2852 01:51:35,000 --> 01:51:37,200 CAN YOU LOWER YOUR HAND IF YOU 2853 01:51:37,200 --> 01:51:39,800 DON'T HAVE ANOTHER QUESTION SO 2854 01:51:39,800 --> 01:51:42,360 WE CAN -- OKAY. 2855 01:51:42,360 --> 01:51:44,320 IF THERE ARE NO OTHER QUESTIONS 2856 01:51:44,320 --> 01:51:47,360 OR COMMENTS PERTAINING TO 2857 01:51:47,360 --> 01:51:48,880 EXPERIMENTAL THERAPEUTICS, THAT 2858 01:51:48,880 --> 01:51:50,120 SUBCOMMITTEE, THE SECOND 2859 01:51:50,120 --> 01:51:50,960 SUBCOMMITTEE REPORT WILL BE 2860 01:51:50,960 --> 01:51:55,520 GIVEN BY DR. ANN BARKER WHO 2861 01:51:55,520 --> 01:51:56,680 CHAIRS SUBCOMMITTEE ON PLANNING 2862 01:51:56,680 --> 01:51:57,360 AND BUDGET. 2863 01:51:57,360 --> 01:51:57,560 ANN? 2864 01:51:57,560 --> 01:52:00,840 >> ALL RIGHT, THANK YOU. 2865 01:52:00,840 --> 01:52:02,000 THANKS TO THE COMMITTEE TODAY. 2866 01:52:02,000 --> 01:52:04,920 WE HAD A GREAT DISCUSSION. 2867 01:52:04,920 --> 01:52:07,400 AND TO OUR EXECUTIVE SECRETARY, 2868 01:52:07,400 --> 01:52:09,280 PATRICK MCGAREY, WHO ALWAYS DOES 2869 01:52:09,280 --> 01:52:11,160 A GREAT JOB FOR BRINGING US A 2870 01:52:11,160 --> 01:52:13,640 LOT OF DETAILS ABOUT PLANNING 2871 01:52:13,640 --> 01:52:17,120 AND BUDGET, WHICH IS COMPLEX. 2872 01:52:17,120 --> 01:52:21,560 SO, WE STARTED OUR MEETING WITH 2873 01:52:21,560 --> 01:52:25,480 SOMETHING IS CLOSE TO MY HEART, 2874 01:52:25,480 --> 01:52:28,320 WE'RE AT A POINT IN CANCER 2875 01:52:28,320 --> 01:52:28,920 RESEARCH SEEING ENORMOUS 2876 01:52:28,920 --> 01:52:31,640 INTEREST ACROSS LOTS OF FIELDS 2877 01:52:31,640 --> 01:52:33,680 OF RESEARCH THAT ACTUALLY 2878 01:52:33,680 --> 01:52:34,960 MAINLINE CANCER RESEARCH WITH 2879 01:52:34,960 --> 01:52:35,960 THINGS THAT REPRESENTATIVE 2880 01:52:35,960 --> 01:52:38,400 CONVERGENCE WITH CANCER WHICH WE 2881 01:52:38,400 --> 01:52:41,040 NEED, AND I THINK MAYBE DUE TO 2882 01:52:41,040 --> 01:52:43,760 THE FIRST MOONSHOT WE HAVE AN 2883 01:52:43,760 --> 01:52:44,840 INFLUX OF APPLICATIONS, STARTING 2884 01:52:44,840 --> 01:52:48,760 ALL THE WAY BACK IN 2013, AND 2885 01:52:48,760 --> 01:52:52,160 50% INCREASE WHICH IS UNHEARD 2886 01:52:52,160 --> 01:52:53,240 OF. 2887 01:52:53,240 --> 01:52:53,880 AND THERE'S NOT ANOTHER MEMBER 2888 01:52:53,880 --> 01:52:55,360 OF THE NIH THAT HAS EVEN 2889 01:52:55,360 --> 01:53:00,320 ANYTHING CLOSE TO THAT KIND OF 2890 01:53:00,320 --> 01:53:00,880 SUBMISSION. 2891 01:53:00,880 --> 01:53:02,560 WE TALKED ABOUT THAT IN TERMS OF 2892 01:53:02,560 --> 01:53:03,960 ITS IMPACT ON EVERYTHING, 2893 01:53:03,960 --> 01:53:05,400 ESSENTIALLY, YOU KNOW, HOW DO WE 2894 01:53:05,400 --> 01:53:06,920 KEEP THE PAYLINES WHERE WE WANT 2895 01:53:06,920 --> 01:53:11,200 THEM TO BE, WHAT ARE OUR SUCCESS 2896 01:53:11,200 --> 01:53:11,520 RATES. 2897 01:53:11,520 --> 01:53:12,800 THE THING CONCERNING HERE IS 2898 01:53:12,800 --> 01:53:14,600 THAT THIS IS AN INFLECTION POINT 2899 01:53:14,600 --> 01:53:16,680 I THINK WHERE SO MUCH IN CANCER 2900 01:53:16,680 --> 01:53:18,840 RIGHT NOW IS SO EXCITING, SO 2901 01:53:18,840 --> 01:53:20,840 MANY PEOPLE, ESPECIALLY YOUNG 2902 01:53:20,840 --> 01:53:23,040 PEOPLE, AND WE DON'T WANT TO 2903 01:53:23,040 --> 01:53:23,680 DISCOURAGE THEM. 2904 01:53:23,680 --> 01:53:24,760 NIH DOES EVERYTHING THEY 2905 01:53:24,760 --> 01:53:27,120 POSSIBLY CAN TO MAKE SURE THAT 2906 01:53:27,120 --> 01:53:29,200 THOSE COMPETITIVE GRANTS ARE 2907 01:53:29,200 --> 01:53:29,440 FUNDED. 2908 01:53:29,440 --> 01:53:34,320 SO, WE MOVED ON FROM THERE TO 2909 01:53:34,320 --> 01:53:38,720 TALK ABOUT 2022, WITH PATRICK'S 2910 01:53:38,720 --> 01:53:39,200 GUIDANCE. 2911 01:53:39,200 --> 01:53:44,160 ESSENTIALLY, IT'S PRETTY MUCH IN 2912 01:53:44,160 --> 01:53:45,600 THE BOOKS WITH ANOTHER MONTH TO 2913 01:53:45,600 --> 01:53:47,520 GO BUT LOOKS AS THOUGH OUR 2914 01:53:47,520 --> 01:53:54,240 APPROPRIATION IS GOING TO BE 2915 01:53:54,240 --> 01:53:56,760 6.9 MILLION, $6.7 MILLION IN THE 2916 01:53:56,760 --> 01:53:59,680 BASE, THINGS THAT ADD INTO THAT 2917 01:53:59,680 --> 01:54:01,040 NUMBER OF 6.9 THAT MAY BE 2918 01:54:01,040 --> 01:54:02,760 FUNDABLE, AND THEY MAY NOT BE 2919 01:54:02,760 --> 01:54:04,440 WITH US FOREVER AND ONE OF THOSE 2920 01:54:04,440 --> 01:54:07,720 ACTUALLY IS THE CANCER MOONSHOT 2921 01:54:07,720 --> 01:54:09,320 MONEY WHICH ACTUALLY THE LAST 2922 01:54:09,320 --> 01:54:11,680 YEAR IS NEXT YEAR, SO WE ALL 2923 01:54:11,680 --> 01:54:12,680 HAVE TO THINK ABOUT THAT. 2924 01:54:12,680 --> 01:54:15,480 LOTS OF PEOPLE ARE THINKING 2925 01:54:15,480 --> 01:54:16,160 ABOUT IT. 2926 01:54:16,160 --> 01:54:18,480 SO FINAL YEAR OF THE MOONSHOT 2927 01:54:18,480 --> 01:54:20,880 AND WE'RE YET TO SEE HOW 2928 01:54:20,880 --> 01:54:21,960 APPROPRIATIONS FOR THE MOONSHOT 2929 01:54:21,960 --> 01:54:25,600 IS GOING TO PLAY OUT IN MOONSHOT 2930 01:54:25,600 --> 01:54:26,240 2.0. 2931 01:54:26,240 --> 01:54:28,880 IT'S IN PROCESS. 2932 01:54:28,880 --> 01:54:30,680 SO, THE METRICS WILL BE DONE. 2933 01:54:30,680 --> 01:54:34,160 I SUSPECT CLOSE TO THE END OF 2934 01:54:34,160 --> 01:54:35,640 THE YEAR FOR 2022, BUT IT LOOKS 2935 01:54:35,640 --> 01:54:38,880 AS THOUGH WE WERE ABLE TO 2936 01:54:38,880 --> 01:54:41,280 SUSTAIN OUR PLAN FOR FUNDING AT 2937 01:54:41,280 --> 01:54:43,280 THE PAY LINES WE HAD THE 2938 01:54:43,280 --> 01:54:43,880 PREVIOUS YEARS. 2939 01:54:43,880 --> 01:54:46,560 AND I THINK THAT'S GREAT NEWS. 2940 01:54:46,560 --> 01:54:48,360 WE ACTUALLY HOPE THAT WE CAN 2941 01:54:48,360 --> 01:54:52,800 KEEP THAT UP AND WE GET TO 15% 2942 01:54:52,800 --> 01:54:55,040 BY 2025. 2943 01:54:55,040 --> 01:54:56,080 THAT'S OUR GOAL. 2944 01:54:56,080 --> 01:54:57,520 THAT'S GOING TO BE HARD. 2945 01:54:57,520 --> 01:55:03,000 I THINK EVERYBODY NEEDS TO 2946 01:55:03,000 --> 01:55:04,320 UNDERSTAND EVERYTHING AFFECTS 2947 01:55:04,320 --> 01:55:04,520 THIS. 2948 01:55:04,520 --> 01:55:05,160 CERTAINLY INFLATION THAT WE 2949 01:55:05,160 --> 01:55:08,760 DIDN'T TALK ABOUT TODAY IS A BIG 2950 01:55:08,760 --> 01:55:10,320 DEAL. 2951 01:55:10,320 --> 01:55:13,800 RAISING PAYLINES AS PATRICK 2952 01:55:13,800 --> 01:55:16,000 POINTED OUT IS A HEAVY LIFT. 2953 01:55:16,000 --> 01:55:20,840 JUST FROM LAST YEAR TO THIS 2954 01:55:20,840 --> 01:55:22,560 YEAR, THAT'S A $39 MILLION PACK 2955 01:55:22,560 --> 01:55:24,520 TO CAPTURE THAT ON HIS BACK, 2956 01:55:24,520 --> 01:55:26,840 GOING UP THE MOUNTAIN. 2957 01:55:26,840 --> 01:55:27,640 THAT'S ADDITIONAL $39 MILLION 2958 01:55:27,640 --> 01:55:29,840 THAT WE HAVE TO CARRY. 2959 01:55:29,840 --> 01:55:32,400 AND SO EVERY YEAR THAT WE WANT 2960 01:55:32,400 --> 01:55:34,400 THE PAYLINE TO GO UP WE HAVE TO 2961 01:55:34,400 --> 01:55:36,240 LOOK AT HOW MUCH ARE WE 2962 01:55:36,240 --> 01:55:39,080 COMMITTING IN THE OUT YEARS, SO 2963 01:55:39,080 --> 01:55:40,360 THAT'S ANOTHER THING, YOU THINK 2964 01:55:40,360 --> 01:55:43,720 OUR GRANTS ARE FOUR AND FIVE 2965 01:55:43,720 --> 01:55:45,520 YEARS AND INCREASINGLY SEVEN, AS 2966 01:55:45,520 --> 01:55:47,560 PEOPLE CONVERT TO R 37s. 2967 01:55:47,560 --> 01:55:50,160 SO, A LOT TO THINK ABOUT HERE IN 2968 01:55:50,160 --> 01:55:52,600 TERMS OF OUR NEW DIRECTOR OF THE 2969 01:55:52,600 --> 01:56:03,080 NCI COMING IN, AND HOW WE'RE 2970 01:56:09,600 --> 01:56:16,360 GOING TO OPTIMIZE PAYLINES. 2971 01:56:16,360 --> 01:56:19,520 2023 IS STILL UP IN THE AIR, 2972 01:56:19,520 --> 01:56:21,600 HOPEFULLY THE SENATE AND HOUSE 2973 01:56:21,600 --> 01:56:22,320 COMING TOGETHER AFTER THE 2974 01:56:22,320 --> 01:56:23,600 ELECTION, NOT BEFORE THE 2975 01:56:23,600 --> 01:56:24,160 ELECTION. 2976 01:56:24,160 --> 01:56:26,680 EVERYBODY IS GOING HOME SHORTLY 2977 01:56:26,680 --> 01:56:30,120 TO CAMPAIGN. 2978 01:56:30,120 --> 01:56:32,240 BUT CURRENTLY, IT'S LOOKING 2979 01:56:32,240 --> 01:56:32,440 GOOD. 2980 01:56:32,440 --> 01:56:34,040 I MEAN, I THINK IT WAS PROPOSED 2981 01:56:34,040 --> 01:56:35,560 IN THE SENATE, AN WHAT'S 2982 01:56:35,560 --> 01:56:37,560 PROPOSED IN THE HOUSE, ARE NOT 2983 01:56:37,560 --> 01:56:40,920 THE SAME THING BUT THEY ARE 2984 01:56:40,920 --> 01:56:41,120 CLOSE. 2985 01:56:41,120 --> 01:56:45,320 AND SO THEY ARE ALSO LOOKING AT 2986 01:56:45,320 --> 01:56:45,560 ARPA-H. 2987 01:56:45,560 --> 01:56:48,680 AND I COME BACK TO ARPA-H IN 2988 01:56:48,680 --> 01:56:52,400 JUST A MINUTE, BUT OUR BUDGET 2989 01:56:52,400 --> 01:56:55,240 ACTUALLY CURRENTLY IN THE SENATE 2990 01:56:55,240 --> 01:57:00,160 IS I THINK 4.2% IN THE HOUSE AND 2991 01:57:00,160 --> 01:57:01,360 6.7% IN THE HOUSE, 4.2% IN THE 2992 01:57:01,360 --> 01:57:02,640 SENATE, AND IT WILL BE SOME 2993 01:57:02,640 --> 01:57:04,360 WHETHER IN THE MIDDLE. 2994 01:57:04,360 --> 01:57:06,400 WE COULD GUESS, BUT THAT'S 2995 01:57:06,400 --> 01:57:07,320 ACTUALLY PRETTY GOOD. 2996 01:57:07,320 --> 01:57:10,200 I THINK THE ISSUE WITH US IS, 2997 01:57:10,200 --> 01:57:12,720 YOU KNOW, LOSING MOONSHOT MONEY 2998 01:57:12,720 --> 01:57:14,640 AND AFTER NEXT YEAR. 2999 01:57:14,640 --> 01:57:17,520 ARPA-H CONTINUES TO BE A REALLY 3000 01:57:17,520 --> 01:57:20,120 INTERESTING FOOTBALL THAT KEEPS 3001 01:57:20,120 --> 01:57:21,080 GETTING TOSSED AROUND. 3002 01:57:21,080 --> 01:57:23,960 AND IT HASN'T GOT AN WHOLE LOT 3003 01:57:23,960 --> 01:57:24,720 BETTER. 3004 01:57:24,720 --> 01:57:27,280 SO, THERE ARE TWO PROPOSALS FOR 3005 01:57:27,280 --> 01:57:33,160 FUNDING THIS IN TERMS OF 2.75 3006 01:57:33,160 --> 01:57:37,000 AND A MILLION TO ADD, IN TWO 3007 01:57:37,000 --> 01:57:38,880 DIFFERENT TIMES. 3008 01:57:38,880 --> 01:57:42,560 THE HOUSE AND SENATE STILL HAVE 3009 01:57:42,560 --> 01:57:43,840 HAVEN'T AGREED ON WHAT THE LEVEL 3010 01:57:43,840 --> 01:57:45,240 OF FUNDING FOR ARPA-H SHOULD BE. 3011 01:57:45,240 --> 01:57:47,000 AND I AM NOT SURE HOW THEY ARE 3012 01:57:47,000 --> 01:57:48,240 GOING TO COME TO THAT. 3013 01:57:48,240 --> 01:57:49,000 THAT'S AN INTERESTING QUESTION 3014 01:57:49,000 --> 01:57:51,080 IN TERMS OF AUTHORIZING THAT AND 3015 01:57:51,080 --> 01:57:52,040 GETTING IT PAID. 3016 01:57:52,040 --> 01:57:56,080 BUT WE ALSO DON'T HAVE A 3017 01:57:56,080 --> 01:57:56,320 DIRECTOR. 3018 01:57:56,320 --> 01:57:57,840 AND WE ALSO DON'T HAVE AN 3019 01:57:57,840 --> 01:57:59,000 AGREEMENT ON WHERE ARPA-H IS 3020 01:57:59,000 --> 01:57:59,800 GOING TO BE. 3021 01:57:59,800 --> 01:58:01,880 WE THOUGHT WE HAD AN AGREEMENT 3022 01:58:01,880 --> 01:58:02,920 BECAUSE WE THOUGHT IT WAS GOING 3023 01:58:02,920 --> 01:58:07,960 TO BE AT NIH FOR A WHILE BUT IT 3024 01:58:07,960 --> 01:58:09,320 LOOKS LIKE CONGRESSMEN ESHOO 3025 01:58:09,320 --> 01:58:10,960 FROM CALIFORNIA AND HER 3026 01:58:10,960 --> 01:58:13,120 COLLEAGUES SAY NO, SO THAT'S AN 3027 01:58:13,120 --> 01:58:14,280 ONGOING CONVERSATION. 3028 01:58:14,280 --> 01:58:15,800 I THINK THIS IS IMPORTANT 3029 01:58:15,800 --> 01:58:16,680 LEGISLATION FOR NCI. 3030 01:58:16,680 --> 01:58:19,960 I THINK A LOT OF THE THINGS WE 3031 01:58:19,960 --> 01:58:21,440 TALKED ABOUT IN EXPERIMENTAL 3032 01:58:21,440 --> 01:58:22,040 THERAPEUTICS FOR EXAMPLE COULD 3033 01:58:22,040 --> 01:58:25,520 BE PAID OUT OF THAT KIND OF 3034 01:58:25,520 --> 01:58:26,080 FUNDING. 3035 01:58:26,080 --> 01:58:33,080 WE TALKED ABOUT THE MOONSHOT, 3036 01:58:33,080 --> 01:58:35,920 IT'S THE REALLY ENERGIZED 3037 01:58:35,920 --> 01:58:39,360 CATALYZED MOONSHOT 2.0, NCI HAS 3038 01:58:39,360 --> 01:58:43,520 SUBMITTED VERY GOOD IDEAS FOR 3039 01:58:43,520 --> 01:58:46,400 THAT AND ESPECIALLY MULTIPLE 3040 01:58:46,400 --> 01:58:48,200 CANCER TESTING, REALLY UPGRADING 3041 01:58:48,200 --> 01:58:51,200 AND RELAUNCHING SORT OF NEXT GEN 3042 01:58:51,200 --> 01:58:52,040 CLINICAL TRIALS. 3043 01:58:52,040 --> 01:58:54,000 BUT DOUG IN OUR DISCUSSION MADE 3044 01:58:54,000 --> 01:58:59,520 THE POINT THAT REALLY IF YOU 3045 01:58:59,520 --> 01:59:01,680 LISTEN TO PRESIDENT BIDEN 3046 01:59:01,680 --> 01:59:03,280 ESTABLISHING CANCER CABINET, 3047 01:59:03,280 --> 01:59:04,400 SETTING UP THE MOONSHOT, HE'S 3048 01:59:04,400 --> 01:59:06,360 REALLY INTERESTED IN DOING MORE 3049 01:59:06,360 --> 01:59:07,800 ABOUT CARE DELIVERY. 3050 01:59:07,800 --> 01:59:11,360 AND CHANGING THE LIVES OF 3051 01:59:11,360 --> 01:59:11,600 PATIENTS. 3052 01:59:11,600 --> 01:59:13,560 MOONSHOT 1.0 WAS ESSENTIALLY 3053 01:59:13,560 --> 01:59:15,320 ABOUT LET'S ACCELERATE RESEARCH. 3054 01:59:15,320 --> 01:59:16,560 THIS IS ABOUT GETTING WHAT WE 3055 01:59:16,560 --> 01:59:20,040 KNOW TO PATIENTS AND DOING IT 3056 01:59:20,040 --> 01:59:21,360 FASTER, BETTER, AND I THINK NCI 3057 01:59:21,360 --> 01:59:27,920 HAS SOME VERY GOOD IDEAS IN THAT 3058 01:59:27,920 --> 01:59:28,440 REGARD. 3059 01:59:28,440 --> 01:59:32,520 WE DID AS A GROUP COMMENDED DOUG 3060 01:59:32,520 --> 01:59:35,400 ON HIS PUBLIC SERVICE, BEYOND 3061 01:59:35,400 --> 01:59:37,680 THE VEIL IN TERMS OF HOW MUCH 3062 01:59:37,680 --> 01:59:39,040 HE'S DONE ESPECIALLY IN THESE 3063 01:59:39,040 --> 01:59:41,640 DIFFICULT BUDGET TIMES. 3064 01:59:41,640 --> 01:59:43,200 I DON'T THINK THAT'S GOING TO 3065 01:59:43,200 --> 01:59:45,360 CHANGE GOING FORWARD FOR OUR NEW 3066 01:59:45,360 --> 01:59:46,200 DIRECTOR. 3067 01:59:46,200 --> 01:59:47,520 YOU KNOW, I HONESTLY THINK -- 3068 01:59:47,520 --> 01:59:51,440 ONE OTHER CONVERSATION WE HAD, 3069 01:59:51,440 --> 01:59:53,200 BECAUSE I SEE DR. SHRIVER ON THE 3070 01:59:53,200 --> 01:59:55,200 PANEL TODAY, WE PACT ABOUT THE 3071 01:59:55,200 --> 01:59:57,760 PACT ACT AS AN EXAMPLE OF WHERE 3072 01:59:57,760 --> 02:00:00,520 NCI CAN PARTNER WITH ANOTHER 3073 02:00:00,520 --> 02:00:00,840 AGENCY. 3074 02:00:00,840 --> 02:00:02,800 FOR EXAMPLE, PACT ACT AS MANY OF 3075 02:00:02,800 --> 02:00:06,840 YOU HEARD REALLY GOT A LOT OF 3076 02:00:06,840 --> 02:00:09,520 PRESS TO LOOK AT CARCINOGENESIS 3077 02:00:09,520 --> 02:00:14,720 AND OTHER EFFECTS IN SERVICE 3078 02:00:14,720 --> 02:00:16,640 PEOPLE WHO SERVED IN VARIOUS 3079 02:00:16,640 --> 02:00:17,760 FIELDS OF COMBAT. 3080 02:00:17,760 --> 02:00:19,560 IT'S AN INTERESTING APPROACH TO 3081 02:00:19,560 --> 02:00:20,560 MAKING LIVES BETTER FOR PEOPLE 3082 02:00:20,560 --> 02:00:22,760 ESPECIALLY IN THE MILITARY WITH 3083 02:00:22,760 --> 02:00:23,000 CANCER. 3084 02:00:23,000 --> 02:00:24,480 THIS IS THE PLACE WHERE IT'S 3085 02:00:24,480 --> 02:00:26,320 GOING TO BE ABOUT 3086 02:00:26,320 --> 02:00:27,400 CARCINOGENESIS, SO VERY COMPLEX 3087 02:00:27,400 --> 02:00:29,480 MIXTURES, SO IT'S A GOOD PLACE, 3088 02:00:29,480 --> 02:00:31,040 I KNOW NCI IS THINKING HOW THEY 3089 02:00:31,040 --> 02:00:32,640 MIGHT PARTNER ON THAT. 3090 02:00:32,640 --> 02:00:35,040 AND THERE ARE OTHER PIECES OF 3091 02:00:35,040 --> 02:00:37,400 LEGISLATION THAT ARE SIMILAR IN 3092 02:00:37,400 --> 02:00:39,120 TERMS OF OFFERING NCI 3093 02:00:39,120 --> 02:00:40,320 PARTNERSHIPS THAT I'M SURE WE'LL 3094 02:00:40,320 --> 02:00:44,560 FOLLOW UP ON. 3095 02:00:44,560 --> 02:00:47,960 SO, WE TALKED ABOUT A LOT IN 3096 02:00:47,960 --> 02:00:49,960 THIS PLANNING AND BUDGET MEETING 3097 02:00:49,960 --> 02:00:53,240 BUT ONE THING I'VE BEEN TALKING 3098 02:00:53,240 --> 02:00:54,800 ABOUT QUITE A LOT, MAYBE TOO 3099 02:00:54,800 --> 02:00:57,080 MUCH, BUT I THINK MULTI-CANCER 3100 02:00:57,080 --> 02:00:59,480 TESTING IS SOMETHING THAT WE 3101 02:00:59,480 --> 02:01:02,200 CAN'T IGNORE AS I SAID EARLIER. 3102 02:01:02,200 --> 02:01:04,240 IT'S A PARADIGM SHIFT, IF YOU 3103 02:01:04,240 --> 02:01:05,840 CAN DETECT CANCER VERY, VERY 3104 02:01:05,840 --> 02:01:07,120 EARLY THAT SOUNDS GREAT, BUT 3105 02:01:07,120 --> 02:01:09,240 THERE'S A LOT OF THINGS THAT 3106 02:01:09,240 --> 02:01:10,520 FLOW FROM THAT. 3107 02:01:10,520 --> 02:01:13,560 AND I THINK I SUGGESTED AT THE 3108 02:01:13,560 --> 02:01:15,680 LAST NCAB MEETING THIS MAY BE AN 3109 02:01:15,680 --> 02:01:20,520 AREA WHERE THE NCAB SHOULD 3110 02:01:20,520 --> 02:01:22,280 REALLY LOOK AT WE'RE DOING 3111 02:01:22,280 --> 02:01:24,880 CLINICAL TRIALS, THE ONLY GROUP 3112 02:01:24,880 --> 02:01:26,000 DOING CLINICAL TRIALS WITH 3113 02:01:26,000 --> 02:01:27,360 SURVIVAL ENDPOINTS IN THE 3114 02:01:27,360 --> 02:01:28,120 MULTI-CANCER DETECTION SPACE. 3115 02:01:28,120 --> 02:01:29,560 THAT'S GOING TO BE CRITICALLY 3116 02:01:29,560 --> 02:01:33,400 IMPORTANT BUT THERE ARE LOTS OF 3117 02:01:33,400 --> 02:01:35,720 OTHER PIECES OF THIS THAT WILL 3118 02:01:35,720 --> 02:01:37,760 INVOLVE THE NCI SO ANYTHING THE 3119 02:01:37,760 --> 02:01:39,640 NCAB CAN DO TO OFFER ADVICE 3120 02:01:39,640 --> 02:01:41,640 WOULD BE WORTH THINKING ABOUT, 3121 02:01:41,640 --> 02:01:47,880 MAYBE A STUDY FROM THE NCAB. 3122 02:01:47,880 --> 02:01:49,920 WE HAD SOME QUESTIONS, PATRICK 3123 02:01:49,920 --> 02:01:52,040 ACTUALLY SHARED LINKS, IF YOU'RE 3124 02:01:52,040 --> 02:01:52,640 INTERESTED WE'VE HAD QUESTIONS 3125 02:01:52,640 --> 02:01:54,360 ON, YOU KNOW, HOW DO I FIND OUT 3126 02:01:54,360 --> 02:01:56,200 HOW MUCH FUNDING IS GOING INTO 3127 02:01:56,200 --> 02:01:57,520 MY CANCER. 3128 02:01:57,520 --> 02:02:00,680 THIS IS AN ADVOCATE QUESTION, 3129 02:02:00,680 --> 02:02:00,960 ACTUALLY. 3130 02:02:00,960 --> 02:02:02,360 AND THERE ARE -- I DON'T HAVE 3131 02:02:02,360 --> 02:02:03,680 THEM EASILY TO SHOW YOU HERE BUT 3132 02:02:03,680 --> 02:02:05,080 THERE ARE PLACES YOU CAN GO ON 3133 02:02:05,080 --> 02:02:08,280 THE WEBSITE AND LOOK THAT UP. 3134 02:02:08,280 --> 02:02:10,360 AND SO ANYWAY, WE ADJOURNED. 3135 02:02:10,360 --> 02:02:13,600 IT WAS A VERY ACTIVE 3136 02:02:13,600 --> 02:02:17,880 CONVERSATION WITH GREAT HOPES 3137 02:02:17,880 --> 02:02:20,400 FOR 2023 AND SPECULATION ABOUT 3138 02:02:20,400 --> 02:02:20,800 2024. 3139 02:02:20,800 --> 02:02:22,480 THERE'S AN ELECTION COMING UP, 3140 02:02:22,480 --> 02:02:25,600 AND NOBODY KNOWS WHERE IT MAY 3141 02:02:25,600 --> 02:02:29,280 ALL END UP, BUT I THINK NCI IS 3142 02:02:29,280 --> 02:02:30,560 WELL POSITIONED CERTAINLY WITH 3143 02:02:30,560 --> 02:02:31,360 THE CONGRESS. 3144 02:02:31,360 --> 02:02:34,000 THEY THINK A LOT OF OUR 3145 02:02:34,000 --> 02:02:35,720 INSTITUTE AND CERTAINLY THE NIH 3146 02:02:35,720 --> 02:02:39,920 AND WE HAVE A LOT OF FRIENDS. 3147 02:02:39,920 --> 02:02:40,320 SO I'M OPTIMISTIC. 3148 02:02:40,320 --> 02:02:41,200 THANK YOU, MR. CHAIRMAN. 3149 02:02:41,200 --> 02:02:44,080 THAT'S MY REPORT. 3150 02:02:44,080 --> 02:02:50,320 >> THANK YOU, DR. BARKER. 3151 02:02:50,320 --> 02:02:54,240 ANY QUESTIONS OR COMMENTS? 3152 02:02:54,240 --> 02:02:58,800 3153 02:02:58,800 --> 02:03:01,840 RELATIVE TO BUDGET AND PLANNING? 3154 02:03:01,840 --> 02:03:03,960 FOR ME IT'S THE PLANNING PART, 3155 02:03:03,960 --> 02:03:05,640 HOW FAR OUT YOU CAN BEGIN TO 3156 02:03:05,640 --> 02:03:08,440 PLAN OR THINK ABOUT THINGS, 3157 02:03:08,440 --> 02:03:09,920 AGAIN CONSIDERING MOON SHOOT, 3158 02:03:09,920 --> 02:03:11,520 YOU KNOW, HOW DOES THAT FUNDING 3159 02:03:11,520 --> 02:03:12,560 OCCURRED? 3160 02:03:12,560 --> 02:03:14,640 WE KNOW HOW IT OCCURRED 3161 02:03:14,640 --> 02:03:15,760 PREVIOUSLY THROUGH 21ST CENTURY 3162 02:03:15,760 --> 02:03:18,600 CURES ACT, AND WILL IT BE A 3163 02:03:18,600 --> 02:03:19,720 SIMILAR MODEL GOING FORWARD? 3164 02:03:19,720 --> 02:03:21,840 WILL IT BE SOMETHING DIFFERENT 3165 02:03:21,840 --> 02:03:28,480 IN ? 3166 02:03:28,480 --> 02:03:30,360 THERE'S THE BASE, WE DON'T LIKE 3167 02:03:30,360 --> 02:03:31,760 TO TOUCH THAT BECAUSE WE KNOW 3168 02:03:31,760 --> 02:03:33,120 WHAT COMES OUT OF THAT. 3169 02:03:33,120 --> 02:03:34,920 SO HOW IS THAT FRAMED? 3170 02:03:34,920 --> 02:03:35,320 IT'S PLANNING. 3171 02:03:35,320 --> 02:03:37,080 WE'RE A YEAR OR TWO AWAY, NOT 3172 02:03:37,080 --> 02:03:38,080 THAT FAR OUT. 3173 02:03:38,080 --> 02:03:39,280 IT'S ALREADY BEEN KICKED OFF 3174 02:03:39,280 --> 02:03:42,360 WITH A FEW PROGRAMS. 3175 02:03:42,360 --> 02:03:45,720 WE STILL DON'T KNOW HOW IT'S 3176 02:03:45,720 --> 02:03:48,400 GOING TO BE FORMATTED. 3177 02:03:48,400 --> 02:03:50,560 >> WELL, I THINK THAT'S A GOOD 3178 02:03:50,560 --> 02:03:50,800 POINT. 3179 02:03:50,800 --> 02:03:54,240 THERE ARE LOTS OF SUBMISSIONS. 3180 02:03:54,240 --> 02:03:56,280 PEOPLE ARE -- THERE WAS -- THEY 3181 02:03:56,280 --> 02:03:58,480 HAVE WHITE HOUSE STAFF THAT WILL 3182 02:03:58,480 --> 02:03:58,920 BEGIN TO PRIORITIZE. 3183 02:03:58,920 --> 02:04:01,160 I DON'T THINK IT WILL LOOK MUCH 3184 02:04:01,160 --> 02:04:02,960 LIKE THE LAST MOONSHOT. 3185 02:04:02,960 --> 02:04:05,960 I THINK IT IS MUCH, MUCH MORE 3186 02:04:05,960 --> 02:04:08,840 PATIENT FOCUSED AND DELIVERY OF 3187 02:04:08,840 --> 02:04:10,400 CARE FOCUSED, AND IMPROVING SOME 3188 02:04:10,400 --> 02:04:12,480 THINGS THAT WE'VE DISCUSSED 3189 02:04:12,480 --> 02:04:14,560 ACTUALLY AROUND ESPECIALLY 3190 02:04:14,560 --> 02:04:15,440 MINORITY AND UNDERSERVED 3191 02:04:15,440 --> 02:04:17,840 POPULATIONS, WHERE WE HAVE BIG 3192 02:04:17,840 --> 02:04:18,200 ISSUES. 3193 02:04:18,200 --> 02:04:21,000 SO, I THINK WE'RE GOING TO HAVE 3194 02:04:21,000 --> 02:04:22,560 TO WAIT AND SEE. 3195 02:04:22,560 --> 02:04:23,720 EVEN THE AMOUNT OF FUNDING THAT 3196 02:04:23,720 --> 02:04:25,280 WILL BE AVAILABLE, I DON'T THINK 3197 02:04:25,280 --> 02:04:26,360 WE YET KNOW. 3198 02:04:26,360 --> 02:04:26,680 >> RIGHT. 3199 02:04:26,680 --> 02:04:28,080 >> AND A LOT OF THIS IS GOING TO 3200 02:04:28,080 --> 02:04:31,280 DEPEND ON OBVIOUSLY ON THE 3201 02:04:31,280 --> 02:04:33,920 ELECTION BUT I AM GLAD TO SEE IT 3202 02:04:33,920 --> 02:04:35,360 CONTINUING AND I THINK WE SHOULD 3203 02:04:35,360 --> 02:04:38,920 ALL BE HAPPY ABOUT THAT PART. 3204 02:04:38,920 --> 02:04:41,400 3205 02:04:41,400 --> 02:04:44,960 THANKS TO THE COMMITTEE. 3206 02:04:44,960 --> 02:04:47,560 I GUESS THE BYPASS BUDGET 3207 02:04:47,560 --> 02:04:49,800 PLANNING GETS UNDERWAY SOON AT 3208 02:04:49,800 --> 02:04:52,160 NCI, SO WE'LL BRING THAT BACK TO 3209 02:04:52,160 --> 02:04:58,800 THE COMMITTEE ONCE IT'S DONE. 3210 02:04:58,800 --> 02:05:02,920 >> WE DO HAVE TIME FOR 3211 02:05:02,920 --> 02:05:04,040 ADDITIONAL QUESTION, AND I'LL 3212 02:05:04,040 --> 02:05:04,400 ASK A QUESTION. 3213 02:05:04,400 --> 02:05:06,760 I DON'T KNOW IF ANYONE CAN 3214 02:05:06,760 --> 02:05:09,360 ANSWER IT. 3215 02:05:09,360 --> 02:05:10,200 IT GOES BACK TO FREDERICK 3216 02:05:10,200 --> 02:05:12,080 NATIONAL LAB. 3217 02:05:12,080 --> 02:05:15,400 YOU KNOW, THINKING ABOUT THE OUT 3218 02:05:15,400 --> 02:05:18,280 YEARS, WHEN WILL THE CONTRACT BE 3219 02:05:18,280 --> 02:05:21,560 RECOMPETED AND HOW DOES THAT 3220 02:05:21,560 --> 02:05:23,360 SORT OF ROLL INTO FUTURE NCI 3221 02:05:23,360 --> 02:05:25,800 BUDGETS? 3222 02:05:25,800 --> 02:05:28,000 3223 02:05:28,000 --> 02:05:29,120 DOUG? 3224 02:05:29,120 --> 02:05:29,440 >> WELL -- 3225 02:05:29,440 --> 02:05:32,960 >> THAT'S A DOUG QUESTION. 3226 02:05:32,960 --> 02:05:36,760 >> JOHN, THE RECOMPETE IS 3227 02:05:36,760 --> 02:05:40,800 SUPPOSED TO BE, YOU KNOW, MORE 3228 02:05:40,800 --> 02:05:42,160 OR LESS SEAMLESS. 3229 02:05:42,160 --> 02:05:49,000 IN OTHER WORDS, IT'S AN OPEN 3230 02:05:49,000 --> 02:05:50,280 COMPETITION. 3231 02:05:50,280 --> 02:05:51,760 THE CURRENT CONTRACTOR CAN APPLY 3232 02:05:51,760 --> 02:05:53,760 IF THEY WANT TO. 3233 02:05:53,760 --> 02:05:57,000 THEY CAN APPLY IN CONJUNCTION 3234 02:05:57,000 --> 02:06:00,840 WITH OTHER GROUPS IF THEY WANT 3235 02:06:00,840 --> 02:06:02,000 TO. 3236 02:06:02,000 --> 02:06:04,520 YOU KNOW, AND THERE WOULD BE 3237 02:06:04,520 --> 02:06:08,480 PRESUMABLY ONE OF TWO OUTCOMES. 3238 02:06:08,480 --> 02:06:12,520 THE CURRENT CONTRACTOR WOULD GET 3239 02:06:12,520 --> 02:06:14,400 THE NEW CONTRACT OR A DIFFERENT 3240 02:06:14,400 --> 02:06:15,680 GROUP WOULD GET THE NEW 3241 02:06:15,680 --> 02:06:18,920 CONTRACT. 3242 02:06:18,920 --> 02:06:23,080 AND THERE WOULD BE, IF YOU WILL, 3243 02:06:23,080 --> 02:06:24,920 A TRANSITION PERIOD. 3244 02:06:24,920 --> 02:06:29,480 BUT THE TRANSITION IS NOT A 3245 02:06:29,480 --> 02:06:31,400 WHOLESALE TURNOVER OF PERSONNEL. 3246 02:06:31,400 --> 02:06:35,280 THERE ARE WHAT ARE REFERRED TO 3247 02:06:35,280 --> 02:06:36,640 AS KEY PERSONNEL. 3248 02:06:36,640 --> 02:06:40,200 AND IT'S A LIMITED NUMBER. 3249 02:06:40,200 --> 02:06:45,120 IT'S FEWER THAN 10 THAT WOULD 3250 02:06:45,120 --> 02:06:45,480 TURN OVER. 3251 02:06:45,480 --> 02:06:47,560 BUT WHAT I'M TRYING TO SAY IS 3252 02:06:47,560 --> 02:06:51,640 THAT IT'S NOT AS THOUGH THE WORK 3253 02:06:51,640 --> 02:06:54,320 THAT WAS GOING ON WOULD STOP. 3254 02:06:54,320 --> 02:06:54,640 >> RIGHT. 3255 02:06:54,640 --> 02:06:57,200 I GUESS THE QUESTION IS THE 3256 02:06:57,200 --> 02:06:58,960 SCALE, RIGHT? 3257 02:06:58,960 --> 02:07:01,520 WILL THE FUNDING LEVELS, THE 3258 02:07:01,520 --> 02:07:03,520 SALE, BE THE SAME? 3259 02:07:03,520 --> 02:07:04,960 THESE ARE THE QUESTIONS I'M 3260 02:07:04,960 --> 02:07:05,400 GETTING AT. 3261 02:07:05,400 --> 02:07:06,680 >> I SEE. 3262 02:07:06,680 --> 02:07:11,640 I MEAN, WHAT HAPPENS IS THAT 3263 02:07:11,640 --> 02:07:13,400 BECAUSE THESE AWARDS ARE MADE 3264 02:07:13,400 --> 02:07:17,320 FOR A LONG TIME PERIOD, WE TEND 3265 02:07:17,320 --> 02:07:22,200 -- YOU KNOW, WE TEND TO HAVE A 3266 02:07:22,200 --> 02:07:24,920 MAXIMUM -- YOU KNOW, RELATIVELY 3267 02:07:24,920 --> 02:07:28,680 HIGH MAXIMUM DOLLAR AMOUNT. 3268 02:07:28,680 --> 02:07:30,440 AND THE -- IT DOESN'T MEAN THAT 3269 02:07:30,440 --> 02:07:32,360 WE GET TO THAT AMOUNT. 3270 02:07:32,360 --> 02:07:34,920 IT'S JUST THAT IT'S FAR EASIER 3271 02:07:34,920 --> 02:07:39,360 TO SAY IT CAN GO UP TO A CERTAIN 3272 02:07:39,360 --> 02:07:40,800 AMOUNT THAN IT IS TO SAY, YOU 3273 02:07:40,800 --> 02:07:43,040 KNOW, LET'S SAY IT COULD BE $200 3274 02:07:43,040 --> 02:07:45,040 MILLION, BUT TURNS OUT YOU WANT 3275 02:07:45,040 --> 02:07:46,560 THREE, THAT'S MUCH HARDER THAN 3276 02:07:46,560 --> 02:07:49,120 TO SAY IT COULD BE FOUR, BUT WE 3277 02:07:49,120 --> 02:07:50,840 ONLY NEED THREE. 3278 02:07:50,840 --> 02:07:52,320 >> GOT IT. 3279 02:07:52,320 --> 02:07:53,200 THANKS, DOUG. 3280 02:07:53,200 --> 02:07:58,360 AGAIN, TO ME IT FALLS WITHIN THE 3281 02:07:58,360 --> 02:08:00,640 CONTEXT OF BUDGET AND PLANNING. 3282 02:08:00,640 --> 02:08:02,920 THANK YOU, DOUG. 3283 02:08:02,920 --> 02:08:05,480 WE NEED TO VOTE, PAULETTE, IS 3284 02:08:05,480 --> 02:08:06,200 THAT CORRECT? 3285 02:08:06,200 --> 02:08:09,160 >> YES, YOU NEED TO VOTE ON EACH 3286 02:08:09,160 --> 02:08:11,720 REPORT INDIVIDUALLY. 3287 02:08:11,720 --> 02:08:14,640 >> OKAY. 3288 02:08:14,640 --> 02:08:14,880 GREAT. 3289 02:08:14,880 --> 02:08:20,840 SO, WE NEED TO -- IS THERE A 3290 02:08:20,840 --> 02:08:23,200 MOTION TO APPROVE -- 3291 02:08:23,200 --> 02:08:27,240 >> NOT TO APPROVE, TO ACCEPT. 3292 02:08:27,240 --> 02:08:29,960 >> TO ACCEPT THE REPORT, 3293 02:08:29,960 --> 02:08:33,720 EXPERIMENTALITY SUBCOMMITTEE 3294 02:08:33,720 --> 02:08:34,200 REPORT. 3295 02:08:34,200 --> 02:08:34,720 >> ACCEPT. 3296 02:08:34,720 --> 02:08:36,760 >> IS THERE A SECOND? 3297 02:08:36,760 --> 02:08:37,240 >> SECOND. 3298 02:08:37,240 --> 02:08:38,880 >> IT'S BEEN PROPERLY MOVED AND 3299 02:08:38,880 --> 02:08:39,160 SECONDED. 3300 02:08:39,160 --> 02:08:40,920 WE CAN NOW VOTE. 3301 02:08:40,920 --> 02:08:45,720 ARE THERE ANY NAYS? 3302 02:08:45,720 --> 02:08:47,920 THERE'S A HAND UP. 3303 02:08:47,920 --> 02:08:51,400 OH, THANKS, AMY. 3304 02:08:51,400 --> 02:08:52,080 OKAY, GREAT. 3305 02:08:52,080 --> 02:08:53,640 ANYONE NEED TO -- 3306 02:08:53,640 --> 02:08:55,200 >> I THOUGHT YOU WERE GOING 3307 02:08:55,200 --> 02:08:55,680 AFFIRMATIVE. 3308 02:08:55,680 --> 02:08:58,240 >> ANYONE NEED TO ABSTAIN? 3309 02:08:58,240 --> 02:08:58,440 OKAY. 3310 02:08:58,440 --> 02:09:01,520 SO, LOOKS LIKE WE HAVE A 3311 02:09:01,520 --> 02:09:04,520 UNANIMOUS VOTE TO ACCEPT THE 3312 02:09:04,520 --> 02:09:05,040 EXPERIMENTAL THERAPEUTICS 3313 02:09:05,040 --> 02:09:05,840 SUBCOMMITTEE REPORT. 3314 02:09:05,840 --> 02:09:06,520 >> OKAY. 3315 02:09:06,520 --> 02:09:08,680 AND THEN YOU NEED TO DO THE 3316 02:09:08,680 --> 02:09:09,840 PLANNING AND BUDGET. 3317 02:09:09,840 --> 02:09:14,560 >> SO, IS THERE A MOTION TO 3318 02:09:14,560 --> 02:09:16,600 ACCEPT THE PLANNING AND BUDGET 3319 02:09:16,600 --> 02:09:19,000 SUBCOMMITTEE REPORT? 3320 02:09:19,000 --> 02:09:21,320 3321 02:09:21,320 --> 02:09:22,400 IS THERE A MOTION? 3322 02:09:22,400 --> 02:09:23,720 >> YES, THERE'S A MOTION. 3323 02:09:23,720 --> 02:09:26,520 >> IS THERE A SECOND? 3324 02:09:26,520 --> 02:09:28,400 IT'S BEEN PROPERLY MOVED AND 3325 02:09:28,400 --> 02:09:29,200 SECONDED. 3326 02:09:29,200 --> 02:09:31,920 NOW WE CAN VOTE. 3327 02:09:31,920 --> 02:09:33,480 VOTE TO ACCEPT THE REPORT. 3328 02:09:33,480 --> 02:09:37,520 ARE THERE ANY NAYS? 3329 02:09:37,520 --> 02:09:40,960 ANY ABSTENTIONS? 3330 02:09:40,960 --> 02:09:44,840 SO LOOKS UNANIMOUS. 3331 02:09:44,840 --> 02:09:48,920 >> SO, NOW, JOHN, WE'LL MOVE 3332 02:09:48,920 --> 02:09:52,960 INTO FUTURE AGENDA ITEMS AND 3333 02:09:52,960 --> 02:09:53,880 OTHER AGENDA ITEMS. 3334 02:09:53,880 --> 02:09:56,120 WHEN HE MOVES INTO THIS 3335 02:09:56,120 --> 02:09:58,200 TERRITORY, THIS IS A GOOD TIME 3336 02:09:58,200 --> 02:10:01,960 FOR BOARD MEMBERS TO COME UP 3337 02:10:01,960 --> 02:10:04,080 WITH SUGGESTIONS, ET CETERA. 3338 02:10:04,080 --> 02:10:08,960 SO KAREN HAS HER HAND UP. 3339 02:10:08,960 --> 02:10:10,600 >> I SEE CHRIS AND KAREN. 3340 02:10:10,600 --> 02:10:12,560 LET'S START WITH CHRIS BECAUSE I 3341 02:10:12,560 --> 02:10:15,760 THINK HE HAD HIS HAND UP BEFORE. 3342 02:10:15,760 --> 02:10:16,280 >> OKAY. 3343 02:10:16,280 --> 02:10:16,920 >> THANKS SO MUCH. 3344 02:10:16,920 --> 02:10:20,360 THIS IS A FOLLOW-UP TO OUR 3345 02:10:20,360 --> 02:10:22,200 DISCUSSION WITH DR. BARKER'S 3346 02:10:22,200 --> 02:10:22,560 SUBCOMMITTEE. 3347 02:10:22,560 --> 02:10:24,000 OF THE BIG UNKNOWN OF ARPA-H, IF 3348 02:10:24,000 --> 02:10:25,960 YOU LOOK AT THE MINUTES FROM OUR 3349 02:10:25,960 --> 02:10:27,440 JUNE MEETING YOU'LL SEE I ASKED 3350 02:10:27,440 --> 02:10:29,240 THAT WE HAVE A REPRESENTATIVE 3351 02:10:29,240 --> 02:10:32,200 FROM ARPA-H PRESENT TO THIS 3352 02:10:32,200 --> 02:10:32,440 COMMITTEE. 3353 02:10:32,440 --> 02:10:34,400 IN OUR PLANNING FUNCTION, SO WE 3354 02:10:34,400 --> 02:10:35,520 CAN ADVISE THE NCI PROPERLY ON 3355 02:10:35,520 --> 02:10:37,200 FUTURE STRATEGY. 3356 02:10:37,200 --> 02:10:39,440 I'LL MAKE THAT REQUEST AGAIN. 3357 02:10:39,440 --> 02:10:42,600 NOW THAT DR. RUSSELL IS 3358 02:10:42,600 --> 02:10:44,160 APPOINTED, THAT DR. RUSSELL MEET 3359 02:10:44,160 --> 02:10:47,200 WITH US AT OUR NEXT SCHEDULED 3360 02:10:47,200 --> 02:10:47,440 MEETING. 3361 02:10:47,440 --> 02:10:50,280 >> THAT'S GREAT TIMING. 3362 02:10:50,280 --> 02:10:51,160 >> THANK YOU. 3363 02:10:51,160 --> 02:10:52,160 >> PERHAPS A PERMANENT DIRECTOR 3364 02:10:52,160 --> 02:10:54,840 IN PLACE AS WELL, GREAT TIMING. 3365 02:10:54,840 --> 02:10:56,160 OKAY, KAREN? 3366 02:10:56,160 --> 02:10:57,160 >> YES, JOHN, THANKS. 3367 02:10:57,160 --> 02:11:00,080 I WOULD LIKE TO MAKE A REQUEST 3368 02:11:00,080 --> 02:11:01,200 THAT WHEN THE CANCER CENTER 3369 02:11:01,200 --> 02:11:02,720 SUBCOMMITTEE PRESENTS THAT THEY 3370 02:11:02,720 --> 02:11:04,960 PROVIDE SOME DATA TO US AROUND 3371 02:11:04,960 --> 02:11:06,440 WHICH OF THE COMPREHENSIVE 3372 02:11:06,440 --> 02:11:08,000 CANCER CENTERS DO NOT ACCEPT 3373 02:11:08,000 --> 02:11:10,240 MEDICAID SO THAT MAYBE WE CAN 3374 02:11:10,240 --> 02:11:12,440 PROVIDE SOME STRATEGIES AROUND 3375 02:11:12,440 --> 02:11:15,600 WAYS TO RETHINK HOW WE ARE 3376 02:11:15,600 --> 02:11:17,720 THINKING ABOUT ACCESSING AND 3377 02:11:17,720 --> 02:11:21,120 SUPPORT AROUND RESEARCH AND 3378 02:11:21,120 --> 02:11:22,120 CLINICAL TRIAL ENGAGEMENT. 3379 02:11:22,120 --> 02:11:22,440 >> RETHINK. 3380 02:11:22,440 --> 02:11:23,920 OKAY, GREAT. 3381 02:11:23,920 --> 02:11:25,920 I'LL TAKE THE CHAIR'S 3382 02:11:25,920 --> 02:11:28,720 PREROGATIVE BEFORE MOVING TO 3383 02:11:28,720 --> 02:11:29,680 HOWARD, WHICH IS IT WOULD BE 3384 02:11:29,680 --> 02:11:32,120 GREAT TO SEE THE TRAJECTORY OF 3385 02:11:32,120 --> 02:11:36,680 THE NUMBER OF ESI SUBMISSIONS 3386 02:11:36,680 --> 02:11:39,880 AND ESI-FUNDED GRANTS OVER SOME 3387 02:11:39,880 --> 02:11:40,120 PERIOD. 3388 02:11:40,120 --> 02:11:41,640 PARTICULARLY AT LEAST ONE OR TWO 3389 02:11:41,640 --> 02:11:43,480 OF THE COVID YEARS. 3390 02:11:43,480 --> 02:11:46,480 JUST TO LOOK AT THE TRAJECTORY, 3391 02:11:46,480 --> 02:11:47,080 RIGHT? 3392 02:11:47,080 --> 02:11:49,600 OF ESI GRANT SUBMISSIONS AND 3393 02:11:49,600 --> 02:11:50,880 THOSE THAT ARE FUNDED, OVER 3394 02:11:50,880 --> 02:11:52,240 MAYBE FIVE OR TEN YEARS. 3395 02:11:52,240 --> 02:11:53,600 THAT WOULD BE I THINK REALLY 3396 02:11:53,600 --> 02:11:56,320 GREAT TO SEE. 3397 02:11:56,320 --> 02:11:58,640 3398 02:11:58,640 --> 02:12:02,360 3399 02:12:02,360 --> 02:12:02,840 HOWARD? 3400 02:12:02,840 --> 02:12:06,200 >> YEAH, THANK YOU. 3401 02:12:06,200 --> 02:12:07,080 3402 02:12:07,080 --> 02:12:07,200 3403 02:12:07,200 --> 02:12:13,240 I'D LIKE TO PROPOSE A TIMELY 3404 02:12:13,240 --> 02:12:15,400 PRESENTATION ABOUT THE CURRENT 3405 02:12:15,400 --> 02:12:20,080 STATUS AND PLANS OF 3406 02:12:20,080 --> 02:12:21,040 IMMUNO-ONCOLOGY BIOMARKERS. 3407 02:12:21,040 --> 02:12:26,640 I'M AWARE THAT SOME SENIOR STAFF 3408 02:12:26,640 --> 02:12:30,160 WORKING ON THIS AT NCI HAVE 3409 02:12:30,160 --> 02:12:32,960 ALREADY STARTED TO LEARN FROM 3410 02:12:32,960 --> 02:12:35,840 PAST MISTAKES AND PITFALLS WITH 3411 02:12:35,840 --> 02:12:38,760 BIOMARKERS, AND COULD PROBABLY 3412 02:12:38,760 --> 02:12:41,400 HELP US AVOID THE SAME GOING 3413 02:12:41,400 --> 02:12:42,960 FORWARD, IF WE, YOU KNOW, WE 3414 02:12:42,960 --> 02:12:46,280 DON'T WANT TO, YOU KNOW, LET 3415 02:12:46,280 --> 02:12:47,320 HISTORY REPEAT ITSELF. 3416 02:12:47,320 --> 02:12:49,480 WE'D RATHER LEARN FROM HISTORY I 3417 02:12:49,480 --> 02:12:49,720 THINK. 3418 02:12:49,720 --> 02:12:50,440 AND MOVE FORWARD. 3419 02:12:50,440 --> 02:12:54,320 AND I THINK IT WOULD BE TIMELY 3420 02:12:54,320 --> 02:12:57,120 AGAIN BECAUSE OF THIS TRAINING 3421 02:12:57,120 --> 02:12:59,040 WORK THAT'S GOING ON, AND WE ALL 3422 02:12:59,040 --> 02:13:02,280 I THINK AGREE, I HOPE WE AGREE, 3423 02:13:02,280 --> 02:13:07,600 THAT THE MAJOR INVESTMENTS BY 3424 02:13:07,600 --> 02:13:10,880 THE SIMACs AND MOONSHOT 3425 02:13:10,880 --> 02:13:12,640 PROGRAM, IMMUNO-ONCOLOGY 3426 02:13:12,640 --> 02:13:13,600 BIOMARKERS APPLICABLE TO 3427 02:13:13,600 --> 02:13:15,040 ENRICHMENT FOR CELL THERAPIES, 3428 02:13:15,040 --> 02:13:16,000 GENE THERAPIES, ET CETERA, ARE 3429 02:13:16,000 --> 02:13:16,400 THEY IMPORTANT. 3430 02:13:16,400 --> 02:13:19,760 WE WANT TO GET IT RIGHT. 3431 02:13:19,760 --> 02:13:24,360 AND ALSO MAYBE HELP INFLUENCE 3432 02:13:24,360 --> 02:13:25,920 GRANT APPLICATIONS GOING FORWARD 3433 02:13:25,920 --> 02:13:28,280 AND OUR EVALUATION OF GRANT 3434 02:13:28,280 --> 02:13:28,640 APPLICATIONS. 3435 02:13:28,640 --> 02:13:29,400 >> ABSOLUTELY. 3436 02:13:29,400 --> 02:13:33,400 IT'S A GREAT POINT. 3437 02:13:33,400 --> 02:13:34,680 SO, IMMUNOTHERAPEUTIC BIOMARKERS 3438 02:13:34,680 --> 02:13:37,760 AND WHAT'S HAPPENING INTERNALLY 3439 02:13:37,760 --> 02:13:40,280 AT THE NCI, AND SO IT'S GREAT. 3440 02:13:40,280 --> 02:13:42,760 THANKS, HOWARD. 3441 02:13:42,760 --> 02:13:43,120 FANTASTIC. 3442 02:13:43,120 --> 02:13:45,440 SO WE'RE RIGHT AT THE TOP OF THE 3443 02:13:45,440 --> 02:13:45,960 HOUR. 3444 02:13:45,960 --> 02:13:49,840 AND SO THIS WOULD CONCLUDE THE 3445 02:13:49,840 --> 02:13:51,360 OPEN SESSION OF THE NCAB 3446 02:13:51,360 --> 02:13:51,920 MEETING. 3447 02:13:51,920 --> 02:13:54,240 THERE WILL BE A 10-MINUTE BREAK, 3448 02:13:54,240 --> 02:13:56,360 ONLY BOARD MEMBERS AND 3449 02:13:56,360 --> 02:13:57,880 DESIGNATED NCI STAFF SHOULD 3450 02:13:57,880 --> 02:13:58,280 RETURN. 3451 02:13:58,280 --> 02:14:02,280 ALL SHOULD SIGN OFF THIS LINK 3452 02:14:02,280 --> 02:14:03,200 AND UTILIZE THE NEW WEB LINK FOR 3453 02:14:03,200 --> 02:14:04,240 THE CLOSED SESSION, WITHIN TEN 3454 02:14:04,240 --> 02:14:05,560 MINUTES. 3455 02:14:05,560 --> 02:14:06,080 THANK YOU ALL FOR ATTENDING 3456 02:14:06,080 --> 00:00:00,000 TODAY'S MEETING.